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ABSTRACT
1. Astrocyte-enriched cultures prepared from the neonatal
rat cerebral cortex were used to assess the effects of
putative mitogens on astroglial proliferation. Subconfluent
cultures, 11 div, were deprived of serum, thus halting cell
division, and then exposed to these agents. 10% v/v foetal
3calf serum elicited increases in [ H]thymidine incorporation 
into astrocyte DNA ranging from 245% to 434% over control.
3
Insulin elicited a dose-dependent increase in [ H]thymidine 
incorporation (EC^^ = 16y(MJml  ^). Platelet-derived growth 
factor and phosphatidic acid had a biphasic effect on
3
[ H]thymidine incorporation apparently due to the presence 
of high concentrations of their respective vehicles, 
ethanediol and CHCl^:MeOH (1:2 v/v), at the higher mitogen 
concentrations tested.
2. The effects of platelet-derived growth factor and
3
phosphatidic acid on [ H]thymidine incorporation were 
dependent upon the age of the cultures used. For example, 
at 5 div platelet-derived growth factor reduced 
incorporation whereas phosphatidic acid increased 
incorporation compared to control.
3. The phosphatidic acid mitogenic signal could be 
amplified from a 13% to 43% increase over control by 
increasing the time of serum depletion from 24h to 48h.
The mitogenic effect of phosphatidic acid was dependent upon 
the presence of long chain fatty acids.
4. Prolonged phorbol ester pretreatment, abolished the 
mitogenic action of phosphatidic acid on astrocytes and also 
reduced that of 10% v/v foetal calf serum by 41%.
5. In order to determine whether the mitogenic effects of 
phosphatidic acid involved phosphoinositide turnover
3
cultures prelabelled with [ H]inositol were exposed to 
phosphatidic acid and inositol phosphates accumulation and 
inositol phospholipid labelling monitored. Phosphatidic 
acid elicited a dose- and time-dependent increase in the 
accumulation of total and individual labelled inositol 
phosphates which was dependent upon a low extracellular 
calcium concentration and phosphatidic acid containing long 
chain fatty acids.
6. Phosphatidic acid stimulated changes in inositol 
phospholipid labelling and ^^Ca^^ efflux and both effects 
were dependent on phosphatidic acid containing long chain 
fatty acids.
7. Phosphatidic acid had no detectable effect on 
phosphoinositide turnover but did stimulate efflux 
from fibroblasts.
8. The possible release of phosphatidic acid from 
agonist-stimulated astrocytes was studied by exposing
3
[ H]arachidonic acid prelabelled cultures to carbachol, ATP 
and noradrenaline. All three agonists increased the 
formation of labelled phosphatidic acid but they did not 
evoke phosphatidic acid release from astrocytes.
9. R59 022, a diacylglycerol kinase inhibitor, inhibited
carbachol-stimulated phosphatidic acid production and ^^Ca^^ 
efflux but had no effect on carbachol-induced \
phosphoinositide turnover.
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CHAPTER 1 GENERAL INTRODUCTION
Over the last ten years it has become clear that the 
communication processes within the central nervous system 
(CNS) can no longer be thought of as comprising solely the 
electrically excitable neurons as the signal processors.
The CNS also contains non-excitable cells. The neuroglia 
constitute the largest group of these non-excitable cells, 
and are divided into macroglia and microglia. Microglia, 
unlike macroglia, are cells of non-neural origin. Macroglia 
can be further subdivided into the myelin-producing cells,
the oligodendrocytes, and the astrocytes. Astrocytes can be
)
classified depending upon their morphology as being either 
protoplasmic, mainly situated in the grey matter, or fibrous 
and located in the white matter. Much evidence has now 
emerged that points to glia, particularly astrocytes 
adopting a much more active role in CNS functions than was 
previously thought.
Astrocytes had been thought of as fulfilling a passive 
function by acting as a physical packing material located 
between neurons and the blood supply. In this location they 
contribute to the blood-brain barrier. The complex physical 
interactions of astrocytes with neurons and the 
microvasculature had hampered their study in vivo and it is 
only since the advent of techniques for the preparation, 
identification and maintenance in culture of pure or 
enriched populations of astrocytes that the study of the 
role of astrocytes in CNS function has been made possible. 
The ability to produce primary cultures of rat cerebral
1
astrœytes using, for example, the methods of Manthorpe et 
al (1979) or McCarthy and De Vellis (1980), and the 
identification of the astrocyte specific intermediate 
filament protein, glial fibrillary acidic protein (GFAP)
(Eng et al 1971) by immunohistochemistry has provided a 
convenient in vitro model for such study of astrocyte 
function.
The increased study of this particular cell type has 
resulted in the proposal of many more dynamic roles for 
astrocytes. It is now known that astrocytes provide a 
guidance system for correct axonal elongation to their 
target sites (Lauder and McCarthy 1986) and provide trophic 
factors for neuronal support, differentiation and the 
promotion of local neuritic outgrowth during development 
(Manthorpe et al 1986).
Astroglial cells are also involved in the induction of the 
blood-brain barrier. The endothelial cells of brain 
capillaries are different from those in the rest of the body 
in having tight junctions which make them impermeable to 
water-soluble substances. The capillaries in the brain are 
surrounded by astrocytic processes and it was thought that 
these formed the physical barrier. It is now known that the 
endothelial cells form the blood-brain barrier but that 
endothelial cell tight junction formation appears to be 
under the influence of astrocyte-derived factors (Arthur et 
al 1987; Janzer and Raff 1987; Tao-Cheng et al 1987).
The close physical association of astrocytes with neurons,
2
neuronal processes and the synaptic cleft has suggested that 
astrocytes may play a part in the process of 
neurotransmission. It is now widely accepted that the main 
method of inactivation of amino acid neurotransmitters is by 
reuptake after release. Astrocytes have been found to be 
involved in the inactivation at the synapse of the 
excitatory and inhibitory neurotransmitters glutamate and 
gamma amino butyric acid (GABA) respectively. Neuronally- 
released glutamate and GABA are taken up by astroglial high 
affinity uptake systems (Hertz and Schousboe 1986; Hosli et 
al 1986) and metabolised to glutamine by the astrocyte 
specific enzyme glutamine synthetase (Norenberg and 
Martinez-Hernandez 1979), which removes the toxic metabolite 
ammonia at the same time. Glutamine can then be used by 
neurons as the precursor for subsequent glutamate and GABA 
synthesis . The presence of high affinity uptake systems in 
primary cultures of astrocytes for catecholamine and 
serotonin neurotransmitters may also demonstrate the 
importance of astrocytes in monoamine neurotransmitter 
inactivation (Kimelberg 1986).
As well as their role in transmitter inactivation astrocytes 
have also been found to function in maintaining the ionic 
environment for the correct functioning of neurons. Excess 
extracellular ions produced by neuronal activity cause 
depolarisation of the glial cell membrane and ions are 
taken up by astrocytes (Gardner-Medwin 1985) possibly via 
channels localised in particular regions of the astrocyte 
membrane (Landis 1986). Astrocytes are also involved in the 
maintenance of the pH environment of neurons since other ion
3
transport systems also exist in the astrocyte membrane for 
the coupled transport-exchange of Na^ and ions as well as 
for the exchange of Cl and HCOg (Kimelberg and Ransom
1986).
The presence of receptors for a large number of neuroactive 
substances on astrocytes, for example, glutamatic acid and 
GABA (Bowman and Kimelberg 1984; Kettenman et al 1988), the 
amines 5-hydroxytryptamine (Whitaker-Amitia 1988) and 
noradrenaline (Hirata et al 1983; Cambray-Deakin 1985; 
Bockaert and Ebersolt 1988) as well as those for a number of 
neuroactive peptides (Van Calker and Hamprecht 1980; Wilkin 
and Cholewinski 1988), (for review see Murphy and Pearce
1987) has lent further weight to the idea that astrocytes 
are indeed capable of acting as targets for signal molecules 
released by neurons. These astroglial receptors are 
functional in that they have been found to be coupled to 
intracellular second messenger systems. A number of 
neuroactive substances have been found to be linked to the 
adenylate cyclase and guanylate cyclase signal transduction 
pathways in astrocytes ( for reviews see Van Calker and 
Hamprecht 1980; Hamprecht 1986), for example, astroglial^- 
adrenergic receptor activation increases the level of cAMP 
(McCarthy et al 1985). Astrocyte receptor activation has 
also been reported to be linked to phosphoinositide (PPI) 
turnover (Murphy and Pearce 1987; Pearce and Murphy 1988) 
with the subsequent mobilisation of cytosolic calcium (Ca^^ ) 
and protein kinase C (PKC) activation (Berridge 1984; 
Nishizuka 1986).
The physiological relevance of such receptors on astrocytes 
is an area of intense research. One question to be answered 
is whether the activation of these astroglial receptors 
allows the release of substances which in turn could 
modulate the activity of adjacent neurons or other cell 
types in the CNS, thus allowing a two-way communication 
process.
Kainic acid-induced release of the excitatory amino acids 
glutamic and aspartic acid from rat hippocampus astrocytes 
has been observed as well as the release of glutamine and 
the inhibitory neuromodulator taurine (Lehmann and Hansson 
1988). adrenergic receptor activation also releases 
taurine from cultures of astrocytes (Shain et al 1986) and 
Ca^^-dependent K^-stimulated taurine efflux has been 
demonstrated from rat cerebellar astrocytes (Philibert et al 
1988).
Eicosanoid production and release by astrocytes has been 
demonstrated (Keller et al 1985; Murphy et al 1985; Jeremy 
et al 1987; Keller et al 1987; Murphy et al 1988) and this 
has recently been seen in response to -purinergic receptor
stimulation (Murphy and Pearce 1988b). Astroglial 
muscarinic cholinergic receptor activation has been found to 
produce an increase in a lipoxygenase metabolite (De George 
et al 1986b), These arachidonic acid metabolites may 
influence not only surrounding neurons but the cells of the 
adjacent microvasculature as well.
Astrocytes are the predominant glycogen store in the CNS
5
(Phelps 1972) and have been thought of as performing a 
nutritive role in relation to neurons. Ordinarily the blood 
supply to the CNS is thought to provide adequate supplies of 
glucose for all CNS functions but under conditions when 
the localised glucose supply may be inadequate, for example, 
during periods of intense neuronal activity, glucose can be 
released from astrocytes for use by neurons. Changes in 
extracellular concentration as well as neurotransmitter 
levels can signal neuronal activity to the surrounding 
astrocytes (Pentreath 1982; Cambray-Deakin et al 1988a; 
1988b).
The CNS had been thought of as being insulated from the 
effects of the immune system. However, the ability of 
astrocytes to act as antigen-presenting cells and as 
producers of substances which regulate the activities of 
cells involved in the immune response, for example, primary 
cultures of astrocytes have been found to produce and 
release the leukotriene C^ (Hartung and Toyka 1987), has 
again highlighted the astrocyte's ability to interact with 
other cell types (for review see Fierz and Fontana 1986).
A long established characteristic of astrocytes has been 
their ability to increase in size and number in response to 
CNS injury, this process being known as reactive gliosis. 
Proliferating astrocytes are observed during the pre- and 
postnatal period of life but the number of proliferating 
cells decreases with increasing age (Korr 1986). This 
proliferation of astrocytes after CNS trauma has been 
assumed to be the reason for the lack of regeneration of the
6
adult mammalian CNS (Lindsay 1986 ). Whether mature neurons 
lack the ability to regenerate or the inability to 
regenerate is due to the intervention of astrocytes either 
by direct means, by formation of a physical barrier to 
axonal elongation, a glial scar, or indirect means due to 
the lack of neuronotrophic factors and guidance cues is 
unknown. The formation of a glial scar as a physical 
barrier to axonal elongation to prevent regeneration is now 
thought to be a very simplistic explanation in view of the 
much more dynamic role envisaged for astrocytes within the 
CNS (Reier 1986). The signals involved in initiating the 
response of reactive gliosis are not known but in view of 
the importance of post-trauma proliferation of astrocytes in 
the CNS factors involved in astroglial proliferation 
certainly warrant investigation.
Thus the aim of this project was to study the proliferation 
of rat cortical astrocytes in primary cultures in response 
to the well-characterised growth factors, insulin and 
platelet-derived growth factor (PDGF) and the less well- 
characterised mitogen phosphatidic acid (PA) (Chapter 2). 
Astroglial proliferation was monitored by using
O
[ H]thymidine incorporation into astrocyte DNA and increased 
DNA content as measures of DNA synthesis.
Some proliferative agents have been reported to utilise PPI 
turnover to bring about their growth factor action. In 
Chapter 3 investigations were undertaken to determine 
whether the growth factor-like action of PA on astrocytes 
involved PPI breakdown and calcium mobilisation. The
7
possible involvement of PA as an intracellular signalling 
molecule in agonist-stimulated PPI metabolism was considered 
in Chapter 4 by performing experiments employing an 
inhibitor of PA production.
This thesis contains three results chapters, each with their 
own introduction, methods and materials, results and 
discussion sections. A summary of the general conclusions 
of the results obtained is given in Chapter 5 together with 
a discussion of the intracellular function of PA in view of 
the results obtained in this study and the evidence that is 
accumulating concerning PA as an intracellular messenger 
molecule.
CHAPTER 2 THE EFFECT OF VARIOUS SUBSTANCES ON ASTROCYTE 
PROLIFERATION
2.1. INTRODUCTION
The control of neuronal and glial cell division plays an 
important role in the correct development of the nervous 
system. The close physical association of neurons and 
astrocytes in the CNS has prompted the question of whether 
the development of these two cell types is interdependent. 
Consequently, studies of the ways in which these two cell 
types communicate with each other may shed light on the 
relative importance of one cell type to the correct growth 
and development of the other (for reviews see Lauder and 
McCarthy 1986; Manthorpe et al 1986).
A number of different types of communication are involved 
and these can be broadly grouped into either signals from 
the extracellular environment or those involving direct 
cell-cell communication. Agents present in the 
extracellular environment, whether produced at a distance 
from the target cell or by cells adjacent to the target 
cell, can act to induce or inhibit the growth and/or 
differentiation of that target cell (Manthorpe et al 1986). 
Such extracellular agents can also act as chemotactic agents 
involved in cell migration (Dressier et al 1985). Direct 
cell-cell communication can occur via specialised areas of 
contact, for example, gap junctions or coated vesicles 
(Hatten et al 1984). Cells are also capable of recognising 
other cells due to the presence of specific cell surface
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glycoproteins, for example, neuronal cell adhesion moleceule 
and neuron-glia cell adhedsion molecule (Bunge and Waksman 
1985 ). These molecules are involved in regulating correct 
cellular organisation. Components of the extracellular 
matrix such as laminin, fibronectin, collagens and 
proteoglycans may also be involved in determining the 
correct interactions between neuronal and non-neuronal cell 
types during development (Hatten et al 1985; Kleinman et al 
1981).
Much interest has focused on the extracellular agents that 
have been found to affect cell growth. The term growth 
factor is used to describe polypeptide hormones that affect 
cell growth. Much evidence about growth factors has come 
from work on cultured murine 3T3 cell lines (Rozengurt 
1986). Extracellular growth factors bring about their 
physiological action by binding to specific high affinity 
receptors on their target cell. There are two broad groups 
of growth factor receptors. One group of growth factors 
have been found to activate protein tyrosine kinase located 
in the cytoplasmic domain of their receptor causing the 
redistribution and endocytosis of the receptor (for review 
see Hunter and Cooper 1985). This activation brings about 
the phosphorylation of the receptor itself and may be 
accompanied by the phosphorylation of specific proteins 
which can then function as intracellular mitogenic signals. 
Examples of growth factor receptors which possess this 
protein tyrosine kinase activty include the receptors for 
epidermal growth factor (EGF) (Ushiro and Cohen 1980), 
insulin (Goldfine 1987), insulin-like growth factor I (IGF
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I) (L'Allemain and Poussegur 1986) and PDGF (Ek et al 1982; 
Bishop 1985; Rozengurt 1986; Yarden et al 1986). The other 
group of growth factors interact with receptors which do not 
possess this intrinsic protein tyrosine kinase activity. 
Members of this group of growth factors include bombesin, 
bradykinin, vasopressin and oC-thrombin and the receptors for 
these factors are thought to couple to GTP-binding proteins 
(L'Allemain et al 1986; Chambard et al 1987). The coupling 
of these receptors to a GTP-binding protein (Bourne 1986) 
activates the hydrolysis of the phosphoinositide 
phosphatidylinositol 4,5-bisphosphate (Ptdlns(4,5 )P2 ) by 
phospholipase C (PL C). The resultant mobilisation of 
intracellular calcium (Ca^\ ) and the activation of PK C are 
thought to bring about the physiological actions of these 
growth factors (Michel1 1982; Whitman and Cantley 1988). PPI 
hydrolysis has been shown to play an important part in the 
regulation of cell proliferation (Berridge 1987b; Nishizuka
1988).
The observation that certain growth factors exhibit 
synergism has supported the idea that they may operate 
through the separate signal transduction pathways outlined 
above. Growth factors have been separated into either 
competence or progression factors based on which pathway 
they employ (Murayama and Ui 1987b). Bradykinin, fibroblast 
growth factor (FGF), PDGF, thrombin and vasopressin 
(Habenicht et al 1981; Berridge et al 1984) have been 
classified as competence factors since they allow the 
initiation of DNA synthesis by the progression factors EGF 
or insulin. Progression factors activate the protein
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tyrosine kinase activity of their own receptors (Macara
1985). The signals elicited by growth factors have also 
been classified by Rozengurt (1986) into two categories: 
either regulatory signals or obligatory events. The 
regulatory signals mediate the action of specific growth- 
promoting agents, whereas obligatory events are those that 
must take place for DNA synthesis and cell division to 
occur. PDGF, which has been classified as a competence 
factor by Murayama and Ui (1987b), can, in contrast to other 
competence factors, stimulate DNA synthesis and cell 
division in Swiss 3T3 cells in the absence of any other 
factor (Rozengurt 1986). PDGF has been reported to 
stimulate PPI turnover (Habenicht et al 1981) and the PDGF 
receptor possesses protein tyrosine kinase activity (Ek et 
al 1982).
Competence factors stimulate a complex array of early 
biochemical events. The activation of receptors for 
competence factors leads to the hydrolysis of the inositol 
lipid PtdIns(4 ,5 )P2 by PL C which yields the two 
intracellular second messengers, diacylglycerol (DG) and 
inositol 1,4,5-trisphosphate (Ins(1,4,5)P^) (Berridge and 
Irvine 1984). DG activation of PKC (Nishizuka 1986) leads 
to phosphorylation and thus activation of the Na^/H^ 
antiporter (Moolenaar et al 1984a) which increases the 
efflux of H^ and the influx of Na^ causing intracellular 
alkalinisation (Moolenaar et al 1983). Increased 
intracellular pH (pH^ ) appears to be a necessary step in the 
initiation of DNA synthesis (Moolenaar 1986). As well as 
increases in h’*’ and Na"*" flux across the plasma membrane an
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increase is also seen in Ca^^ efflux (Berridge et al 1984). 
This increase in efflux, which occurs in the absence of 
extracellular Ca^ ^, is thought to result from an increase in 
the intracellular Ca^^ concentration ([Ca^^]^) (Moolenaar et 
al 1984b). Ca"*"^ is mobilised from intracellular stores by
the action of Ins(1,4,5)Pg (Streb et al 1983). These 
increases in pH^ and [Ca++]^ appear to be obligatory steps 
in the initiation of DNA synthesis and represent a common 
sequence of signals in response to mitogenic stimulation 
(Hesketh et al 1985).
Genes involved in the regulation of the signal transduction 
pathways that are required for normal cell proliferation are 
commonly subverted in the oncogenic, cancer-forming process 
(Bishop 1987). Proto-oncogene products acquire cell 
transforming properties as a result of mutations that 
convert proto-oncogenes to oncogenes. Evidence about the 
signal transduction pathways used by growth factors in the 
control of normal cell growth has come from the study of 
such oncogene products (Berridge 1986). Oncogene products 
can reduce or eliminate a cell's requirements for the 
extracellular growth factors that are usually required to 
initiate proliferation, thus leading to uncontrolled growth. 
Oncogene products may mimick regulatory signals at a number 
of steps in mitogenic signal transduction pathways.
Oncogene products have been found to be homologous to growth 
factors and growth factor receptors, for example, the 
product of the v-sis oncogene is homologous to the B chain 
of PDGF (Waterfield et al 1983) and that of the v-erb B 
oncogene is a truncated EGF receptor (Downward et al 1984).
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The abl, ros and src oncogene products have been found to 
have protein tyrosine kinase activity (Hunter and Cooper 
1985; Bishop 1985) and that of ras exhibits GTPase activty 
(McGrath et al 1984). The myc and fos oncogenes are thought 
to code for proteins which function within the nucleus 
(Kelly et al 1983; Kruijer et al 1984). The effect of 
oncogene transformation on PPI turnover has provided 
evidence for an association between mitogenesis and PPI 
metabolism. For example, microinjection of transforming 
protein H-ras into Xenopus oocytes affects the enzymes of 
PPI breakdown whereas the normal protein has no detectable 
effect (Lacal et al 1987). All these different stages in 
the signal transduction pathway obviously have an important 
part to play in the control of normal cell growth.
Astrocytes have been shown to produce neuronotrophic agents, 
that is, agents that are required for the growth and 
survival of neurons, as well as agents that stimulate 
neuritic extension, neurite promoting factors (Manthorpe et 
al 1986). Astroglial cells grown in culture have been 
reported to produce a trophic factor which is involved in 
the expression of choline acetyltransferase activity by 
cholinergic neurons from the septal-diagonal band brain 
region of the 17 day old embryonic rat (Seaton et al 1988). 
They have also been reported to be a source of brain-derived 
basic fibroblast growth factor (bFGF) (Ferrara et al 1988) 
which has been shown to support the survival and elaboration 
of neurites of cerebral cortical neurons (Morrison et al
1986).
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Astroglia are also involved in determining the structural 
organisation of the brain. During embryogenesis radial glia 
provide the structural framework for the migration of 
granule cells in the cerebellum (Mason et al 1988). At 
later periods in brain development astroglia secrete 
extracellular matrix components which are thought to promote 
selective axonal growth (Bunge and Waksman 1985).
As well as a role in neuronal survival and growth during 
development, astroglial cells are also involved in the 
response of the CNS to injury. At the site of injury an 
increase in the size and^number of astrocytes occurs leading 
to the formation of a glial scar. This gliosis is 
accompanied by a change in astrocyte morphology from the 
polygonal protoplasmic astrocyte to the fibrous appearance 
of the reactive astrocyte (Nathaniel and Nathaniel 1981). 
Following injury the axons of the adult mammalian CNS do not 
regenerate well, if at all. Astrocytes may be responsible 
for this lack of regeneration by their proliferation to form 
a glial scar which then acts as a physical barrier to 
neurite growth (Nieto-Sampedro et al 1985; Lindsay 1986). 
Axonal and myelin degradation may also have a role to play 
in the control of glial proliferation (Politis and Miller 
1988). The stimuli involved in switching on this reactive 
gliosis are unknown. However, the presence of EGF, FGF, 
insulin, IGF I, insulin-like growth factor II (IGF II), 
nerve growth factor (NGF) and PDGF, in the brain (Herschmann 
1986 ) has prompted questions about their physiological role 
in the development, maintenance and function of the CNS. 
Further evidence of a role for growth factor action in the
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CNS comes from in vivo brain injury studies in which 
increased EGF receptor immunoreactivity has been seen in 
reactive astrocytes adjacent to the site of injury (Nieto- 
Sampedro et al). Another interesting question is whether 
these growth factors could also act as regulators of 
astroglial function, particularly in reactive gliosis.
The action of a variety of agents on astrocyte proliferation 
has already been investigated and a summary of these results 
is presented in Table 2.1. Growth factors which have been 
shown to increase the proliferation or differentiation of 
astroglial cells include astroglial growth factor 1 and 2 
(AGF 1 and 2), chick brain-derived growth factor (CBGF), 
foetal calf serum (FCS), glial growth factor (GGF), glial 
maturation factor (GMF), glial stimulating factor (GSF), IGF
1 and II, interleukin 1 (IL 1) and human placental-derived 
mitogenic factor (hPDMF). Contradictory results have been 
obtained for the effects of EGF, FGF, insulin and PDGF on 
astroglial proliferation. Differences in the astroglial 
proliferative response may be dependent on the type of cell 
preparation investigated. Other agents reported to 
stimulate proliferation in astroglial cells are carbachol, 
fibronectin, the ganglioside GM 1, hydrocortisone, the 
phorbol ester phorbol 12-myristate 13-acetate (PMA), the 
phospholipid PA, the prostaglandin ' putrescine
and thrombin. Bradykinin, dibutyryl cyclic AMP, interleukin
2 (IL 2), myelin basic protein, NGF and vasopressin were 
shown to have no effect on astroglial proliferation.
Collagen I and IV, glial-conditioned medium and heparin were 
found to have inhibitory effects on the proliferation of
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Table 2.1. The effects of various agents on astroglial cell 
proliferation.
Agent Cell Type
Foetal brain Astroglial Cerebellar Cerebral 
cells cells * astrocytes astrocytes
AGF 1 
AGF 2 
CBGF 
EGF
FGF
GGF
GMF
GSF
Insulin
IGF I 
IGF II 
NGF 
PDGF
17
17
17
34
34
,13,19
.31
34
26,34
18
15
15
18
6,14,16
15
28
28
.3,32
_29
4,21,22,
23,27,28,29
21,22,24
'3,29
15
hPDMF 
FCS 
IL 1 
IL 2
34
20
15 3,8,24,33
11,25
17
Table 2.1. continued,
Agent Cell Type
Foetal brain Astroglial Cerebellar Cerebral 
cells cells * astrocytes astrocytes
34
X
+5,34
X
12
12
33
X
30
21,22
_8
Brady­
kinin
2
Carbachol +
Collagen 
I & IV
dibutyryl 
CAMP
Fibro­
nectin
Glial condi­
tioned medium
GM 1
Heparin
Hydrocor­
tisone
Myelin basic 
protein
PMA
PA
PGF2%C
Putre­
scine
Thrombin
Vaso­
pressin
* Astroglial cells refers to astrocytes obtained from corpus
callosum or whole brain. + stimulates proliferation, - no
effect on proliferation, x inhibits proliferation.
18
24
23
21,22
21,22
27
8
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astroglial cells. The proliferation of astroglial cells 
therefore seems to be subject to regulation by a very wide 
variety of mitogenic agents.
The effects of some of the growth promoting agents outlined 
in Table 2.1. on neuronal cells as well as non-neuronal 
cells have also been studied and differences in their 
effects on these two cell types are seen. Although 
conflicting reports appear in the literature about the 
effect of EGF and FGF on astroglial proliferation, EGF has 
been shown to have no effect on oligodendrocyte or neuronal 
proliferation (Leutz and Schachner 1981) but FGF has been 
reported to stimulate both oligodendrocyte and neuronal 
proliferation (Morrison et al 1986; Perraud et al 1987).
GGF has been shown to be an astroglial but not an 
oligodendrocyte mitogen (Brockes et al 1980) and hPDMF acts 
on astrocytes but not neurons (Mercanti et al 1987). PDGF's 
mitogenic activity also extends to oligodendrocytes (Besnard 
et al 1987) but it does not appear to have any effect on 
neuronal proliferation (Morrison et al 1986; Besnard et al
1987). Thrombin has been identified as a potent astrocyte 
mitogen but oligodendrocytes and neurons are unresponsive 
(Morrison et al 1986; Perraud et al 1987). More than a 
single growth factor is obviously involved in the growth and 
development of the CNS but little is yet known about the 
importance of such differential effects of these growth 
promoting agents on non—neuronal and neuronal cells.
Interplay also occurs between different cell types in the 
CNS. Forebrain neurons were found to enhance the
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differentiation of astrocytes from different brain regions 
to different extents. This effect was found to be dependent 
on both trophic factors (Hunt et al 1987) and direct contact 
with the nerve cell matrix (Hayashi et al 1988). However, 
in another study (Hatten and Selanski 1988) cerebellar 
granule neurons were found to inhibit the proliferation of 
astrocytoma and cerebellar astroglial cells. Brain 
fibroblasts have also been found to enhance glial cell 
(Estin and Vernadakis 1986) and neuroblast proliferation 
(Gensburger et al 1986). The relative importance of these 
interactions between different cell types in the CNS is 
unknown but all contribute to the correct growth and 
development of the CNS.
The signal transduction mechanisms utilised by the growth 
factors reported to affect astroglial proliferation are now 
beginning to be studied, but more information is available 
from experiments performed on other types of cells. As can 
be seen from Table 2.2. EGF, FGF, insulin, IGF I and PDGF 
have all been found to activate protein tyrosine kinase in a 
variety of different cell types, including fibroblasts and 
glia. Contradictory results have been obtained for the 
effect of EGF and insulin on PPI turnover perhaps indicating 
the existence of receptor subtypes that are linked to 
different signal transduction pathways in different cells. 
EGF stimulated PPI turnover in A431 human carcinoma cells 
but had no effect on 3T3 fibroblasts. Insulin had no effect 
on PPI turnover in isolated fat cells and BC3H-1 myocytes 
but DG production and PKC activation have been implicated in 
its action on BC3H-1 myocytes. Activation of PPI turnover
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Table 2.2. The mechanism of action of a number of growth 
promoting agents
Agent Kinase activation Phosphoinositide
Tyrosine kinase Protein kinase C turnover
EGF
FGF
Insulin
IGF I
PDGF
Phorbol
ester
12,28,29
^12,14,29
^12,26,29
+8,12,29
25
PA ?
Serum ?
Bradykinin ?
Thrombin ?
Vasopressin ?
18,19
3,13
17
18,27
7
18,19
4,18,20
21
18,19
22
16,18
13,18
3,13,15
;ii
.17,23
24,27
"9
10
10
21
15,21
1,2,6,11
1,2
1,2,6
+ activation, - no activation, ? response not known
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is not seen in response to FGF. Whereas bradykinin, PA,
PDGF, serum, thrombin and vasopressin have been reported to 
activate PPI turnover. Studies on astrocyte cultures have 
shown that bradykinin and vasopressin (Cholewinski and 
Wilkin 1988) as well as PA (Murphy and Pearce 1988a) induce 
PPI turnover. EGF and insulin have no effect on PPI 
turnover in astrocytoma cells or astrocytes (Blackshear et 
al 1987; Pearce et al unpubl.).
Primary cultures of rat neonatal cortical astrocytes provide 
a useful model for the investigation of the proliferative 
action of various agents. A cell population enriched in 
astroglial cells is obtained by mechanical and enzymatic 
dissociation of rat neonatal cerebral cortices. Such 
primary cultures produce sufficient material to allow 
biochemical investigations to be carried out. Using the 
0q H  culture method outlined in the Methods and Materials 
section of this chapter confluent astrocyte-enriched 
cultures are obtained by 18 days in vitro (div). In order 
to assess the proliferative action of a number of growth 
factors, younger cultures, that are still capable of 
proliferating, are required. Consequently, subconfluent 
cultures grown for 11 div were used. Astrocytes in vitro 
are randomly distributed with respect to their position in 
the cell cycle. Synchronisation of these cells allows an 
amplification of the response to specific growth factors 
because a larger proportion of the cells are then in the 
same phase of the cell cycle. By reducing the serum content 
of the growth medium a quiescent state can be achieved, 
where growth of the cells is arrested but they are still
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viable. The cells can then be stimulated to re-enter the 
cell cycle by re-addition of serum or other growth factors. 
This synchronisation technique has provided a sensitive 
method for the identification of glial mitogens (Nieto- 
Sampedro et al 1985; Langan and Volpe 1986; Murphy et al 
1987; Kniss and Burry 1988).
In the remainder of this chapter I shall present evidence to 
show that:
(i) Insulin, PDGF and PA stimulated cerebral astrocyte 
proliferation as measured by [^ h]thymidine incorporation 
into DNA.
(ii) The proliferative action of PDGF and PA differed with 
the age of cerebral astrocytes in culture.
(iii) The effect of PA on cerebral astrocyte proliferation 
was dependent on PA containing long chain fatty acids.
(iv) Phorbol ester pretreatment abolished the proliferative 
action of PA and reduced that of FCS on cerebral astrocytes.
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2.2 METHODS AND MATERIALS
2.2.1. Astrocyte Cell Culture.
j\strocyte-enriched primary cultures from neonatal rat 
cerebral cortex were prepared essentially according to the 
method of Dutton et al (1981). The brains of 1 or 2 day old 
rat pups were removed and the cerebral cortices detached 
from the hind brain and the underlying structures. The 
cortices were then thoroughly cleaned of meninges and 
chopped at 40CJam intervals with two passes at right angles 
to each other using a Mcllwain tissue chopper. The tissue 
was enzymatically dissociated by suspension in a trypsin 
solution (250 /<gml"^) made up in disaggregation medium of 
the following composition: glucose 14 mM, bovine serum 
albumin (BSA) 3 mgml"^ and MgS0^.7H^0 1.5 mM in Ca - and 
Mg++-free Earles balanced salt solution. The suspension was 
transferred to a trypsinization flask and incubated in a 
shaking water bath at 37°C for 15 minutes. A solution 
containing trypsin inhibitor (192/igml )^, DNase (6.4//gml 
4) and MgS0^.7H^0 (240/AM) in disaggregation medium was 
then added and the resulting suspension transferred to 
plastic tubes and centrifuged at 200g for 5 seconds. The 
supernatant was removed and the cell pellet resuspended in a 
solution containing trypsin inhibitor (1.2 mgml ), DNase 
(40/gml"^) and MgS0^.7H^0 (1.5 mM) in disaggregation
medium.
The cells were then mechanically dissociated by trituration 
through a 1.5mm diameter stainless steel cannula. The
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resulting cell suspension was underlaid with a 4% w/v BSA 
solution and the intact cells were pelleted through the BSA 
underlay by centrifugation at 200g for 5 minutes. The 
supernatant and the BSA underlay, which contained cell 
debris, were removed and the cell pellet resuspended in a 
small volume of growth medium (Q^ ) of the following 
composition: Eagles Minimal Essential Medium containing 
Earles salts (glutamine-free) supplemented with FCS 10% v/v, 
glutamine 2 mM, glucose 33 mM and gentamycin sulphate 65 
/cgml’  ^(10% v/v FCS GM). The number of cells in the 
suspension was determined by diluting 20/Æ of suspension in 
20ml Isoton buffer and counting 0.5ml samples of this 
suspension using a Coulter counter (Coulter Electronics 
Ltd. ) with a 140/m aperture. The cell suspension was then 
appropriately diluted with 10% v/v FCS GM to give a seeding 
density of 100 cells mm"^. Cells were then seeded onto 
poly-D-lysine-coated (50/*gml ^) 60mm. diameter dishes, 6 
well plates (35mm. diameter) or 24 well plates (15mm. 
diameter). The cells were grown in a humid, 5% CO^ / 95% 
air atmosphere at 37°C and the medium was renewed every 3 or 
4 days. Confluent cultures are obtained by 18 div. 
Subconfluent cultures were used at 11 div.
Comprehensive characterisation of these astrocyte-enriched 
cultures has been carried out in this laboratory by Cambray- 
Deakin (Ph.D. thesis. Open University) and Murphy (unpubl.). 
Using indirect immunofluorescence the prominent cell type in 
these cultures was found to be labelled by antibodies to the 
astrocyte specific marker glial fibrillary acidic protein 
(GFAP). The majority of these GFAP+ cells were of a
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flattened, polygonal morphology, that is. Type I astrocytes 
(Temple and Raff 1985). Very few process-possessing 
astrocytes. Type II cells, were seen. These cultures were 
not labelled by antibodies to neurofilament protein or 
galactocerebroside indicating the absence of neuronal and 
oligodendroglial cells. Cells labelled with antibodies to 
fibronectin (FN+) were seen indicating the presence of 
fibroblasts. These fibroblasts were found to be of 
meningeal origin and good removal of the meninges was 
essential to reduce meningeal fibroblast contamination of 
the astrocyte-enriched cultures. The amount of FN+ cells 
present did vary from batch to batch of astrocyte-enriched 
cultures but routinely constituted only 5-10 % of the cells 
present. To control for the contamination of these 
astrocyte-enriched cultures by fibroblasts, meningeal 
fibroblast cultures were prepared (for culture method see 
Chapter 3 section 3.2.5.). These meningeal cultures 
contained densely-packed, multi-layered, columnar cells. In 
some studies their response was compared to that of 
astrocyte-enriched cultures. The nature of these astrocyte- 
enriched cultures must be borne in mind when discussing 
studies using these preparations. However, they do provide 
a source of a sufficient quantity of an enriched population 
of astrocytes for biochemiacl analysis in which the major 
contaminating cell tyupe has been identified and whose 
presence can be controlled for.
Examination of the astrocyte-enriched cultures by phase 
contrast microscopy showed the presence of round, phase 
bright cells on top of the astrocyte layer. The
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phagocytosis of Indian ink by these cells identified them as 
macrophages. The macrophage content of these cultures also 
varied, increasing with time in culture, but these 
macrophages were easily removed from the astrocyte layer by 
thorough washing.
A sample from each batch of cultures was examined by phase 
contrast microscopy prior to experimentation to check the 
state of the astrocyte layer and to estimate whether there 
was gross fibroblast contamination.
2.2.2. Assessment of astrocyte proliferation in response to 
a number of growth factors.
2 .2 .2 .1 . [^ H]Thymidine incorporation,
The proliferative action of various agents was determined by 
measuring [^H]thymidine incorporation into these primary 
cultures of astrocytes. [^H]Thymidine is nearly exclusively 
incorporated into the DNA of cells which are in S phase of 
the cell cycle, that is, DNA synthesis is occurring at the 
time of [^H]thymidine application. DNA turnover in the 
course of DNA repair also incorporates [ H] thymidine but the 
rate of incorporation is much lower than in dividing cells 
(Korr 1986). [^H]Thymidine incorporation is therefore
interpreted as labelling in the course of DNA synthesis 
preparing for cell division, that is, labelling of a 
proliferating cell.
Quiescent astrocytes were obtained by depleting astrocytes
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of serum for 24h. The astrocytes were grown in 24 well 
plates for 11 div. Serum depletion was carried out by 
rinsing the cultures with growth medium without PCS (GM-FCS) 
and then incubating them in fresh GM-FCS for 24 hours at 
37°C in a 5% CO^ / 95% air atmosphere. The depletion medium 
was then removed, the cells rinsed and fresh GM-FCS added to 
which the appropriate growth factor was added. The cultures 
were then incubated for 24 or 48h. In each experiment two 
controls were also performed. After serum depletion some 
cells had fresh GM-FCS only added to them. These controls 
were performed to determine the basal level of methy1- 
[^H]thymidine incorporation into DNA in the absence of any 
added growth factor. Another set of cells had 10% v/v PCS 
GM added backed to them to assess their response to serum, a 
potent mitogen for astrocytes. The inclusion of these 
controls allowed the comparison of results from different 
batches of astrocytes. A summary of the experimental 
protocol followed is shown in Figure 2.1.
DNA synthesis by these cultures was then monitored by the 
incorporation of methyl-[^H]thymidine essentially according 
to the method described by Murphy et al (1987). The 
exposure medium was removed, the cells rinsed with GM-FCS 
and fresh GM-FCS supplemented with l/iC± of methyl- 
[^H]thymidine was added to each well and after 2 hours 
incubation the labelled medium removed. The cells were 
washed with physiological salt solution (PSS) of the 
following composition : NaCl 116 mM, NaHCO^ 26 mM, glucose 
20 mM, KCl 2.5 mM, MgS0^.7H^0 1.5 mM, NaH^P0^.2H2 0 1 mM and 
phenol red 10 mg/500ml pre-gassed with 5% CO^ / 95% air.
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Figure 2.1. Summary of experimental protocol for 
assessment of growth factor-induced
q
[H]thymidine incorporation into astrocyte- 
enriched cultures.
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FIG. 2.1
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After washing the cells were solubilised in 50(y%l O.IM NaOH. 
The cells were scraped from the wells after 10 to 15 minutes 
and transferred to eppendorf tubes. BSA (250y^ Xg/well) was 
added as a carrier and protein precipitated with 1 0% w/v 
trichloroacetic acid (TCA). After 10 minutes at 4°C, the 
precipitated protein was pelleted by centrifugation at 
l,200g for 10 minutes. After two more washes with TCA the 
protein pellets were solubilised overnight with 250^ 
Protosol. The Protosol suspension was then neutralised with 
25C^ 2M HCl to reduce chemiluminescence and 8ml of the 
toluene-based scintillant Cocktail T added. After mixing, 
the [^H]thymidine content of each sample was assessed by 
liquid scintillation counting.
2.2.2.2. DNA content
The proliferative action of PA on astrocyte-enriched
cultures was also assessed by measuring the DNA content of
treated cultures using the fluorochrome Hoechst 33258,
( 2- [2- ( 4 -hydroxyphenyl) -6-benzimidazolyl] -6- ( 1 -methyl-4-
piperazyl)-benzimidazol.3HC1) (also known as bis-
benzimidazole) essentially according to the method of
Labarca and Paigen (1980). This method is simple, rapid and
3convenient compared to the time-consuming [ H]thymidine 
incorporation technique. Hoechst 33258 binds specifically 
to DNA. These experiments were carried out essentially as 
described for the [^H]thymidine incorporation experiments, 
except that cultures were grown in 6 well plates for 1 0 , 11 
or 12 div. Serum depletion was carried out by incubation in 
GM containing 0.1% v/v PCS instead of GM-FCS because longer
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depletion times of 48h and 72h were used as well as 24h. 
Cells were then exposed for 48h to either 0.1% v/v PCS GM, 
10% v/v PCS GM or 0.1% v/v PCS GM and PA at the appropriate 
concentration. A summary of the experimental protocol used 
is shown in Figure 2.2.
After rinsing twice with PSS, 1ml of deionised was added 
to each well. The cells were then frozen and thawed and the 
DNA content of the resulting cell suspension determined. An 
aliquot of cell suspension in 1ml of H^O was added to 1ml of 
DNA assay buffer which contained 2 /fgml  ^Hoechst 33258, 4M 
NaCl in O.IM sodium phosphate buffer pH7.4, giving a final 
Hoechst 33258 concentration of IjJgml ^. Hoechst 33258 gains 
access to the DNA once the chromatin has been dissociated by 
the presence of the high salt concentration and maximum 
enhancement of fluorescence is seen at pH 7.4. After 
thorough mixing the fluorescence of the sample was 
determined using an excitation wavelength of 356nm, an 
emission wavelength of 492nm and a slit width of 5nm. The 
fluorescence obtained was compared to that obtained for a 
standard DNA solution from calf thymus. The fluorescence of 
a reagent blank containing 1ml H2O and 1ml DNA assay buffer 
was determined. The fluorescence of the challenge compounds 
and the PSS washes was also checked to see if they 
interfered with the DNA assay.
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Figure 2.2. Summary of experimental protocol for assessment 
of growth factor action on DNA content of 
astrocyte-enriched cultures.
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2.2.2.3. Phorbol ester pretreatment
Tumour-promoting phorbol esters are capable of mimicking 
some of the effects of DG on PKC (Ashendel 1985). The 
phorbol ester 12-0-tetradecanoyl-phorbol-13-acetate (TPA) 
has been shown to activate PKC directly without activating 
PPI turnover (Castagna et al 1982). In astrocytes, the 
proliferative action of the phorbol ester PMA suggests a 
role for PKC activation in the control of glial cell growth 
(Murphy et al 1987; Bhat 1989).
The contribution made by PKC activation to the mitogenic 
action of PA on astrocytes was assessed by treating 
astrocyte-enriched cultures with the phorbol ester 
PMA, and comparing the effect of PA on treated and untreated 
cells. Phorbol ester pretreatment was carried out by 
incubating subconfluent cultures (11 div) with lyiiM'PMA in 
0.1% v/v PCS GM for 6h essentially according to the method 
of McCardle et al (1987). After removing the PMA medium, 
the cells were rinsed and incubated for a further 42h in 
0.1% v/v PCS GM. Untreated cultures were incubated in 0.1% 
v/v PCS GM only for 48h. This PMA pre - treatment has been 
shown by other workers in this laboratory to reduce 
astrocyte PKC activity by almost 95% for up to at least 96h 
after treatment (Murphy and Pearce 1988a). Treated and 
untreated cells were then exposed for 48h to either 0.1% v/v 
PCS GM, 10% v/v PCS m  or 0.1% v/v PCS GM and PA at 100 
yukgml"^ . After exposure, astrocyte cell suspensions were 
obtained and the DNA content determined as described above.
A summary of the experimental protocol used is shown in
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Figure 2.3.
2.2.3. Growth factor additions
The insulin stock, 26.9 units ml”  ^in deionised water and 
the PDGF Stock, 167 units ml”  ^in IM NaCl, 10 mM pH
7 . 4 in 50% v/v ethanediol were both diluted appropriately in 
avi-FCS for addition. In initial experiments PA (Sigma) was 
dissolved in chloroform:methanol (1:2 v/v) (CHCl^:MeOH 1:2 
v/v) and this stock diluted appropriately for use.
Subsequent experiments were performed using an aqueous 
suspension of PA (Sigma or Serdary). An aqueous suspension 
of PA in PSS was obtained by sonication at IC^ for two 10 
second bursts on ice, with a 30 second rest in between, 
using a Soniprep 150 (MSE Scientific Instruments). A 5 or 
10 mgml”  ^stock was freshly prepared and appropriately 
diluted for use.
2.2.4. Statistical analysis
Statistical analysis was carried out using the Mann-Whitney 
U test. Various degrees of statistical significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.01, 
**** 0.001.
2.2.5. Materials
All materials used for tissue culture were obtained from Gibco 
Ltd. or Sigma Chemical Co.. Plasticware for tissue culture 
was obtained from Nunc. Hoechst 33258, insulin, the sodium
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salts of all the following PAs: PA from egg yolk lecithin,. 
PA containing lauric acid (PA di-C^2.Q^' PA containing 
myristic acid (PA di-C^^.^), PA containing palmitic acid (PA 
di-C^^,Q) and PA containing oleic acid (PA di-C^ ^^ g.^ ) and PMA 
were obtained from Sigma. PA (NH^  salt) was obtained from 
Serdary Research Labs., Canada. Partially purified PDGF 
from porcine platelets was obtained from Bioprocessing Ltd., 
County Durham. Protosol, the tissue and gel solubiliser was 
obtained from New England Nuclear. Cocktail T scintillant 
and the materials for the incubation medium were obtained 
from BDH. Methyl[^H]thymidine (51Ci/mmol) was obtained from 
Amersham International PLC.
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Figure 2.3. Summary of the experimental protocol for
assessment of the contribution made by PKC 
activation to the growth factor action of PA 
on astrocytes.
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2.3. RESULTS
3
2.3.1. The effect of insulin and PDGF on [ H]thymidine 
incorporation into astrocyte DNA.
Preliminary experiments were carried out using growth
o
factor-induced [H]thymidine incorporation into the DNA of 
subconfluent astrocyte cultures (11 div), as a measure of 
astrocyte DNA synthesis. Cells were grown in 24 well plates 
(15mm diameter). In initial experiments the mitogenic 
action of insulin and PDGF on astrocytes was investigated, 
since both of these growth factors have been reported to 
stimulate DNA synthesis in astrocytes (Murphy et al 1987; 
Besnard et al 1987 ).
From Fig. 2.4a it can be seen that insulin caused a dose-
1 3dependent (EC^q = 16/*Uml“ ) increase in [ H] thymidine
incorporation into astrocyte DNA after a 48h exposure.
Maximum stimulation was found at 1000 ytUml  ^insulin, and
this was equivalent to 74% of the response produced by
exposure to GM containing the potent mitogen FCS. 10% FCS
3
m  caused a 345% increase in [ H]thymidine incorporation 
compared to the Q^-FCS control.
In contrast to the effect of insulin, increasing 
concentrations of PDGF produced a biphasic dose-response 
curve for [^H]thymidine incorporation into astrocyte DNA 
after a 48h exposure (Fig. 2.4b). No increase in 
[^H]thymidine incorporation was seen in response to 0.005
-1and 0.025 Uml PDGF but 0.050, 0.125, 0.250 and 0.500 Uml
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Fig. 2.4a and b. Insulin- and PDGF-induced [ H]thymidine
incorporation into astrocyte DNA.
Subconfluent astrocyte cultures (11 div) were serum depleted 
for 24h and then exposed to various concentrations of either 
insulin or PDGF for 48h. Results are expressed as % of GM- 
FCS control. Results for insulin (fig. 2.4a) are mean +/- 
standard error of the mean (SEM) of 6 values, from 2 
experiments using 24 well plates. Mean disintegrations per 
minute (dpm) for GM-FCS control = 706 dpm. Results for PDGF 
(fig. 2.4b) are mean +/- SEM of values from 4 experiments (n 
= from 3 to 15) using 24 well plates. Mean dpm for GM-FCS 
control = 386 dpm. Statistical analysis was carried out 
using the Mann-Whitney U test. Various degrees of 
statistical significance are indicated as follows;- * p 
level 0.05, ** 0.025, *** 0.01 and **** 0.001. Each 
condition compared to appropriate GM-FCS control. - .
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3PDGF all caused significant increases in [ H]thymidine 
incorporation into astrocyte DNA. Maximum stimulation, of 
196% over GM-FCS control, was found at 0.125 Uml  ^PDGF. 
This response was equivalent to 45% of that elicited by 10% 
FCS GM in the same experiments.
However, at concentrations of 0.250 and 0.500 Uml PDGF- 
stimulated [^H]thymidine incorporation was lower than that 
elicited by 0.125 Uml"^ PDGF. The PDGF preparation used in 
these experiments was supplied in a solution containing 50% 
v/v ethanediol as a preservative. In order to determine 
whether the lower incorporation responses that were seen at 
the higher PDGF concentrations tested (0.250 and 0.50 Uml ^) 
were due to the higher final concentrations of ethanediol 
(0.75 and 1.50 % v/v respectively), a preliminary experiment 
was carried out to determine the effect of ethanediol on 10% 
FCS-stimulated [^H]thymidine incorporation. The effect of 
the potent mitogen 10% FCS GM in the presence of increasing 
concentrations of ethanediol on [ H]thymidine incorporation 
was compared to that in the presence of 10% FCS GM alone. A 
36% reduction in [^H]thymidine incorporation into astrocyte 
DNA was seen in response to 10% FCS QYI in the presence of 
1.5% v/v ethanediol compared to that seen in response to 10% 
FCS GM alone (Fig. 2.5). 10% FCS GM elicited an increase in
DNA synthesis that was 313% greater than that seen in 
response to the GM-FCS control.
Some variation was seen in the response of different batches 
of astrocytes to 10% FCS GM. Increases of 245%, 434% and
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Fig. 2.5. The effect of increasing ethanediol concentration 
on 10% FCS GM-induced [ H]thymidine incorporation 
into astrocyte DNA.
Subconfluent cultures (11 div) were serum depleted for 24h 
and then exposed to either 10% FCS GM alone or 10% FCS GM in 
the presence of increasing concentrations of ethanediol for 
48h. Results are mean +/- SEM for n = 3 values frcan 1 
experiment using 24 well plates. Results are expressed as % 
of GM-FCS control. GM-FCS control mean dpm = 771. 
Statistical analysis was carried out using the Mann-Whitney 
U test. Various degrees of statistical significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.01 
and **** 0.001. Ethanediol containing samples compared to 
10% FCS GM control.
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313% over the GM-FCS control were seen in the insulin, PDGF 
and ethanediol experiments respectively. All these 
experiments were performed on astrocyte cultures at 11 div 
but astrocytes grown for the same length of time in vitro 
may still show different rates of growth. The effect of 
PDGF on younger astrocyte cultures was therefore 
investigated to see if there was a variation in the 
responsiveness of astrocytes to proliferative stimuli with 
respect to age in culture. The effect of increasing
o
concentrations of PDGF on [H]thymidine incorporation into 
astrocyte DNA of 5, 6 and 8 div cultures was investigated.
PDGF had no stimulatory effect on incorporation into 
astrocyte DNA of 6 or 8 div cultures at any of the 
concentrations tested when compared to the GM-FCS control 
(Fig. 2.6). PDGF, at all concentrations tested had an
O
inhibitory effect on [H]thymidine incorporation into cells 
grown for 5 div. Reductions of 55%, 73%, 77% and 56% 
compared to the GM-FCS control were seen in response to 
0.050, 0.125, 0.250 and 0.500 Uml“  ^PDGF respectively. 
Variation was also found in the response of different age 
cultures to 10% FCS GM. Cells became more responsive to 10% 
FCS GM with increasing age in culture. At 5 div an increase 
of 178% over the GM-FCS control was seen which increased to 
292% at 6 div and 483% at 8 div. The 10% FCS GM response in 
the previous PDGF experiment using 11 div cultures was a 
434% increase over the GM-FCS control.
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Fig. 2.6. PDGF-induced [H]thymidine incorporation into 5,
6 and 8 div astrocytes.
Astrocyte cultures 5, 6 or 8 div were serum depleted for 24h 
and then exposed to increasing concentrations of PDGF for 
48h. Results are mean +/- SEM for 3 or 4 values from 1 
experiment using 24 well plates and are expressed as % of 
GM-FCS control. GM-FCS control mean dpm = 236 at 5 div, 409 
at 6 div and 912 at 8 div. Statistical analysis was carried 
out using the Mann-Whitney U test. Various degrees of 
statistical significance are indicated as follows:- * p 
level 0.05, ** 0.025, *** 0.01 and **** 0.001. Each 
condition compared to appropriate GM-FCS control.
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Q
2.3.2. The effect of PA on [H]thymidine incorporation into 
astrocyte DNA.
3
PA obtained from Sigma caused an increase in [ H]thymidine 
incorporation into astrocytes when ccanpared to the GM-FCS 
control after 48h exposure (Fig. 2.7). PA had a significant 
stimulatory effect at 20 and 50 yugml  ^but not at 75 or 100 
yugml"^.
For these experiments PA was diluted from a 10 mgml  ^stock 
made up in CHCl^iMeOH (1:2 v/v). The highest PA 
concentration tested of 100yugml  ^consequently contained 1% 
v/v CHCl^:MeOH (1:2 v/v). The lack of response of 
astrocytes to the higher PA concentrations tested may have 
been due to a detrimental effect of the CHCl^:MeOH (1:2 v/v) 
present on the astrocytes as was the case for ethanediol in 
the PDGF experiments. To test this idea the influence of 
increasing concentrations of CHClg:MeOH (1:2 v/v) on the
o
effect of 10% FCS GM on [H]thymidine incorporation into 
astrocyte DNA was investigated. Astrocytes were incubated 
with 10% FCS GM in the presence of increasing concentrations 
of CHClg:MeOH (1:2 v/v) for 48h and the response of these 
cells compared to that in response to 10% FCS GM alone.
The presence of 0.5% and 1.0% v/v CHClg:MeOH (1:2 v/v) had a 
significant effect on the activity of 10% FCS GM on 
[^H]thymidine incorporation into astrocyte DNA. When 
solvent was present at these concentrations lower 
incorporation was seen when compared to that in the presence 
of 10% FCS GM alone (Fig.2.8). Reductions of 31% and 46% in
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Fig. 2.7. PA-induced [^H]thymidine incorporation into 
astrocyte DNA.
Subconfluent astrocyte cultures (11 div) were serum depleted 
for 24h and then exposed to PA for 48h. Results are mean 
+/- SEM for n = 9 values from 3 experiments using 24 well 
plates and are expressed as % of GM-FCS control. Mean dpn 
for GM-FCS control = 435. Statistical analysis was carried 
out using the Mann-Whitney U test. Various degrees of 
statistical significance are indicated as follows:- * p 
level 0.05, ** 0.025, *** 0.01 and **** 0.001. Each 
condition compared to 04-FCS control.
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Fig. 2.8. The effect of increasing CHCl^iMeOH (1:2 v/v) 
concentration on 10% PCS GM-induced 
[^H]thymidine incorporation into astrocyte DNA.
Subconfluent astrocyte cultures (11 div) were serum depleted 
for 24h and then exposed to either 10% PCS GM alone or 10% 
PCS GM in the presence of increasing concentrations of 
CHClg:MeOH (1:2 v/v). Results are mean +/- SEM n = 8 from 1
experiment using 24 well plates and are expressed as % of
GM-PCS control. GM-PCS mean dpm = 628 for 0.01%, 750 for 
0.1%, 789 for 0.5% and 814 for 1.0%. Statistical analysis 
was carried out using the Mann-Whitney U test. Various 
degrees of statistical significance are indicated as
follows:- * p level 0.05, ** 0.025, *** 0.01 and **** 0.001.
Each condition compared to appropriate 10% PCS GM control.
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the [^H]thymidine incorporation response t^ 10% FCS GM were 
seen in the presence of 0.5% and 1.0% v/v CHCl^:MeOH (1:2 
v/v) respectively (Fig. 2.9). 0.01, 0.1 and 0.5% v/v
CHCl^îMeOH (1:2 v/v) had no significant effect on the 
response of astrocytes to 10% FCS GM. Subsequent 
experiments were carried out using an aqueous suspension of 
PA.
The effect of PA obtained from Sigma in aqueous suspension 
on DNA synthesis of younger cultures of astrocytes, 5, 6 or 
8 div was also investigated. PA at all concentrations 
tested was found to stimulate incorporation into cells grown 
for 5 div. 0.1 and 1yUgml”  ^PA were found to increase 
[^H]thymidine incorporation into astrocyte DNA at 6 div but 
inhibit incorporation at 8 div. PA at 10 and 100^gml had
no effect on 6 or 8 div cells (Fig. 2.10).
2.3.3. The variation in the astrocyte proliferative 
response.
Variation was again seen in the response of astrocytes to 
10% FCS Q/I with age in culture. Larger responses were seen 
to 10% FCS GM in this experiment with different age 
astrocyte cultures than in the previous experiment looking 
at the effect of PDGF on cultures of different ages. The 
[^H]thymidine incorporation experiments described above were 
performed using cells grown in 24 well plates. The data 
from the insulin experiment is shown in Table 2.3., it shows 
large variation in the dpm recovered from each of the 4 
wells in each row that were treated with the same insulin
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Fig. 2.9. The inhibitory effect of CHCl^:MeOH (1:2 v/v) on 
the effect of 10% FCS GM on [^H]thymidine 
incorporation into astrocyte DNA.
Subconfluent astrocyte cultures (11 div) were serum depleted 
for 24h and then exposed to either 10% FCS GM alone or 10% 
FCS GM in the presence of increasing concentrations of 
CHClg:MeOH (1:2 v/v) for 48h. Results are mean +/- SEM n =
8 frcxn 1 experiment using 24 well plates and are expressed 
as % of 10% FCS GM response. Mean dpm 10% FCS GM control = 
3026 for 0.01%, 3479 for 0.1%, 2879 for 0.5% and 2887 for 
1.0%. Statistical analysis was carried out using the Mann- 
Whitney U test. Various degrees of statistical significance 
are indicated as follows:- * p level 0.05, ** 0.025, ***
0.01 and **** 0.001. Each condition compared to appropriate 
10% FCS GM control.
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Fig. 2.10. PA-induced [H]thymidine incorporation into 5, 
6 and 8 div astrocytes.
Subconfluent astrocyte cultures (5, 6 or 8 div) were serum 
depleted and then exposed to PA at 0.1, 1, 10 or 100^Agml 
for 48h. Results are mean +/- SEM n = 3 from 1 experiment 
using 24 well plates and are expressed as % of GM-FCS 
control. GM-FCS mean dpm = 153 for 5 div, 232 for 6 div and 
584 for 8 div. Statistical analysis was carried out using 
the Mann-Whitney U test. Various degrees of statistical 
significance are indicated as follows: - * p level 0.05, ** 
0.025, *** 0.01 and **** 0.001. Each condition compared to 
appropriate GM-FCS control.
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Table 2.3. Variation in dpm recovered from astrocyte cell 
cultures grown in 24 well plates.
Subconfluent astrocyte cultures (11 div) were serum depleted 
for 24h and then exposed to various concentrations of 
insulin for 48h. Results are dpm recovered from each well 
of two 24 well plates from 1 experiment.
dpm
Plate 1 Plate 2
GM-FCS 230 449 700 768 360 328 796 816
10% FCS GM 2169 2412 2314 2430 1901 2313 2602 2524
Insulin yAUml 
1 635 942 806 838 752 1606 510 1178
10 901 1043 1546 1082 776 916 1318 1156
100 1163 2410 1885 1654 1274 2150 1895 1428
1000 . 1140 1872 2254 1789 1272 2374 1907 1707
62
concentration. For example the dpm recovered in response to
the GM-FCS control varied from 230 to 768 dpm. The
variation seen in the 10% FCS m  response of astrocytes
could have been due to a large variation in the number of
responsive cells in each well of these 24 well plates. The
3effect of 10% FCS GM on the incorporation of [ H]thymidine 
into cells in all 24 wells of two 24 well plates was 
therefore investigated.
As can be seen from Table 2.4. large variation in 
[^H]thymidine incorporation into DNA was found in response 
to 10% FCS GM across the 24 well plate. The incorporation 
varied from 669 to 3852 dpm on plate 1 and from 403 to 2451 
dpm on plate 2. When the results from all 24 wells of each 
plate are combined the variation was equivalent to 10% of 
the mean value for plate 1 and 9% for plate 2, but if each 
row of 4 wells is looked at individually much greater 
variation is seen ranging from 13 to 32% of the mean. The
[^H]thymidine incorporation experiments were carried out by 
making different additions to each row, but large variation 
in the number of responsive cells present in different rows 
of these 24 well plates were found. The 24 well plates 
seemed to be inherently variable so it was decided to look 
at astrocytes grown in 6 well (35mm diameter) plates to see 
if this problem could be overcome.
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Table 2.4. Variation in 10% FCS GM-induced [ H]thymidine 
incorporation into astrocyte DNA.
Subconfluent astrocyte cultures (11 div) were serum depleted 
for 24h and then exposed to 10% FCS C34 for 48h. Results are 
expressed as mean +/- SEM (n = 4) for each row of 24 well 
plate frcxn 1 experiment. Variation = SEM as % of mean 
value.
Plate 1 dpm Mean+/-SEM Variation
10% FCS GM
Plate 2
10% FCS GM
1030 953 2197 1241 1355 +/- 287 21
1965 1607 777 964 1328 +/- 277 21
1770 3852 1623 823 2017 +/- 646 32
1535 2312 1460 842 1537 +/- 301 20
1617 1108 1373 509 1152 +/- 238 21
669 1201 1262 1078 1053 +/- 133 13
Overall 1407 +/- 143 10
dpm Mean+/-SEM Var:
573 1414 2451 1261 1425 +/- 388 27
827 1021 1215 1370 1108 +/— 236 21
987 1101 1517 766 1093 +/- 158 14
794 1620 1147 590 1038 +/— 226 22
1197 454 776 459 722 +/- 175 24
403 724 801 600 632 +/- 87 14
Overall 1003 +/- 95 9
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2.3.4. Comparison of astrocytes grown in 24 and 6 well 
plates.
The variability of subconfluent astrocyte cultures grown in 
24 and 6 well plates was investigated by looking at the DNA 
content of each well of each plate. A typical standard 
curve for the standard calf thymus DNA preparation is shown 
in Fig. 2.11. The DNA content of an aliquot of the 
astrocyte cell suspension frcxn each well was determined by 
comparison of its fluorescence with that of the calf thymus 
standard. From Table 2.5. it can be seen that there is much 
greater variation in the DNA content of the astrocyte cell 
suspension from a 24 well plate, the standard deviation (SD) 
being 85% of the mean compared to that from a 6 well plate, 
where the SD was only 13% of the mean. The DNA content of 
astrocyte cultures grown for different lengths time in 6 
well plates was also determined (Fig. 2.12). From Fig. 2.13 
it can be seen that the rate of proliferation c±ianges with 
time in vitro. The assay of the DNA content of astrcx^yte 
cultures provided a less variable, simple and rapid method 
for the assessment of the growth factor-like action of PA. 
Consequently all further investigations were carried out 
using the œnvenient DNA content assay and the less variable 
astrocyte cultures grown in 6 well plates.
2.3.5. Further investigations into the mitogenic action of 
PA on astrcxzytes.
The mitogenic action of PA (from Serdary Res. Labs) on 
astrocytes was assessed by measuring the DNA content after
65
Fig. 2.11. A typical standard curve for DNA from calf 
thymus.
Fluoresecence of calf thymus DNA solution 0-5 y^gml is 
shown. Fluorescence is expressed in arbitary units.
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Table 2.5. DNA content of astrocyte cell suspension grown 
in 24 or 6 well plates.
The DNA content of an aliquot of each astrocyte cell 
suspension from each well was determined.
DNA yug/well
24 well (13 div) 0.14 0.38 0.00 0.21 0.06 0.00
0.14 0.35 0.16 0.00 0.60 0.38
0.42 0.40 0.06 0.31 0.54 0.16
0.74 0.24 0.45 0.00 0.18 0.00
Mean +/- SD = 0.25 +/- 0.21 (100% +/- 85%) n = 24
6 well (13 div) 10.0
13.6
11.0
12.8
13.6
14.0
Mean +/- SD = 12.5 +/- 1.63 (100% +/■- 13%) n = 6
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Fig. 2.12. DNA content of astrocyte cultures grown for 
different lengths of time in vitro.
The DNA content of astrocytes grown in vitro for varying 
lengths of time was determined. Results are expressed as 
mean +/- SEM (n = 6) from 1 experiment.
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Fig. 2.13. The rate of proliferation of astrocytes in 
culture.
Results are mean +/- SEM n = 6 and are expressed as the 
increase in DNA content divided by time in vitro.
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exposure of subconfluent astrocyte cultures (11 div) to PA 
for 48h. The fluorescence of the 10% FCS GM, 0.1% FCS GM 
and lOOyUgml”  ^PA exposure medium was also examined. As can 
be seen from Table 2.6. 0.1% FCS GM, 10% FCS GM and PA at 
lOO^gml”  ^all fluoresce and consequently could interfere 
with the determination of the DNA content of the astrocyte 
cell suspension. Thorough washing of the astrocyte cultures 
with PSS after exposure and prior to the determination of 
the DNA content, to remove all traces of the exposure medium 
was therefore very important. The fluorescence of these 
washes was also checked and as can be seen from Table 2.6. 
this was negligible, indicating that the measured 
fluorescence of the astrocyte cell suspension was an 
accurate measure of DNA content and was not due to 
contamination of the astrocyte cell suspension with exposure 
medium.
Exposure of astrocyte cultures, that had been serum depleted 
for 24h, to PA at 100//-gml^  ^for 48h elicited an increase in 
DNA content of 13% over the 0.1% FCS GM control (Fig. 2.14). 
A 51% increase in DNA content was found in response to 10% 
FCS GM. The response to PA was equivalent to 25% of the 
response to 10% FCS GM. PA at 10/^gml”  ^caused a small but 
significant increase in DNA content of 11 div cells after 
48h exposure (Fig. 2.15) but PA at 1 y^gml had no effect.
In an attempt to amplify PA's mitogenic activity the effect 
of increasing the time of serum depletion was investigated. 
For these experiments the cells were serum depleted in GM 
containing 0.1% FCS rather than 0% FCS because of the
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Table 2.6. Fluorescence of exposure medium and PSS washes 
of astrocyte cultures.
An aliquot of the exposure medium and the subsequent 
PSS washes was taken and the fluorescence determined in 
duplicate and the equivalent DNA content calculated by 
comparison with the DNA standard.
Exposure medium Equivalent DNA content (^gml
0.1% FCS GM 1.55
10% FCS GM 2.35
PA lOOytAgml  ^ 0.65
PSS 0.00
Washes from 0.1% FCS GM 0.00
10% FCS GM 0.00
PA 100yULgml  ^ <0.10
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Fig. 2.14. DNA content of astrocyte cultures depleted of 
serum for varying lengths of time.
Subconfluent cultures were serum depleted for varying 
lengths of time and then exposed to PA at lOOyAgml  ^for 
48h. Results are expressed as mean +/- SEM. n = 4 wells 
for each condition, except for 48h, 11 div n = 6 wells.
0.1% FCS GM control 24h, 11 div 3.31 /ig DNA/well
48h, 11 div 4.40
72h, 12 div 9.33
Statistical analysis was carried out using the Mann-Whitney
U test. Various degrees of statistical significance are 
indicated as follows :- * p level 0.05, ** 0.025, *** 0.01 
and **** 0.001. Each condition compared to appropriate 0.1% 
FCS GM control.
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Fig. 2.15. DNA content of astrocytes exposed to PA at 1 and 
10 yUgnil 1.
Subconfluent cultures (11 div) were serum depleted for 48h 
and then exposed to PA at 1 or 10 y/gml  ^for 48h. Results
are mean +/- SEM (n = 4 wells) and are expressed as % of
0.1% FCS GM. 0.1% FCS GM control 7.58/Ag DNA/well for PA 1,
6. SOyui 9 DNA/well for PA 10
Statistical analysis was carried out using the Mann-Whitney 
U test. Various degrees of statistical significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.01 
and **** 0.001. Each condition compared to appropriate 0.1% 
FCS GM control.
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increased time of depletion. Increasing the time of 
depletion from 24h to 48h increased the response elicited by 
PA at 100yugml”  ^from a 13% increase to a 43% increase over 
the 0.1% FCS GM control (Fig. 2.14). An increase in the 
response to 10% FCS GM was also seen from 51% to 75% over 
the 0.1% FCS GM control. After 48h serum depletion the 
response to PA was equivalent to 57% of that elicited by 10% 
FCS GM. Increasing the time of serum depletion still 
further to 72h however had a detrimental effect, eliminating 
the mitogenic activity of PA and reducing the 10% FCS GM 
response to less than that seen after only 24h depletion.
The growth factor-like action of PA of differing fatty acid 
chain length composition was determined by exposing cells to 
PA at lOOyUgml”  ^containing different fatty acids for 48h 
(Table 2.7.). Only PAs containing longer chain fatty acids, 
that is PA from lecithin and PA containing oleic acid 
(Ci8.i) caused increases in the DNA content of astrocyte 
cultures. PA containing palmitic myristic (Cg^ .^Q)
or lauric (C^2*0^ acid had no effect on DNA content.
2.3.6. The effect of phorbol ester pretreatment on the 
mitogenic action of PA on astrocytes.
The contribution made by PKC activation to the mitogenic 
action of PA on astrocytes was assessed by treating the 
astrocyte cultures with the phorbol ester PMA prior to PA 
addition. This was achieved by incubating cultures with 1 
^M PMA in 0.1% FCS GM for 6h, and then in fresh 0.1% FCS GM 
for 42h, prior to exposure to PA at 100/^gml 1 for 48h. The
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Table 2.7. DMA content of astrocytes exposed to different 
fatty acid chain length PAs.
Subconfluent astrocyte cultures (11 div) were serum depleted 
for 48h and then exposed to PAs of differing composition for 
48h. Results are mean +/- SEM n = 4 wells and are expressed 
as DNAyUg/well and as % of 0.1% PCS GM control. Statistical 
analysis was carried out using the Mann-Whitney U test. 
Various degrees of statistical significance are indicated as 
follows:- * p level 0.05, ** 0.025, *** 0.01 and **** 0.001. 
Each condition compared to the 0.1% PCS OVl control.
Sample DNA^^g/well % of 0.1% control
0.1% PCS GM 13.70 +/- 0.25 100 +/- 2
10% PCS GM 21.14 +/- 0.43 154 +/- 3
^12:0 13.40 +/- 0.70
98 +/- 5
^14:0 14.30 +/- 1.10
104 +/— 8
(:l6:0 14.80 +/-
0.80 108 +/- 6
^^^18:1 15.50 +/- 0.40
113 +/- 3 *
PA lecithin 15.30 +/- 0.80 112 +/- 6 *
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response of phorbol ester-treated astrocytes to PA was 
compared to that of untreated cells. PA elicited a 20% 
increase over the 0.1% PCS GM control in the DMA content of 
untreated astrocyte cultures (Pig. 2.16). PMA pretreatment 
abolished the mitogenic action of PA on astrocytes. In 
untreated cells 10% PCS GM elicited a 66% increase in DMA 
content over the 0.1% PCS GM control, whereas, in treated 
cells 10% PCS GM elicited only a 39% increase over the 
control.
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Fig. 2.16. DNA content of astrocytes exposed to 
PA +/- PMA pretreatment.
Subconfluent cultures (11 div) were either serum depleted 
only for 48h or treated with PMA ( 1 yuiM in 0.1% PCS GM ) for 
6h and then serum depleted for 42h. Treated and untreated 
cells were then exposed to PA at 100 /^gml  ^for 48h. Results 
are mean +/- SEM n = 8 wells from 2 experiments and are 
expressed as % of 0.1% PCS GM control.
0.1% PCS GM control - PMA 4.09yug DNA/well
+ PMA 4.33jxg DNA/well 
Statistical analysis was carried out using the Mann-Whitney 
U test. Various degrees of statistical significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.01 
and **** 0.001. Each condition compared to the appropriate
0.1% PCS GM control.
82
FIG. 2.16
200-1
150-
OccH
Zoo
1 0 0 -
0.1% PCS
10% PCS
0.1% PCS + PA
-PMA +PMA
83
2.4. SUMMARY
(i) Insulin elicited a dose-dependent increase in
[^H]thymidine incorporation into astrocyte DNA. PDGF and PA 
both had a biphasic effect on [ H]thymidine incorporation 
into astrocyte DNA due to the presence of high 
concentrations of their respective vehicles, ethanediol and 
CHClgiMeOH (1:2 v/v) at the higher PDGF and PA 
concentrations tested.
\ 3
(ii) PDGF had an inhibitory effect on [ H]thymidine 
incorporation into astrocyte DNA of cells grown for 5 div 
whereas PA was stimulatory at this time. PDGF had no effect 
on those cells grown for 6 or 8 div and the lower 
concentrations of PA that were tested had a stimulatory 
effect at 5 div and an inhibitory effect at 8 div.
(iii) Large variation was seen in the 10% FCS-GM stimulated 
[^H]thymidine incorporation into astrocytes grown in 24 well 
plates. This prompted the use of the less variable 6 well 
plates and the simple and rapid DNA assay method.
(iv) PA was shown to be mitogenic using this DNA content 
assay and that the signal could be amplified by increasing 
the time of serum depletion from 24 to 48h. This effect of 
PA was dependent on the presence of PA containing long chain 
fatty acids.
(v) Phorbol ester pretreatment abolished the mitogenic 
action of PA on astrocytes and reduced that of 10% FCS-GM.
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2.5. DISCUSSION
The presence of structurally, physiologically and 
biochemically distinct high affinity receptors for insulin 
in glial (Clarke et al 1984; 1988) and neuronal cell 
cultures (Boyd Jr. et al 1985) has raised questions about 
the physiological role of insulin in the CNS. The presence 
of insulin-like immunoreactivity in primary cultures of 
neurons from rat brain (Raizada 1983) and the release of 
immunoreactive insulin from neuronal cells in culture after 
depolarisation could provide a means of communication 
between neuronal and glial cells (Clarke et al 1986).
This communication between neuronal and glial cells could be 
involved in the control of the growth and development of the 
CNS. Insulin, at physiological concentrations, was found to 
be a potent glial mitogen in this study as well as -in a 
number of others (Morrison and de Vellis 1981; Lenoir and 
Honegger 1983; Morrison et al 1985; Murphy et al 1987;
Shemer et al 1987) and has been found to enhance astroglial 
proliferation and survival in culture (Sensenbrenner et al
1986), although it was reported to have no mitogenic action 
by some other workers (Pruss et al 1982; Avola et al 1988, 
Kniss and Burry 1988). Insulin also had a proliferative 
action on primary cultures of 1 day old neonatal rat neurons 
(Shemer et al 1987) and the survival of 19 day foetal 
neurons required the addition of insulin (Kadle et al 1988). 
Neonatal neuronal cultures also proliferate in response to 
IGF I (Shemer et al 1987). IGF I and IGF II also act as 
glial mitogens (Lenoir and Honegger 1983). Insulin and IGF
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I are also thought to play a role in oligodendrocyte 
development (Van der Pal et al 1988). When used at 
physiological concentrations, that is, of between 2 and 6nM 
insulin binds to insulin receptors only but at higher 
concentrations it can also bind to the IGF I receptor 
(Clarke et al 1984). Insulin may be having its 
physiological action by binding to its own receptor where it 
is added at physiological concentration (Murphy et al 1987) 
but at higher concentrations (Morrison and de Vellis 1981; 
Lenoir and Honegger 1983; Morrison et al 1985; Shemer et al
1987) it may be acting by binding to the IGF I receptor. In 
the studies by Pruss et al (1982), Avola et al (1988) and 
Kniss and Burry (1988), where a lack of proliferative action 
of insulin was seen, insulin degradation could not have been 
the cause since it was present at concentrations above those 
thought physiological and half of the immunoreactive insulin 
added has been found to still be present in the culture 
after 24h (Lenoir and Honegger 1983).
The mechanism of growth factor action of insulin on 
astrocytes is unknown, but in other cell types it has been 
found to involve protein tyrosine kinase activation (Kasuga 
et al 1982). There has been some controversy over whether 
insulin is capable of activating PKC (Spach et al 1986; 
Cooper et al 1987) and PPI turnover (Pennington and Martin 
1985; Farese et al 1986). It is now thought that the 
actions of insulin are bought about by the hydrolysis of 
glycosyl-phosphatidylinositol by a specific PL C to generate 
an inositol phosphate glycan and a structurally distinct DG 
(Saltiel and Cuatrecasas 1988). This inositol phosphate
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glycan mimicks certain actions of insulin and the distinct 
DG may be involved in the activation of one or more of the 
PKCs that have been identified (Nishizuka 1988).
Further work is obviously required to elucidate the 
physiological significance of insulin in the CNS in vivo but 
its release from neurons and its proliferative action on 
astrocytes does suggest a putative role in the control of 
astroglial growth.
PDGF receptors have been found on a number of different 
astroglial preparations (Herschmann 1986) and PDGF has been 
reported to act as a glial mitogen (Besnard et al 1987;
Noble et al 1988; Yong et al 1988) as was found in this 
study. The PDGF preparation used in this study however 
elicited a biphasic dose response curve. At higher PDGF 
concentrations a lower than expected astroglial 
proliferative response was seen. It appears from 
preliminary studies that this may have been due to the 
presence of ethanediol which was used as preservative in the 
PDGF preparation. At the higher PDGF concentrations that 
were tested ethanediol was present at a concentration that 
was found to reduce the effect of 10% FCS GM on astroglial 
proliferation.
The response to PDGF in this study seemed to vary with 
astrocyte age in culture but the pattern observed was in 
general agreement with previously reported results (Besnard 
et al 1987). PDGF had no effect on cells grown for 6 or 8 
div but did stimulate incorporation into cells grown for 11
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div. Besnard et al (1987) found that astrocytes were 
unresponsive at 5 and 15 div but maximally stimulated at 10 
div. PDGF has been found to influence glial development in 
the rat optic nerve (Noble et al 1988). Type 1 astrocytes 
secrete a soluble factor, which has been identified as PDGF, 
which is capable of promoting the division and motility of 
oligodendrocyte-Type 2 astrocyte (0-2A) progenitor cells, 
and of inhibiting the premature differentiation of 0-2A 
cells into oligodendrocytes. Antibodies to PDGF have been 
found to block the action of Type 1 astrocytes on 0-2A 
cells (Noble et al 1988). There is evidence from murine 
teratocarcinoma stem cells, which are used as a model to 
study the development of the mouse blastocyst, that a 
transition from a PDGF-producing to a PDGF-responsive cell 
type may be possible (Ross et al 1986). PDGF produced by 
Type 1 astrocytes may be involved in gliogenesis during 
development and later they may become responsive to PDGF as 
part of their role in the response to CNS injury thus 
explaining the age dependent effects of PDGF on astroglial 
proliferation.
A role for PDGF in the reactive gliosis that is seen in 
response to CNS injury has been proposed by Besnard et al 
(1987). PDGF released by platelets at the site of injury 
penetrates into the surrounding brain tissue through edema 
fluid (Takamiya et al 1986) may, by acting as a mitogen and 
chemoattractant, stimulating adjacent cells to divide and 
form the characteristic glial scar.
The mitogenic action of PA was established using
88
[^H]thymidine incorporation and DNA content of astrocyte 
cultures. Murphy and Pearce (198&^ showed a dose-dependent 
increase in incorporation into astrocyte cultures but in 
this study the results from the incorporation study were 
complicated by the presence of CHCl^iMeOH at the higher PA 
concentrations tested. An inhibitory effect of CHClgiMeOH 
on FCS-induced proliferation was seen and ethanol has also 
been reported to inhibit astroglial proliferation (Davies 
and Vemadakis 1984). However, a dose-dependent increase in 
DNA content of astrocyte cultures in response to aqueous PA 
was seen. Differences were also seen in the response of 
cells of different ages to PA. Unlike the inhibitory effect 
that PDGF had on 5 div astrocytes these cells responded to 
all PA concentrations tested. Differences were also seen in 
the response of 6 and 8 div cells to PA from those to PDGF. 
At 6 div a stimulatory effect was seen at lower PA 
concentrations but these concentrations were inhibitory at 8 
div, whereas PDGF had no effect on these cells.
This mitogenic action of PA on astrocytes appears to be 
dependent on the presence of long chain fatty acids. Only 
PA containing C^g.^ and PA produced from lecithin increased
DNA content, whereas PA containing ^14:0 ^16:0
fatty acids were ineffective. This requirement for longer 
chain length fatty acids has also been seen in other cell 
types. In NIH 3T3 cells PA containing C^2;Q °^ ^ 14:0 
acids had little effect on [^H]thymidine labelling (Yu et al
1988). This effect also seems to be specific for the 
phospholipid PA. Yu et al (1988) found that 
phosphatidylcholine (PC), phosphatidylethanolamine (PE) and
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3lysoPE had little effect on NIH 3T3 cells and [H]thymidine
incorporation into Rat-1 fibroblasts was not effected by
phosphatidylinositol (Ptdlns) or phosphatidylserine (PS)
(Moolenaar et al 1986). Liposomes made of PA and PC but not
3those of PS and PC were able to stimulate [ H]thymidine 
incorporation into Swiss 3T3 cells. PA and PC were also 
presented to these cells in aqueous buffer rather than in 
liposomes and still stimulated DNA synthesis (Siegmann 
1987). The ganglioside GMl has been shown to stimulate 
astroglial proliferation (Skaper and Varon 1987). GMl and 
PA share some structural similarity in that they both 
possess lipophilic and hydfophilic domains. PA in common 
with GMl is able to inhibit the cAMP-dependent conversion of 
flat, epithelial-like astroglia to process-bearing, stellate 
astroglia. This PA effect is again dependent on the 
presence of longer chain length fatty acids and appears to 
be specific for PA since PC, PE, Ptdlns and PS were without 
effect (Skaper et al 1989). Endogenously produced PA, 
formed by the action of phospholipase D (PL D) on membrane 
phospholipids, was also able to inhibit this cAMP-dependent 
morphological conversion. All these reports support the 
idea that the stimulation is specific for PA.
Serum is capable of stimulating PPI turnover in fibroblasts 
(L'Allemain and Pouyssegur 1986; Moolenaar et al 1986) and 
consequently PPI hydrolysis may be permanently switched on 
in cells in the presence of serum. Serum contains 
phospholipids (Krause and Debuch 1987) and by increasing the 
period of serum depletion progressive enhancement of the 
effect of agents known to stimulate PPI turnover may be
90
seen. Thrombin stimulates PPI turnover in fibroblasts and 
increasing growth factor deprivation results in a 
progressive increase in the effect of thrombin on PPI 
hydrolysis (L’Allemain et al 1986). Thrombin also has a 
proliferative effect on astroglial cells (Perraud et al
1987). PA is proposed to elicit its growth factor-like 
action by stimulating PPI turnover. Could the effect of PA 
be amplified like that of thrombin? By varying the time of 
serum depletion prior to PA exposure an amplification of the 
response to PA was seen. The growth medium itself which was 
used for culturing astrocytes was found to contain PA. 23% 
of the radioactivity recovered in the phospholipid fraction 
of growth medium labelled with [^H]arachidonic acid ([ H^]AA) 
was associated with PA (see later, chapter 4). 
Desensitisation to PA might therefore have occurred which 
was eleviated by increasing the time of serum depletion.
PKC activation has been demonstrated to play a role in the 
proliferative response of a number of cell types (Nishizuka
1986). Activation of PKC by DG is thought to activate the 
antiporter (Moolennaar 1986) which is involved in 
cytosolic alkalinisation (Moolenaar et al 1983) required for 
the initiation of DNA synthesis. Phorbol ester, a direct 
activator of PKC in vivo and in vitro (Castagna et al 1982), 
has been found to mimick the action of growth factors in 
raising pH^ (Moolenaar et al 1984a). The presence of PKC in 
primary cultures of astrocytes (Neary et al 1986; Murphy et 
al 1988) and phorbol ester's ability to stimulate 
proliferation of glial cells (Murphy et al 1987; Bhat 1989) 
suggest a role for PKC activation in the control of glial
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cell growth. PKC activation is also implicated in 
astroglial growth from the observation that FCS increases 
the activity of the Na*'/n*' antiporter (Skaper and Varon
1987). Further evidence is the ability of l-(5- 
isoquinolinylsulphonyl)-2-methyl-piperazine, H7, a potent 
PKC inhibitor (Halenda and Rehm 1987) to block the effect of 
PMA on glial cell proliferation (Bhat 1989).
Prior incubation with PMA abolished PA's proliferative 
action on astrocytes. In astrocytoma and astroglial cells 
the early phase of PKC activation by phorbol ester produces 
a positive response which is then followed by negative 
feedback control of some cell surface receptors (Orellana et 
al 1985; Pearce et al 1988). This down-regulation has been 
found to be a major function of PKC activation (Nishizuka 
1985). PA has been shown to cause PKC-mediated activation 
of Na'^/H'*' exchange in A431 human carcinoma cells and the 
mechanism of action of PA has been proposed to be via 
stimulation of PPI turnover (Moolenaar et al 1986). The 
abolition of PA's mitogenic action on phorbol ester 
pretreated astroglial cells could be attributed to the down- 
regulation of PA cell surface receptors. This sugests that 
PKC activation does appear to be involved in the growth 
factor action of PA on astrocytes in culture. The phorbol 
ester PMA has been found to have a mitogenic effect 
on astrocytes (Murphy et al 1987; Bhat 1989) although at 
concentrations lower than that employed for phorbol ester 
pretreatment studies. However, IMA pretreatment of Swiss 
3T3 cells had no effect on PA's ability to stimulate 
proliferation in these cells (Yu et al 1988). There may be
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cell specific differences in the mechanisms used by PA to 
elicit its growth factor action. Some 3T3 cells may not 
depend upon stimulation of phospholipid metabolism for their 
response to mitogenic signals (Yu et al 1988). Growth 
factor regulation of PKC may also differ in cells that are 
still capable of proliferating and those that are 
differentiated (Morrison et al 1988). Phorbol ester is 
long-lived in the cell when compared to the rapidly produced 
and degraded DG. Consequently studies using phorbol esters 
may have different effects to that of DG and this 
reservation must be expressed in connection with 
these studies. PKC activation and Ca"*"*" mobilisation act in 
synergy to bring about the cellular response but the 
initial increase in [Ca^ ]^ is transient so PKC activation 
and the subsequent phosphorylation of target proteins may be 
required to ensure that the long term responses such as 
proliferation occur.
Astrocytes have been shown to proliferate in response to a 
number of agents that are thought to act via the activation 
of PPI turnover, for example PDGF, serum and thrombin. The 
activation of PPI turnover does not however automatically 
mean that a particular agent will also elicit astroglial 
proliferation. Bradykinin and vasopressin have been shown 
to stimulate PPI turnover in astrocytes but have no effect 
on astroglial proliferation (Cholewinski and Wilkin 1988). 
Carbachol, histamine, noradrenaline and serotonin, agents 
known to activate inositol phospholipid hydrolysis in 
astrocytes (Pearce et al 1985; 1986a) have also been shown 
to have no effect on astroglial proliferation (Murphy et al
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unpubl.). However, recent results show that carbachol and 
noradrenaline are capable of stimulating DNA synthesis in 
primary astrocytes derived from neonatal rat brain 
(Ashkenazi et al 1989). The action of carbachol was 
mediated by and muscarinic acetylcholine receptor 
subtypes. These receptor subtypes were shown to be more 
efficient at activating PPI hydrolysis than the or Mg 
receptor subtypes. The degree to which carbachol stimulated 
DNA synthesis was well correlated with the degree of PPI 
hydrolysis activation. Carbachol was also mitogenic for SK- 
N-SH human neuroblastoma cells and 1321 N1 human astrocytoma 
cells which possess M^ muscarinic receptors. The reason for 
the inability of carbachol to stimulate DNA synthesis in the 
study of Murphy et al is unknown since these cells do 
express M^ receptor subtypes and carbachol-induced PPI 
turnover was found to be mediated by the M^ receptor subtype 
(Murphy et al 1986). Serotonin, although having no effect 
on astroglial proliferation, has been reported to be a 
mitogen for Chinese hamster lung fibroblasts (Seuwen et al
1988). Serotonin is thought to act by stimulating PPI 
turnover because no synergy was seen with thrombin, 
suggesting that they share a common pathway of signal 
transduction and because serotonin was able to potentiate 
the action of EGF, FGF and insulin which act via protein 
tyrosine kinase stimulation.
As mentioned above PA is thought to elicit its growth 
factor-like action via the stimulation of PPI turnover 
(Moolenaar et al 1986). A number of agents that activate 
PPI hydrolysis, for example, carbachol, noradrenaline, PDGF,
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serum and thrombin do have a mitogenic action on astrocytes 
(Besnard et al 1987; Murphy et al 1987; Perraud et al 1987; 
Ashkenazi et al 1989). Does PA which is also mitogenic for 
astrocytes (Murphy and Pearce 1988a; this study) also 
activate inositol phospholipid hydrolysis in astrocytes? 
Investigations into whether PA is capable of stimulating PPI 
turnover in astrocytes are described in the following 
chapter.
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CHAPTER 3. PHOSPHATIDIC ACID STIMULATES PHOSPHOINOSITIDE 
TURNOVER AND Ca"^  ^MOBILISATION IN ASTROCYTES.
3.1. INTRODUCTION
In the previous chapter the mitogenic action of PA on 
astrocytes, initially reported by Murphy and Pearce (1988a), 
was confirmed with the finding that PA increased 
[^H]thymidine incorporation into astrocyte DNA and increased 
the DNA content of astrocyte cultures. The abolition of the 
mitogenic action of PA by PKC down-regulation suggests a 
role for PPI turnover in the effect of PA on astroglial 
proliferation.
The mechanism of action of a number of mitogenic agents, 
some of which have been shown to be astrocyte mitogens, is 
thought to involve the activation of PPI turnover. A number 
of other mitogens are thought to employ the activation of 
protein tyrosine kinase (see Chapter 2 Table 2.2. ). The 
P ih i  1 i  “h y  of a number of mitogens to stimulate proliferation 
has been well correlated with their action on PPI turnover 
(Whitman and Cantley 1988; Ashkenazi et al 1989; Chapter 2 
Table 2.2.). PDGF and thrombin, which are astrocyte and 
fibroblast mitogens (Scher et al 1979; Perez-Rodriguez et al 
1981; Ek et al 1982; Besnard et al 1987; Perraud et al 1987; 
Noble et al 1988; Yong et al 1988), have been found to 
activate PPI breakdown in fibroblasts (Habenicht et al 1981; 
Berridge et al 1984; Hesketh et al 1988) and in platelets 
and fibroblasts respectively (Billah and Lapetina 1982; 
Agranoff et al 1983; L'Allemain et al 1986). Serum, which
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is a potent astrocyte mitogen (Murphy et al 1987; Skaper and 
Varon 1987; Avola et al 1988; Kniss and Burry 1988), is also 
capable of stimulating PPI breakdown (Moolenaar et al 1985 
and 1986; L'Allemain et al 1986). Other mitogens, for 
example, bradykinin, vasopressin and bombesin (Rozengurt et 
al 1979; Owen and Villereal 1983; Rozengurt and Sinnett- 
Smith 1983) are also thought to use the activation of PPI 
turnover to bring about their proliferative action (Berridge 
and Irvine 1984; Yano et al 1984; Hesketh et al 1988). It 
has been proposed that the mitogenic action of PA involves 
the stimulation of PPI turnover (Moolenaar et al 1986).
Increases in the metabolism of inositol lipids have 
therefore been associated with the mitogenesis of cells from 
several tissues where it is thought to be involved in the 
early events in the cellular processes that lead to 
proliferation and differentiation (Michell 1982; Bérridge 
1986 and 1987a). It is the changes in [Ca"*"^ ] concentration 
and pH^ , via the PKC activation of the Na'^/H'*' antiporter, 
which act in synergy to bring about the obligatory steps 
involved in initiating DNA synthesis (Rozengurt 1986) and is 
summarised in Figure 3.1.
The importance of Ptdlns(4,5)P2 hydrolysis in the 
stimulation of mitogenesis has been also demonstrated by 
Matuoka et al (1988). They showed that a monoclonal antibody 
to Ptdlns(4,5)P2 abolished the mitogenic action of PDGF, a 
growth factor known to stimulate PPI turnover, on NIH 3T3 
cells (Fukami et al 1988). This antibody had no effect on
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Figure 3.1. Summary of events leading from growth factor- 
receptor binding to an increase in [Ca^ ]^ and 
pH. .
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the proliferative action of EGF, FGF or insulin,
growth factors which do not stimulate PPI turnover in these
cells.
As a link has been established between inositol lipid 
metabolism and cell division a review of this signalling 
system, outlining the major pathways involved in the 
metabolism of inositol phospholipids and inositol 
phosphates, is given in Figure 3.2. This figure is by no 
means exhaustive and more detailed information can be found 
in Irvine et al (1988) and Majerus et al (1988). The 
interaction of these proliferative agents with their 
respective receptor on their target cell initiates the 
hydrolysis of the minor membrane phospholipid 
PtdIns(4 ,5 )P2 by PL C. The cell surface receptor is coupled 
to PL C via a G protein designated G^ (Cockcroft and 
Gomperts 1985; for reviews see Taylor and Merritt 1986 and. 
Gilman 1987). Ptdlns(4,5 )P2 hydrolysis yields the two 
intracellular second messengers DG and Ins(l,4,5)Pg (for 
comprehensive reviews of this signal transduction pathway 
see Berridge 1984; Berridge and Irvine 1984; Hokin 1985; 
Abdel-Latif 1986; Downes 1986; Nahorski et al 1986; Berridge 
1987b; Fisher and Agranoff 1987; Nishizuka 1988; Berridge 
and Irvine 1989 ).
Ins(l,4,5)Po mobilises intracellular calcium from a non- 
mitochondrial pool (Streb et al 1983) by binding to high 
affinity receptors (Willcocks et al 1987) which are linked 
to a calcium channel (Berridge 1987b). The intracellular 
calcium pool has characteristics which suggest that it is
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Figure 3.2. Major pathways of metabolism of inositol 
phospholipids and inositol phosphates.
Enzymes of major pathways
1. Ptdlns synthetase
2. PtdIns-3-kinase (Type I)
3. PtdIns-4-kinase (Type II)
4. Ptdlns(4)P phosphomonoesterase
5. Ptdlns(4)P-5-kinase
6 . Ptdlns(4,5)P^  phosphomonoesterase
7. Phospholipase C
8 . DG kinase
9. CMP-PA synthetase
10. Ins(1,4,5)P^/Ins(1,3,4,5)P^-5-phosphatase
11. Ins(1,4,5)P^-5-phosphatase
12. Inositol polyphosphate-1-phosphatase
13. InsP phosphatase
14. Ins(1,4,5)Pg-3-kinase
15. Ins( 1 ,3,4)P2 ’"6—kinase
16. Ins(1,3,4,6 )P^-5-kinase
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the endoplasmic reticulum (ER) but only a part of it is 
Ins(1,4,5)P^-sensitive. Ins(l/4,5)Pg receptors are localised 
on the nuclear envelope, and on parts of the ER near the 
nucleus. Recently, it has been suggested that a cytoplasmic 
organelle, that is not continuous with the ER but is close 
to it, called a "calciosome", which has characteristics of 
the sarcoplasmic reticulum, may be the Ins(1,4,5)P^ - 
sensitive calcium pool (Volpe et al 1988). The locations of 
the Ins(1,4,5)Pg-sensitive and -insensitive pools are 
therefore still uncertain and their relationship to 
calsiosomes is not yet clear (Berridge and Irvine 1989).
As can be seen from Figure 3.2. Ins(l,4,5)Pg can be 
sequentially dephosphorylated to inositol (Downes et al 
1982; Storey et al 1984) or phosphorylated to inositol 
1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P^) (Batty et al 
1985; Irvine et al 1986b). Ins(1,3,4,5)P^ has been proposed 
to act as an additional intracellular messenger (Irvine et 
al 1984b; Batty et al 1985). In association with 
Ins(l,4,5)P^ it is thought to regulate the entry of calcium 
from the external medium (Irvine and Moor 1986 ; Morris et 
al 1987: Irvine 1989; Berridge and Irvine 1989). Changes in 
calcium entry from outside the cell may be important during 
long term processes like proliferation (Hesketh et al 1985).
More highly phosphorylated forms of inositol, inositol 
pentakisphosphate (InsP^) and inositol hexakisphosphate 
(InsPg) also exist. Until recently these had only been 
found in plants and avian red blood cells but now they have 
also been identified in animal cells (Heslop et al 1985).
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There is little evidence of association of InsP^ or InsP^ 
with receptor-activated PPI turnover (Heslop et al 1985; 
Nahorski and Batty 1986), although they have been proposed 
to act as a phosphate store (Irvine et al 1988). A role as 
extracellular messengers has however been proposed by 
Vallejo et al (1987). An enzyme that is capable of 
hydrolysing InsP^ has been found on the extracellular 
surface of NIH 3T3 cells (Carpenter et al 1989).
DG activates the calcium- and phosphatidylserine-dependent 
PKC, which phosphorylates serine and threonine residues on 
its target proteins (Nishizuka 1984). DG can also be 
released by the Ca"*”^ -dependent action of another PL C, on 
phosphatidylinositoi 4-phosphate (Ptdlns(4)P) and Ptdlns, 
which has been reported in platelets (Majerus et al 1985).
DG is metabolised either via a DG lipase to yield 
arachidonic acid which is used as a precursor for 
prostaglandins and leukotrienes (Irvine 1982) or is 
phosphorylated by DG kinase to PA. This latter pathway 
seems to be the predominant route used by platelets (Billah 
et al 1981) and in brain (Van Rooijen et al 1985; Dudley and 
Spector 1986 ).
It was Michell (1975) who suggested that increased inositol 
phospholipid metabolism may be responsible for the receptor- 
stimulated increase in [Ca^^]^ that initiates a number of 
physiological responses in cells. It was thought that the 
initial reaction involved Ptdlns metabolism which was 
measured by increased ^^P labelling of Ptdlns and PA. PA, 
which is formed during receptor-activated Ptdlns breakdown,
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was thought to be responsible for the changes that were seen 
in [Ca'^'^’lj^ since it was seen to accumulate in response to 
calcium mobilising stimuli (Lapetina and Cuatrecasas 1979; 
Putney et al 1980; Salmon and Honeyman 1980). PA also 
provoked calcium translocation across an organic phase in a 
Pressman cell (Tyson et al 1976) and into liposomes (Serhan 
et al 1981 and 1982; Blau and Weissmann 1988). It was 
proposed that PA acted as a calcium ionophore to bring about 
the physiological effects of these stimuli in a variety of 
different cell types (Barritt et al 1981; Harris et al 1981; 
Ohsako and Deguchi 1981 and 1983). Controversy did exist 
however about the calcium ionophore hypothesis of PA action 
since Holmes and Yoss (1983) showed that PA was unable to 
translocate calcium across PC membranes.
It is now known that Ptdlns(4,5 )P2 is the major phospholipid 
hydrolysed (Michell et al 1981), and that Ins(1,4,5)P^ is 
the intracellular messenger formed during PPI turnover that 
is responsible for calcium mobilisation. This put an end to 
the calcium ionophore hypothesis of PA. However, recent 
work on the growth factor-like action of PA on fibroblasts 
has renewed interest in PA as an intracellular signal 
molecule (Moolenaar et al 1986; Siegmann 1987; Yu et al 
1988).
PA has been found to stimulate PPI turnover in fibroblasts 
and that this was not due 1:0 its acting as an ionophore 
since the effects were independent of extracellular calcium 
(Moolenaar et al 1986; Murayama and Ui 1987a). PA- 
stimulated PL C hydrolysis of Ptdlns(4,5)P2 in platelet
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membranes has also been reported (Jackowski and Rock 1989). 
The effect of PA was dependent on the presence of longer 
chain length fatty acids, for example, palmitic or
stearic acid (C^g.^) at and arachidonic acid (C^Q.^) at 
(see Figure 3.3.), similar to those found in the 
endogenous molecule, rather than lauric acid ( 1^ 2 *0  ^ both 
R and Rg (Moolenaar et al 1986; Murayama and Ui 1987a). PA 
has also been reported to increase [Ca^^]^ (Moolenaar et al 
1986; Kawase and Suzuki 1988). PA is thought to bring about 
changes in [Ca'^ '^ ]^  by stimulating PPI turnover to produce 
Ins(l,4,5)Pg (Moolenaar et al 1986).
Astrocytes have been found to possess a variety of receptor 
types which are coupled to PPI turnover, for example 
adrenergic, muscarinic cholinergic (Pearce et al 1985,
Pearce et al 1986a and Gonzales et al 1985 ), histamine, 5— 
hydroxytryptamine (Pearce et al 1985; Arbones et al 1988), 
quisqualate-preferring glutamate (Pearce et al 1986b), P2- 
purinergic (Pearce et al 1989), angiotensin II receptors 
(Raizada et al 1987) and receptors for a number of peptides 
(Cholewinski and Wilkin 1988; Cholewinski et al 1988) (for 
reviews see Murphy and Pearce 1987 and Pearce and Murphy 
1988). Could PA also be activating PPI turnover in 
astrocytes to bring about its mitogenic action?
The ability of agonists to stimulate inositol phospholipid 
hydrolysis can be studied by monitoring the accumulation of 
the intracellular metabolites of inositol phospholipid 
breakdown. This was made possible by the observation that 
the myo-inositol level of the cerebral cortex of rats
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Figure 3.3. Stereochemical configuration of PA showing the 
stereospecific numbering of the fatty acid side 
chains attached to the carbon atoms.
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treated with lithium was decreased, with an associated 
increase in the myo-inositol 1 -phosphate content, due to the 
inhibition by lithium of the enzyme myo-inositol 1- 
phosphatase (Allison et al 1976). The addition of lithium 
can thus be used to amplify the agonist-dependent PPI 
turnover responses of a variety of cell types (Berridge et 
al 1982). The separation of the inositol phosphates is 
affected by anion exchange chromatography and that of the 
inositol phospholipids by thin layer chromatography (TLC).
The action of PA on inositol phosphate accumulation and 
inositol phospholipid labelling in astrocytes and 
efflux from astrocytes was investigated. The responses of 
fibroblasts to PA were also determined.
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In the remainder of this chapter I shall present evidence to 
show that:
/ .
(i) PA increased the accumulation of total and individual 
inositol phosphates in astrocytes and that this effect was 
dependent on extracellular calcium and the presence of PA 
containing long chain fatty acids.
(ii) PA reduced the labelling of Ptdlns(4,5)P2 at short 
time points and after 5 minutes reduced the labelling of 
Ptdlns and increased that of PtdIns(4)P and Ptdlns(4,5)P2 *
PA increased efflux from astrocytes. Both these
effects were dependent on the presence of PA containing long 
chain fatty acids.
(iii) PA had no detectable effect on PPI turnover in
!
fibroblasts but did stimulate efflux.
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3.2. METHODS AND MATERIALS.
3.2.1. Astrocyte Cultures.
Astrocyte-enriched cultures were prepared as described in 
Chapter 2 section 2.2.1. and grown in either 60mm diameter 
dishes or 6 well plates (35mm diameter).
3.2.2. Phosphoinositide metabolism.
3.2.2.1. Labelling.
Astrocyte-enriched cultures, 18-22 div, were labelled with 
[^ H] myo-inositol (15 Ci/mmol ). The GM was removed from each 
culture dish or well and 2ml. of labelled GM ( 1 y*Ci/ml ) was 
added. The final concentration of inositol was lOyUM. The 
cultures were incubated at 37°C in a 5% CO^ /95% air 
atmosphere for either 24, 48, or 72 hours.
3.2.2.2. Incubations.
After labelling, the medium was removed and the cultures 
washed twice with PSS (for composition see Chapter 2 section 
2.2.2.1). 2ml. of PSS was then added to each dish or well 
and the cultures returned to the incubator for 45 minutes. 
The cultures were then washed twice and 2ml of fresh PSS 
added, supplemented with lithium chloride and calcium 
chloride, to a final concentration of 5 and 2.5mM 
respectively. For short time point incubations where 
changes in Ins(l,4,5)Pg were being studied lithium chloride
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was omitted since lithium chloride has been found to inhibit 
the formation of Ins(l,4,5)Pg (Batty and Nahorski 1985). In 
experiments where the calcium conditions were varied 
additional calcium chloride was either omitted, or it was 
omitted and ethyleneglycol-bis-(b-aminoethyl ether) N,N'- 
tetraacetic acid (EGTA) added to a final concentration of 
0.5mM. The cultures were incubated for 15 minutes in the 
presence of lithium and calcium prior to the appropriate 
agonist addition being made. For some incubations lithium 
was added at the same time as agonist and calcium was 
already present in the PSS. After incubation for the 
appropriate length of time the incubations were stopped by 
removing the incubation medium, washing twice with PSS and 
adding 1ml. of CHClg-.MeOH mixture (1:2 v/v) to each dish or 
well. The cells were scraped from the culture dish or well 
and transferred to test-tubes. 0.3ml of CHClg and 0.3ml of 
deionised water were added to each tube and after thorough 
mixing the phases were separated by centrifugation at 180g 
for 10 minutes at 4°C. An aliquot of the lower chloroform 
layer was removed, dried and 1ml of H^O and 8ml of Cocktail 
T or Emulsifier Safe scintilllant added for liquid 
scintillation counting of labelled inositol lipids.
3
3.2.2.3. Measurement of [ H]inositol phosphates 
accumulation.
A 0.75ml. aliquot of the upper aqueous phase was taken and 
diluted with 2ml. deionised water for separation of inositol 
phosphates (IPs) by ion exchange chromatography as described 
by Berridge et al (1982). 0.5ml of a 50% v/v suspension of
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Dowex ion exchange resin in the formate form was added to 
the IPs mixture. After mixing the suspension was 
transferred to a column and allowed to settle. Free 
[^H]myo- inositol was eluted by washing the column with five 
2ml. volumes of 5mM myo-inositol and glycerophosphoinositol 
(GPI) and the [^H]-labelled IPs were eluted with 1ml. of IM 
ammonium formate in O.IM formic acid and collected for 
liquid scintillation counting. In scane experiments GPI was 
eluted before the IPs by washing with five 2ml aliquots of 
5mM borax, 60mM sodium formate and the IPs collected by 
elution with 1ml of IM ammonium formate in O.IM formic acid.
Separations of the individual IPs formed were also carried 
out, but for these experiments the aqueous extracts from 4 
culture dishes or the 6 wells from a 6 well plate were 
pooled and diluted appropriately. A 1ml. aliquot of a 50% 
v/v suspension of formate form Dowex resin was added and 
after mixing the suspension was transferred to a column.
This simple chromatographic technique does not allow the 
separation of the individual inositol phosphate isomers , 
for example Ins(l,3,4)Pg and Ins(l,4,5)Pg, and for this 
reason the individual inositol phosphates are referred to 
according to the number of phosphates present with no 
designation of position of those phosphate groups. The 
column was washed with four 2ml. aliquots of 5mM myo-
o
inositol and the eluted [ H]myo-inositol discarded. The 
last myo-inositol wash was collected for liquid 
scintillation counting. The individual IPs were eluted with 
formate solutions of increasing strength according to the 
method of Brown et al (1984). GPI was eluted with five 2ml.
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aliquots of 5mM borax, 60mM sodium formate. InsP^ was eluted 
with eight 2ml. aliquots of 5mM borax, 150mM sodium formate. 
InsP^ was eluted with five 2ml. aliquots of 0.3M ammonium 
formate in O.IM formic acid. InsPg was eluted with three 
2ml. aliquots of 0.75M ammonium formate in O.IM formic acid. 
Each 2ml. aliquot was collected and 10ml of scintillant 
added for the determination of the [ H]inositol content of 
each IP fraction by liquid scintillation counting.
3.2.2.4. Expression of results.
The radioactivity recovered in IPs was corrected to a 
standard incorporation of radiolabel (10 dpm) into the 
inositol lipids of each culture. The incorporation of label 
into inositol lipids was between 85,000 and 130,000 dpm for 
60mm diameter dishes and between 45,000 and 65,000 dpm for 
35mm diameter wells from a 6 well plate. The radioactivity 
recovered in IPs where individual IPs from 4 culture dishes 
or a 6 well plate were examined was also corrected to a 
standard incorporation of radiolabel (1 0  ^dpm) into the 
inositol lipids. The incorporation into inositol lipids 
from 4 culture dishes and a 6 well plate was approximately 
400,000 dpm. This normalisation was carried out to allow 
comparison of results from experiments using different 
batches of cells.
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3 .2 .2 .5 . [^H]Inositol phospholipid composition.
Determination of the labelled inositol phospholipid 
composition of astrocyte cultures was carried out by TLC 
according to the method of Jolies et al (1981). An aliquot 
of the CHClg layer obtained from the PPI turnover 
experiments containing the labelled inositol phospholipids 
was taken and dried. High performance silica gel 60F TLC 
plates, treated with 1% w/v potassium oxalate in MeOHzH^O 
(2:3 v/v) were activated by heating at 110°C for 15 minutes. 
Each lipid sample was resuspended in an aliquot of 
CHClgZMeOHzH^O (75:25:2 v/v) for application to the TLC 
plate. A phospholipids standard mixture containing 5yU.g, of 
the sodium salt in CHClg, of each of the following 
phospholipids: PA, Ptdlns, PtdIns(4)P and Ptdlns(4,5)P^  was 
run on each plate. Separation was achieved by a mobile 
phase containing CHClg:acetone:MeOH: acetic acid:H^O 
(40:15:13:12:8 v/v). The following values were obtained 
for these phospholipid standards: PA 0.93; Ptdlns 0.53;
Ptdlns(4)P 0.36 and Ptdlns(4,5)P^  0.29. The phospholipids 
were visualised by exposure to iodine vapour. The spots were 
scraped, 0 .5ml H^O and 8ml of scintillant added and the 
[^H]inositol content of the inositol phospholipids 
determined by liquid scintillation counting.
3.2.3. Measurement of "^ C^a^  ^efflux
3.2.3.1. Labelling and Incubations
Calcium efflux was determined by using an adaptation of the
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method of Lazarewicz and Kanje (1981). Cells grown for 18- 
22 div in 6 well plates were labelled in GM containing 
2/lCiml”  ^^^ Ca"^ "^  for 24h. After incubation for 5 or 10 
minutes in a pre-gassed PSS of the following composition (in 
mM): NaCl 116, NaHCOg 26.2, Glucose 5.5, KCl 5, MgSO^ 1.5, 
CaCl^ 1.3 and NaH^PO^ 1, cells were incubated at room 
temperature in 2ml aliquots of PSS for three or four 1 
minute intervals to establish basal ^^Ca efflux. Agonist 
was then added at the appropriate concentration to the cells 
in 2ml PSS for 1 minute and ^^Ca^^ efflux into this aliquot 
monitored. Post agonist addition efflux into four further 
2ml PSS aliquots was also monitored. The cells were then 
solubilised by adding 1ml O.IM NaOH to each well to allow 
the determination of the amount of radiolabel remaining in 
the cells. After 10 minutes the cells were scraped from the 
well. Each well was then washed with 1ml H^O and this was 
added to the NaOH aliquot. The ^^ Ca"*"^  content of the PSS 
aliquots and the solubilised cell suspension was determined 
by liquid scintillation counting.
3.2.3.2. Expression of results
efflux was calculated as the ^^Ca^ released per
minute as a percentage of that remaining in the cell at that
45— ++
time. The effect of a 1 minute incubation with PA on ca 
efflux was expressed as a percentage of the efflux prior to 
the addition of PA.
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3.2.4. Protein content
Growth medium was removed and the cells rinsed twice with 
PSS. 1ml H^O was added to each dish or well and the cells 
removed by scraping. The protein content of an aliquot of 
the astrocyte suspension was determined by using the method 
of Lowry et al (1951) using BSA as the standard.
3.2.5. Fibroblast cultures.
The meninges from 12 neonatal rat cerebral cortices were 
pooled and incubated in disaggregation medium containing 2.5 
mgml"^ collagenase for 15 minutes at 37°C in a shaking water 
bath. The cells were then mechanically dissociated by 
trituration through a 1.5mm diameter stainless steel 
cannula. The cell suspension was diluted in growth medium, 
plated onto 6 well (35mm diameter well) plates and grown in 
a humid 5% 00^/95% air atmosphere with medium changes every 
3 or 4 days. Confluent cultures were obtained after 14-18 
div.
3.2.6. Statistical analysis
Statistical analysis was carried out using the Mann-Whitney 
U test. Students unpaired t-test was used for the 
0xp©riments where individual inositol phosphates were 
determined. Various degrees of significance are indicated 
as follows:- * p level 0.05, ** 0.025, *** 0.01, **** 0.005.
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3.2.7. Materials
Collagenase, PA from egg yolk lecithin, the sodium salts of
PA containing different chain length fatty acids, Ptdlns
from soybean, Ptdlns(4)P and Ptdlns(4,5)P2 from bovine brain
were obtained frcxn Sigma. PA as the free acid in CHClgiMeOH
was obtained from Lipid Products, Surrey and PA as the
ammonium salt in CHClgiMeOH was obtained from Serdary
Research Labs. Inc., Canada. Ion exchange chromatography
materials were obtained from Sigma and BDH. Lithium
chloride, the TLC solvents, potassium oxalate and iodine
were obtained from BDH. High performance silica gel 60F TLC
3plates were obtained from Merck. Myo-[2- H]inositol
45(water:ethanol 9:1 v/v) 15Ci/mmol and calcium chloride in 
0.15M HCl (15 mCi/mg calcium) were obtained from Amersham 
International PLC.
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3.3. RESULTS.
3
3.3.1. The effect of PA on the accumulation of [ H]inositol
phosphates in astrocytes.
3.3.1.1. Concentration dependence
Astrocyte-enriched cultures that had been prelabelled for 
24h with [^H]myo-inositol were exposed to various 
concentrations of PA for 30 minutes in the presence of 
lithium chloride (5mM). The addition of PA caused a dose- 
dependent increase in IPs accumulation in the concentration 
range 10 to SOOyUgml-^ (Figure 3.4. (exp 1)). 0.1 and 1
yutgml"^  PA were without effect. At 50/*gml  ^PA (71/A-M)
maximal stimulation of 183% of control was seen, giving an
'soECp.^  of 2 5 / ^ 1  ^ (36/AM)
In a similar experiment where the effects of 1, 10, 50 and 
lOOyxgml"^ PA were investigated (Figure 3.4., exp 2), 10 
/Agml"^  was this time without effect but maximal stimulation 
was again seen at 50/Agml"^ but the increase was only 129% 
of control compared to 183% for the previous experiment. The 
dose response curve did however give an EC^^ similar to that 
obtained in the previous experiment. Thus an increase in 
P P I  turnover was seen in astrocytes in response to PA but 
this response was found to be variable.
When the data from this experiment (Figure 3.4. exp 1) is 
plotted with that obtained by Murphy and Pearce (1988; also 
Pearce and Murphy 1988) for the effect of PA on
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Figure 3.4. The concentration dependence of PA-induced
[^H]inositol phosphates accumulation (GPI and 
IPs).
Astrocyte-enriched cultures (18 div) were prelabelled for 
24h and then exposed to various concentrations of PA (in the 
presence of 5mM lithium chloride) for 30 minutes. Results 
are mean +/- SEM (n = 6 for exp 1 and n = 3 for exp 2) using 
60mm dishes and are expressed as % of control incubations 
(no PA added). Mean dpm for control incubations = 1150 dpm 
for n = 6 and 723 dpm for n = 3. Statistical analysis was 
carried out using the Mann-Whitney U test. Various degrees 
of significance are indicated as follows:- * p level 0.05,
** 0.025, *** 0.001 and **** 0.001. Each condition compared 
to control incubation (no PA added).
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[^H]thymidine incorporation into astrocyte DMA (Figure 3.5.)
3
it can be seen that PA shows the same efficacy for [ H]IPs 
accumulation and DNA synthesis.
PA obtained from Sigma was initially dry and powdery but on 
storage it did take on a more waxy appearance. The source 
of the variable response in astrocytes may therefore have 
been due to the state of the PA that was used. This was 
investigated by comparing the effect of freshly opened PA to 
that which had been stored. The experiment was carried out 
as outlined above with prelabelled astrocytes except that 
the cells were exposed to two different sorts of PA at 50 
u^ugml"^  for 30 minutes and the IPs accumulated determined. As 
can be seen from Table 3.1. both types of PA caused a 
significant increase in IPs accumulated but that in response 
to dry PA was greater than that seen in response to waxy PA, 
152% of control compared to 129% of control respectively.
The variable response of astrocytes to PA may therefore have 
been due to a variation in the state of the PA used in 
different experiments, although a response was still seen 
when PA of a more waxy appearance was used. In an attempt 
to overcome this variation in response to the phospholipid, 
PA was stored as a 10 mgml”  ^stock in CHCl^:MeOH (1:2 v/v) 
in the freezer and diluted appropriately for use.
3.3.1.2. Time Course.
Prelabelled astrocyte-enriched cultures were exposed to 50 
/Agml“  ^PA, diluted from the 10 mgml”  ^stock for varying 
lengths of time. The control incubations were stopped after
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Figure 3.5. The relationship between PA-induced
[^H]inositol phosphates accumulation (GPI and
3
IPs) and PA-stimulated [ H]thymidine 
incorporation.
[^H]Inositol phosphates accumulation (GPI and IPs) see 
Figure 3.4. legend.
[^H]Thymidine incorporation. Subconfluent serum-depleted 
cultures were exposed to various concentrations of PA for 
24h. Results are mean +/- SEM (n = 4) using 24 well plates 
and are expressed as % of 0.1% FCS GM control.
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Table 3,1. The effect of PA in different conditions on the
3
accumulation of [ H]inositol phosphate (GPI and 
IPs).
Astrocyte-enriched cultures (18 div) were prelabelled for
-124h and then exposed to either dry or waxy PA at 50yigml 
for 30 minutes (in the presence of 5mM lithium chloride). 
Results are mean +/- SEM (n = 8) using 60mm dishes. 
Statistical analysis was carried out using the Mann-Whitney 
U test. Various degrees of significance are indicated as 
follows:- * p level 0.05, ** 0.025, *** 0.001 and ****
0.001. Each condition compared to control incubation (no PA 
added).
Sample Normalised dpm % control p level
Control 918 +/- 71 100 +/- 8
PA waxy 1182 +/- 73 129 +/- 8 **
PA dry 1395 +/- 97 152 +/- 11 ***
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the lithium preincubation. After 5 minutes exposure to 50 
y^gmiPA the increase in IPs accumulation was 224% of 
control (Figure 3.6.). The response then declined to only 
122% of control by 60 minutes.
The individual IPs formed by prelabelled astrocyte-enriched 
cultures in response to 50 yu.gml  ^PA for 5 and 30 minutes 
were also examined (Table 3.2.). After 5 minutes exposure 
to 50/xgml”  ^PA increases were seen in the accumulation of 
InsP^ and InsP^ of 280% and 422% of control respectively. An 
increase of 146% of control was also seen in the InsP^ 
fraction at this shorter time point. After 30 minutes 
exposure an increase in InsP^ of 241% of control was 
detected but increases were no longer seen in the InsP^ and 
InsP^ fractions.
The time course experiments outlined in Figure 3.6. and 
Table 3.2. were carried out using the PA stock in CHClg : MeOH 
(1:2 v/v) which was diluted appropriately for use. The 
CHCl^:MeOH vehicle itself"however, was found to stimulate 
PPI turnover in astrocytes. A preliminary experiment was 
carried out to investigate the effect of CHCl^:MeOH (1:2 
v/v) in the concentration range 0.01 to 1.0% v/v on IPs 
accumulation after 30 minutes exposure. 0.5 and 1.0% v/v 
CHCl^:MeOH (1:2 v/v) caused significant increases in 
accumulation of 189% and 382% of control respectively 
(Figure 3.7.).
The time course experiment that was carried out to determine
the total IPs accumulation in response to 50/Agml  ^PA had
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3
Figure 3.6. The time course of PA-induced [ H]inositol 
phosphate accumulation (GPI and IPs).
Astrocyte-enriched cultures (18 div) were prelabelled for 
24h and exposed to PA at 50 ;ugml" for the times indicated 
( in the presence of 5mM lithium chloride ). Results are mean 
+/- SEM (n = 3) using 60mm dishes and are expressed as % of 
control incubations (stopped after lithium preincubation). 
Mean dpm for control incubations = 1305 dpm. Statistical 
analysis was carried out using the Mann-Whitney U test. 
Various degrees of significance are indicated as follows:- 
p level 0.05, ** 0.025, *** 0.001 and **** 0.001. Each 
condition compared to control incubation (stopped after 
lithium preincubation).
*
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Table 3.2. PA-induced individual [ H]inositol phosphate 
accumulation.
Astrocyte-enriched cultures (18 div) were prelabelled for 
24h and then exposed to PA at 50 yULgml"^  for 5 or 30 minutes 
(in the presence of 5mM lithium chloride).
IP fraction
Total dpm/IP fraction 
Time (mins)
5 30
Control PA Control PA
GPI
InsP^
InsP2
InsPa
Total
8185
4986
3110
985
17266
5448
13979
13120
1437
33984
5197
7806
8281
1418
22702
7604
18847
9138
917
36506
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Figure 3.7. The effect of various concentrations of
3CHCl^iMeOH (1:2 v/v) mixture on [ H]inositol 
phosphate accumulation (GPI and IPs).
Astrocyte-enriched cultures (18 div) were prelabelled for 
24h and then exposed to various concentrations of CHClgiMeOH 
(1:2 v/v) for 30 minutes (in the presence of 5mM lithium 
choride). Results are mean +/- SEM (n = 3) using 60mm 
dishes and are expressed as % of control incubations (no 
CHCl^:MeOH added). Mean dpm for control incubations = 1000 
dpm. Statistical analysis was carried out using the Mann- 
Whitney U test. Various degrees of significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.001 
and **** 0.001. Each condition compared to control 
incubation (no CHCl^•MeOH added).
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0.5% CHClgiMeOH (1:2 v/v) present. The increases seen in 
IPs accumulation may consequently have been due to the 
presence of CHClgiMeOH (1:2 v/v). Exposure for longer time 
periods, for example up to 50 minutes, may have had a 
detrimental effect on the cultures. Material was seen to 
have lifted off the dishes after these longer time periods 
and a decrease in the recovery of membrane inositol lipids 
of up to 18% was seen with increasing CHCl^:MeOH (1:2 v/v) 
concentration (Table 3.3.).
The effect of PA in a non-stimulatory concentration of 
CHClg:MeOH (1:2 v/v) on the accumulation of individual IPs 
was therefore investigated to check that PPI turnover was 
being seen in response to PA. Cells that had been 
prelabelled for 72h in this instance were exposed to PA at 
lOOyu^ gml"^  in 0.1% CHCl^:MeOH (1:2 v/v) for 1 minute in the 
absence of lithium and compared to control incubations that 
had 0.1% CHCl^:MeOH (1:2 v/v) added to them. PA still 
caused an increase in the accumulation of InsP^ of 170% of 
control after 1 minute (Table 3.4.). A representative 
elution profile of the ion exchange chromatography of the 
individual IPs is shown in Figure 3.8.
The accumulation of total IPs by prelabelled astrocyte- 
enriched cultures at various time points in response to 50 
yjAgml”  ^PA that contained no solvent, aqueous PA, was also 
examined. PA was prepared from a 10 mgml  ^stock in 
CHClg:MeOH (1:2 v/v) from which the solvent was removed by 
and the PA sonicated in PSS. An increase in accumulation 
of 136% of control was seen by 5 minutes which was
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Table 3.3. The effect of CHClgiMeOH (1:2 v/v) on 
[ H]inositol phospholipid recovery.
Astrocyte-enriched cultures (18 div) were prelabelled for 
24h and then exposed to various concentrations of CHClg:MeOH 
(1:2 v/v) for 30 minutes (in the presence of 5mM lithium 
chloride). Results are mean +/- SEM (n = 3) using 60mm 
dishes. Statistical analysis was carried out using the 
Mann-Whitney U test. Various degrees of significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.001 
and **** 0.001. Each condition compared to control 
incubation (no CHClg:MeOH added).
% Concentration Dpm in lipids p level
of CHCl^:MeOH 
(1:2 v/v)
0 117990 +/- 2476
0.01 111654 +/- 1494
0.10 105478 +/- 5398
0.50 103129 +/- 1627 **
1.00 96792 +/- 561 **
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Table 3.4. The effect of PA in 0.1% CHCl^:MeOH (1:2 v/v) on
3the accumulation of individual [ H]inositol 
phosphates.
Astrocyte-enriched cultures were prelabelled for 72h and 
then exposed to PA at 100yjigml  ^in 0.1% CHCl^îMeOH (1:2 
v/v) for 1 minute (in the absence of lithium chloride). 
Results are mean +/- SEM (n = 3) using 60mm dishes. 
Statistical analysis was carried out using the Mann-Whitney 
U test. Various degrees of significance are indicated as 
follows:- * p level 0.05, ** 0.025, *** 0.001 and ****
0.001. Each IP fraction compared to appropriate control IP 
fraction.
Total normalised dpm/IP fraction
Sample InsP^ ^^^^3 ^ level
Control 2629 +/-243 3160 +/-421 559 +/- 59
PA 2361 +/- 92 2978 +/-192 953 +/-152 *
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Figure 3.8. Representative elution profiles of the ion
3exchange chromatography of [ H]inositol 
phosphates.
Astrocyte-enriched cultures prelabelled for 24h were exposed 
to 50/Agml”  ^PA for 1 minute (in the absence of lithium).
The aqueous phase from the pooled cultures was applied to
o
the column and the [H]inositol phosphates eluted as 
follows: 4x 2ml. inositol 5mM washes discarded and lx2ml.
inositol wash collected; 5x2ml. 5mM borax, 60mM sodium 
formate to elute GPI; 8x2ml. 5mM borax, 150mM sodium formate 
to elute InsP^; 5x2ml. 0.3M ammonium formate in O.IM formic 
acid to elute InsP^ and 3x2ml. 0.75M ammonium formate in 
O.IM formic acid to elute InsP^.
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maintained at approximately this level for up to 30 minutes 
(Figure 3.9.). After exposure for 60 minutes a slight 
reduction to 125% of control was seen.
The individual IPs formed by prelabelled astrocyte-enriched 
cultures in response to 50yAgml  ^aqueous PA at 1, 2 (in the 
absence of lithium), 5 and 30 (in the presence of lithium) 
minutes are shown in Table 3.5. Increases over control in 
the InsPg and InsP^ fractions were seen after exposure to PA 
for 1 and 2 minutes, a 74% increase being seen in the InsP^ 
fraction at both time points and the increase in InsP2 at 2 
minutes (60%) being larger than that at 1 minute (50%). The 
1 and 2 minute incubations were carried out in the absence 
of lithium so no increases were seen in the InsP^ fractions. 
An increase in InsPg accumulation was no longer seen after 5 
and 30 minute PA exposure. The InsP^ fraction showed an 
increase over control of 112% at 5 minutes but no increase 
was detectable after 30 minutes. These incubations were 
carried out in the presence of lithium and consequently 
increases were seen in the InsP^ fraction of 61% and 84% 
over control at 5 and 30 minutes respectively.
The individual [^H]IPs formed by prelabelled astrocytes in 
response to PA either in solvent or PA aqueous were also 
examined in the same experiment. Cells were exposed to PA 
in 0.1% CHCl^iMeOH (1:2 v/v) or aqueous PA, both at 100 
y&gml"^ , for 1 minute and compared to the appropriate solvent 
or aqueous control. Similar increases in the InsP2 and 
InsP^ fractions were seen with both types of PA ( Table 3.6.)
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Figure 3.9. The time course of aqueous PA-induced
q
[H]inositol phosphate accumulation (GPI and 
IPs).
Astrocyte-enriched cultures (18 div) were prelabelled for 
48h and then exposed to PA at SO/Agml"^ for the times 
indicated (in the presence of 5mM lithium choride). Results 
are mean +/- SEM (n = 3) using 60mm dishes and are expressed 
as % of control incubations (stopped after lithium 
preincubation). Mean dpm for control incubations = 1612 
dpm. Statistical analysis was carried out using the Mann- 
Whitney U test. Various degrees of significance are 
indicated as follows :- * p level 0.05, ** 0.025, *** 0.001 
and **** 0.001. Each condition compared to control 
incubation (stopped after lithium preincubation).
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Table 3.5. The time course of PA-induced individual 
q
[H]inositol phosphate accumulation.
Astrocyte-enriched cultures (18 div) were prelabelled for 
24h and then exposed to PA at 50 yuugml  ^for the times 
indicated (T = 1 and 2 minutes in the absence of lithium, T 
= 5 and 30 minutes in the presence of lithium). Results are 
mean +/- SEM (n = 3) using 60mm dishes. Statistical 
analysis was carried out using the Mann-Whitney U test. 
Various degrees of significance are indicated as follows:- * 
p level 0.05, ** 0.025, *** 0.001 and **** 0.001. Each IP 
fraction compared to appropriate control IP fraction.
Time Sample
(mins)
1 Control
PA
Total normalised dpm/IP fraction
InsP. InsPr InsP,
4110 +/- 830 5316 +/- 618 1315 +/-282
4259 +/- 304 7989 +/-1043* 2289 +/-278*
Control 3887 +/- 390 5313 +/- 504 1420 +/-228
PA 4111 +/- 153 8515 +/-1548 2474 +/-117*
Control 7222 +/-1328 4627 +/- 882 950 +/-214
PA 11639 +/-1766* 9820 +/-1823* 1492 +/- 31
30 Control 7155 +/- 384 7754 +/-1266 1208 +/ 257
PA 13151 +/-3113* 9963 +/-1360 1107 +/-279
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Table 3.6. The effect of PA in solvent compared to PA
aqueous on the accumulation of individual 
q
[H]inositol phosphates.
Astrocyte-enriched cultures (18 div) were prelabelled for 
72h and then exposed to 100yUgml  ^PA in 0.1% CHCl^:MeOH 
(1:2 v/v) or aqueous PA for 1 minute.
Sample Total normalised dpm /IP fraction
InsP. InsP, InsP,
Aqueous control 5804
Aqueous PA 6485
4078
8266
2557
3849
Solvent control 6361
Solvent PA 5533
4692
8282
2190
3069
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3.3.1.3. Calcium dependence
The calcium requirements of the PA response were determined 
by exposing prelabelled astrocyte-enriched cultures to 50 or 
lOOyw-gml"^  PA for 30 minutes under varying extracellular 
calcium conditions. Incubations were carried out either in 
the presence of added calcium (+Ca ), in the absence of 
added calcium ( -Ca"*"'" ) or the absence of added calcium and 
the presence of EGTA (-Ca^ + EGTA).
PA at 50 or 100/A-gml"^  in the presence of extracellular 
calcium elicited a 31% and 56% increase respectively in IPs 
accumulated when compared to the appropriate control (Table 
3.7.). In the absence of added calcium, the calcium 
concentration being that of the incubation medium, which is 
approximately 10yuM, PA at 50yu,gml"^  still elicited an 
increase in IPs accumulation over control but it was lower 
than that seen in the presence of added calcium, 12% 
compared to 31%. PA at either 50 or 100/xgml"^ had no 
effect on IPs accumulation when all available calcium was 
removed by the presence of EGTA. Calcium dependency was 
also exhibited by the control incubations.
3.3.1.4. Effect of PAs with fatty acids of differing chain 
lengths.
The effect of PAs of different fatty acid chain length on 
IPs accumulation was determined by exposing prelabelled 
astrocyte-enriched cultures to 50 yugrol  ^PA of differing 
compositions for 30 minutes. For these experiments lithium
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Table 3.7. The calcium dependence of PA-induced
[^H]inositol phosphate accumulation (GPI and 
IPs).
Astrocyte-enriched cultures (18 div) were prelabelled for 
24h and then exposed to PA at 50 and lOOyAgml (in the 
presence of 5mM lithium chloride) for 30 minutes in the 
presence of 2.5mM calcium chloride, the absence of added 
calcium or in the absence of added calcium and the presence 
of 0.5mM EGTA. Results are mean +/- SEM (n = 3) using 60mm 
dishes. Statistical analysis was carried out using the 
Mann-Whitney U test. Various degrees of significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.001 
and **** 0.001. Each condition compared to appropriate 
control.
Sample Normalised dpm
+Ca++ —Ca
++
Control 
PA (50)
1698 +/- 81
2231 +/- 271 *
885 +/- 14 819 +/- 33
989 +/- 25 * 643 +/- 30
Control 1309 +/- 234 ND
PA (100) 2038 +/- 257 * ND
372 +/- 59 
348 +/- 83
ND not determined
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was added at the same time as PA. PA from egg yolk lecithin 
caused an increase in IPs accumulation of 142% of control 
but none of the other PAs tested, containing lauric (PA di- 
C1 2 .0 )/ Palmi'tic (PA di-C^g.Q) or oleic acid (PA di-C^g.^), 
had any effect (Table 3.8.).
The effect of PAs of differing composition on the individual 
IPs formed was determined by exposing prelabelled astrocyte- 
enriched cultures to different PAs for 1 minute in the 
absence of lithium. Only PA from egg yolk lecithin caused 
significant increases in InsPg and InsP^ accumulation of 151% 
and 138% of control respectively (Table 3.9.). PA 
PA containing myristic acid (PA di-C^^.Q) and PA di-C^g.Q 
had no effect on the accumulation of any IP. However, PA 
containing C^g.^ did cause a significant increase in InsP^ 
and InsP2 accumulation of 139% and 142% of control 
respectively.
3.3.2. Effect of PA on phosphoinositide labelling of 
astrocytes.
3.3.2.1. Time Course
The effect of PA on the metabolism of inositol phospholipids 
was further investigated by studying the recovery of 
[^H]inositol in Ptdlns, PtdIns(4)P and Ptdlns(4,5)P2* 
Prelabelled astrocyte-enriched cultures were exposed to PA 
at 50/Xgml”  ^for varying lengths of time. The extracted 
labelled phospholipids were separated by thin layer 
chromatography and a representative diagram of the
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Table 3.8. The effect of PAs of differing fatty acid chain
3
length on PA-induced [ H]inositol phosphate 
accumulation.
Astrocyte-enriched cultures (18 div) were prelabelled for
24h and then exposed to PA di-C^2;0' ^^”^ 16:0'
C^g.^ and PA egg yolk lecithin at 50y&Lgml  ^for 30 minutes 
(in the presence of 5mM lithium chloride). Results are mean 
+/- SEM (n = 3) using 60mm dishes. Statistical analysis was 
carried out using the Mann-Whitney U test. Various degrees 
of significance are indicated as follows:- * p level 0.05,
** 0.025, *** 0.001 and **** 0.001. Each condition compared 
to control (no PA added).
Sample Normalised dpm % control
Control 1664 +/- 68 100 +/- .4
PA di-Ci2:0 1362 +/- 150
82 +/- 9
PA <3i-C^ 6:0 1437 +/- 187
86 +/- 11
PA di-Ci8:l 1705 +/- 254
102 +/- 15
PA lecithin 2367 +/- 134 142 +/- 8
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Table 3.9. The effect of PAs of differing fatty acid chain
3length on PA-induced individual [ H]inositol 
phosphate accumulation.
Astrocyte-enriched cultures (18 div) were prelabelled for 
72h and then exposed to PA di-C^2 ;0 ' ;0'
^16-0' ^^"^18*1 from egg yolk lecithin at 50
yULgml"^  for 1 minute. Results are mean +/- SEM (n = 3) using 
6 well plates. Statistical analysis was carried out using 
the Mann-Whitney U test. Various degrees of significance 
are indicated as follows:- * p level 0.05, ** 0.025, *** 
0.001 and **** 0.001. Each condition compared to control
(no PA added).
Sample
InsP,
Total dpm/IP fraction
InsP, InsP,
Control 4045 +/- 439 3544 +/- 199 933 +/— 90
PA di-Ci2:0 5513 +/- 595 4678
+/- 750 999 +/-207
PA di-Ci4,o 4738 +/- 197 4209 +/- 454 977
+/- 86
PA di-Ci6:0 5059 +/- 502
4201 +/- 533 1313 +/-188
PA ‘^ ■^''18:1 5628
+/- 618 * 5026 +/- 625 * 1179 +/-127
PA lecithin 4700 +/- 659 4882 +/- 117 * 1412 +/-136 *
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separation achieved is shown in Figure 3.10. After 1 and 2 
minute incubations a reduction of approximately 50% was seen 
in the amount of radiolabel recovered in Ptdlns(4,5)?2 
compared to control incubations (Table 3.10.) and no changes 
were seen in the labelling of Ptdlns or Ptdlns(4)P. By 5 
minutes an increase in the labelling of both Ptdlns(4,5)P^ 
and Ptdlns(4)P and a decrease in that of Ptdlns was found in 
response to PA.
3.3.2.2. Effect of PAs with fatty acids of differing chain 
length.
The effect of changing the fatty acid chain length of PA on 
the inositol phospholipid labelling of prelabelled 
astrocyte-enriched cultures was investigated by exposing 
cultures to PA of differing composition for 30 minutes in 
the presence of lithium. After 30 minutes exposure 
increases in the % labelling of PtdIns(4,5)P2 and Ptdlns(4)P 
were seen which seem to be dependent on the presence of 
longer chain fatty acids (Table 3.11.) which is in agreement 
with data obtained from IPs accumulation experiments. Chain 
length dependent decreases were also seen in the labelling 
of Ptdlns.
3.3.3. Effect of PA on efflux from astrocytes.
3.3.3.1. Concentration dependence.
Astrocyte-enriched cultures preloaded with ^^Ca for 24h 
were exposed to various concentrations of PA. After the
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Figure 3.10. A representative diagram of the 
phosphoinositide separation achieved with the 
TLC system employing high performance silica 
gel 60F TLC plates and mobile phase of the 
following composition:
CHClg:acetone:MeOH:acetic acid:H2Û 
(40:15:13:12:8 v/v).
Key to samples applied to TLC plate
Sample number Phospholipid Source
1
2
3
4
5
6
PA Sigma
Ptdlns Sigma
Ptdlns(4)P Sigma
PtdIns(4,5)P2 Sigma
PA Serdary
Mixture of 1,2,3 and 4 Sigma
148
Figure 3.10.
SOLVENT
FRONT
ORIGIN
149
3
Table 3.10. PA-induced changes in [ H]inositol phospholipid 
labelling.
Astrocyte-enriched cultures (18 div) were prelabelled for 
24h and then exposed to PA at SOytAgml”  ^for the time 
indicated. Results are mean +/- SEM (n) using 60mm dishes 
and are expressed as % of the total dpm recovered in the 
phosphoinositides in each phosphoinositide fraction, dpm 
recovered in each phosphoinositide fraction were as follows: 
Ptdlns 170,000-360,000 dpm; Ptdlns(4)P 6,000-10,000 dpm; 
Ptdlns(4,5)P2 800-1500 dpm. Statistical analysis was 
carried out using the Mann-Whitney U test. Various degrees 
of significance are indicated as follows:- * p level 0.05,
** 0.025, *** 0.001 and **** 0.001. Each condition compared 
to control (no PA added).
Time Sample % phosphoinositide labelling
(mins) Ptdlns Ptdlns(4)P Ptdlns(4,5)P2
1 Control (6) 92.0 +/-1.2 3.7 +/-0.6 4.3 +/-0.9
PA (7) 93.4 +/-0.9 4.2 +/-0.6 2.2 +/-0.4 *
2 Control (3) 92.9 +/-1.2 4.0 +/-0.9 3.1 +/-0.6
PA (4) 94.6 +/-0.4 3.8 +/-0.5 1.6 +/-0.4 *
5 Control (1) 95.1 2.3 2.6
PA (1) 91.9 4.8 3.3
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Table 3.11. The effect of PAs of differing fatty acid chain
q
length on [H]inositol phospholipid labelling.
Astrocyte-enriched cultures (18 div) were prelabelled for 
72h and then exposed to PAs of different composition at 
SO/Agml"^ for 30 minutes (in the presence of 5mM lithium 
chloride). Results are from 1 experiment using 60mm dishes, 
dpm recovered in each phosphoinositide fraction were as 
follows: Ptd Ins 360,000 dpm; Ptdlns(4)P 8,800 dpm;
Ptdlns(4,5)P2 800 dpm.
Sample % phosphoinositide labelling 
Ptdlns Ptdlns(4)P Ptdlns(4,5)P2
Control 96.8 1.8 1.4
PA di-C^2:0 94.0 3.3
2.7
PA di-C^4.Q 95.3 2.4 2.4
PA <31-0^ 6:0 96.4 1.8
1.8
PA <33-^ 18:1 92.0 4.5
3.4
PA lecithin 83.3 10.1 6.6
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basal efflux was established PA from either Lipid Products
or Serdary Research Labs, at 1, 10 or 100 ytgml  ^was added
for 1 minute. Both PAs were stored as 100 mgml"^ stocks in
CHClgiMeOH (1:2 v/v) and diluted appropriately for use. PA
at 100/Agml“  ^whether from Lipid Products or from Serdary
caused an increase in ^^Ca efflux of 200% and 188% of
control respectively (Table 3.12.). No significant effect
—1was seen with 1 or 10yugml" PA from either source.
The previous experiment was carried out using a stock 
solution of PA at 100 mgml”  ^in CHClg:MeOH (1:2 v/v). In 
view of its effects on PPI turnover the effect of this 
solvent on ^^Ca^^ efflux was also investigated. No 
significant effect of 0.01% or 0.1% CHClg:MeOH (1:2 v/v) was 
seen and PA from Serdary at 100 /L&gml  ^in 0.1% v/v solvent 
still elicited an increase in efflux (Table 3.13.), although 
the increase was only 20% compared to 88% in the previous 
experiment.
The effect of aqueous PA on ^ ^Ca efflux from astrocytes
was also investigated and a significant increase in efflux
of 15% over control was seen at 100/Xgml  ^(Table 3.13.). 
This increase was similar to that obtained in the experiment 
outlined above but lower than that obtained in the first 
experiment described. Again 1 or 10 yC^ gml PA were without 
effect. Thus PA does cause efflux from astrocytes,
but like the stimulation of PPI turnover, the response was
found to be variable.
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45 ++Table 3.12. The effect of two different PAs on Ca 
efflux from astrocytes.
Astrocyte-enriched cultures (18 div) preloaded with Ca 
were exposed to various concentrations of PA for 1 minute. 
Results are mean +/- SEM (n = 3) using 6 well plates and are 
expressed as % of the efflux sample prior to PA addition, 
dpm in PA exposure fraction 160-740 dpm. Mean residual dpm 
in cells = 2894 dpm. Statistical analysis was carried out 
using the Mann-Whitney U test. Various degrees of 
significance are indicated as follows: - * p level 0.05, ** 
0.025, *** 0.001 and **** 0.001. Each condition compared to 
the efflux sample prior to PA addition.
Sample % Control
Lipid Products PA Serdary PA
PA 1 105 +/- 1 88 +/- 1
PA 10 116 +/- 9 114 +/-14
PA 100 200 +Z-27 * 188 +/- 8 *
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Table 3.13. PA-induced ^^Ca‘"^ efflux from astrocytes.
Astrocyte-enriched cultures (18 div) were preloaded with 
^^Ca^^ for 24h and then exposed to PA at 100yx.gml  ^in 0.1% 
solvent and compared with the appropriate control, or 
exposed to aqueous PA at 1, 10 or 100 /Ugml Results are 
mean +/- SEM (n) using 6 well plates and are expressed as % 
of the efflux sample prior to PA addition, dpm in exposure 
fraction 235-840 dpm. Mean residual dpm in cells = 6926 +/- 
314. Statistical analysis was carried out using the Mann- 
Whitney U test. Various degrees of significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.001 
and **** 0.001. Each condition compared to the efflux 
sample prior to PA addition.
Sample % Control
0.01% solvent 92 +/- 3 (n = 6)
0.1% solvent 96 +/- 6 (n = 4)
PA 100 in 0.1% 120 +/- 6 (n =6) *
Aqueous PA 1 96 +/- 3 (n = 6)
Aqueous PA 10 109 +/- 8 (n = 6)
Aqueous PA 100 115^+/- 5 (n = 4) *
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3.3.3.2. Effect of PAs with fatty acids of differing chain 
length.
The effect of PAs of differing fatty acid chain length on 
45ca** efflux from astrocytes was investigated by exposing 
cells to PAs of varying composition for 1 minute. The 
largest increase in response was seen with PA from egg 
lecithin, although increases in efflux were seen with PA 
containing and C^q:1 acids (Table 3.14.).
The shortest fatty acid chain length PA tested, C^g.Q, had 
no effect on efflux. There did appear to be a gradation in 
the ^^ Ca'*”’ response of astrocytes to differing composition 
PAs.
3.3.4. Effect of PA on [^H]inositol phosphates accumulation 
in, and ^^Ca^^ efflux from fibroblast cultures.
The major contaminating cell type of these astrocyte- 
enriched cultures is fibroblasts of meningeal origin which 
constitute approximately 5-10 % of the cells present. To 
assess whether contaminating fibroblasts were responsible 
for the effect of PA on PPI turnover and the ^^Ca** efflux 
that was seen, the effect of PA was investigated in 
confluent fibroblast cultures. The meninges of 5 neonatal 
rats were used to seed six 6 wells. The mean protein 
content of these confluent cultures was 925 +/- 17/^g/well 
(n = 12) and the mean DNA content was 40.7 +/- 2.5ykg/well 
(n = 12). Prelabelled fibroblast cultures were exposed to 
varying concentrations of PA for 30 minutes. PA had no 
significant effect on IPs accumulation in this cell type
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Table 3.14. The effect of PAs of differing composition on
efflux from astrocytes.
Astrocyte-enriched cultures (18 div) were preloaded for 24h 
with and then exposed to PAs of differing composition
for 1 minute. Results are mean +/- SEM (n = 9) using 6 well 
plates from 3 experiments and are expressed as % of the 
efflux sample prior to PA addition, dpm in PA exposure 
fraction 150-505 dpm. Mean residual dpm in cells = 2105 +/- 
129. Statistical analysis was carried out using the Mann- 
Whitney U test. Various degrees of significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.001 
and ****0.001. Each condition compared to the efflux 
sample prior to PA addition.
Sample % control
PA di-Ci2:0 ^
PA di-Cj^ .^Q 116 +/- 2 *
PA di-C^g.o 117 +/- 5 *
PA di-Cj^ s-l +/- 5 *
PA lecithin 121 +/- 3 *
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(Table 3.15).
45_ ++However Ca'^'^ efflux was increased when preloaded 
astrocytes were exposed to 1 0 0  ^ (Table 3.15.). The 
response, a 17% increase over control, was of a similar 
magnitude to that elicited by PA in astrocytes.
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Table 3.15. PA-induced [^H]inositol phosphate accumulation 
in and efflux from fibroblasts.
Fibroblast cultures (19 div) prelabelled with [ H]myo­
inositol for 24h and then exposed to various concentrations 
of PA (in the presence of 5mM lithium chloride) for 30 
minutes. Results are mean +/- SEM (n = 6) using 6 well 
plates from 2 experiments. Fibroblast cultures (19 div) 
preloaded with for 24h were exposed to varying
concentrations of PA for 1 minute. Results are mean +/- SEM 
(n = 3) using 6 well plates and are expressed as % of the 
efflux sample prior to PA addition, dpm in PA exposure 
fraction 520-685 dpm. Mean residual dpm in cells = 4810 +/- 
164. ND not determined. Statistical analysis was carried 
out using the Mann— Whitney U test. Various degrees of 
significance are indicated as follows: - * p level 0.05, ** 
0.025, *** 0.001 and **** 0.001. Each condition compared to 
the efflux sample prior to PA addition.
PA conc. 
(yU-gml“^)
IP accumulation 
Normalised dpm
efflux
% control
0
1
10
50
100
383 +/- 30 
426 +/- 26 
465 +/- 34 
440 +/- 27 
483 +/- 59
109 +/- 7 
87 +/- 3 
ND
117 +/- 7 *
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3.4. SUMMARY
(i) PA elicited a dose- and time-dependent increase in 
the accumulation of labelled inositol phosphates and 
individual inositol phosphates. This stimulation of PPI 
turnover appeared to be dependent on a low extracellular 
calcium concentration as well as PA containing longer chain 
length fatty acids.
(ii) PA was found to cause time-dependent changes in the 
labelling of inositol phospholipids and this effect of PA 
was also dependent on longer chain length PAs.
(iii) PA produced efflux from astrocytes which again
was dependent on PA containing longer chain length fatty 
acids.
(iv) PA had no detectable effect on PPI turnover in 
fibroblasts but did stimulate Ca efflux from these 
cells.
159
3.5. DISCUSSION.
The ability of PA to promote PPI breakdown in astrocytes was 
demonstrated in this chapter. There does appear to be a 
correlation between PA-stimulated PPI turnover and PA- 
induced DNA synthesis in astrocytes. PA had been found to 
elicit increased [^H]thymidine incorporation into astrocyte 
DNA and increase the DNA content of astrocyte cultures 
(Chapter 2) over a similar concentration range to that which 
had been found to stimulate astrocyte PPI turnover.
Agreement was also seen between the data obtained here for 
the effect of PA on PPI breakdown and data obtained for the 
mitogenic action of PA on astroglial cultures from previous 
work by Murphy and Pearce (1988a).
In other studies on Rat-1 and NIH 3T3 fibroblasts PA
3stimulated PPI turnover and increased [ H]thymidine 
incorporation over the same concentration range (Moolenaar 
et al 1986; Yu et al 1988). Siegmann (1987) found that PA 
either in the form of liposomes or in buffer also increased 
[^H]thymidine incorporation into 3T3 cells. Although the 
concentration of PA used in this study was higher and the 
exposure time only 30 minutes, the cells may still have been 
exposed to a lower level of PA for a longer period of time 
due to the presence of some residual PA after the cells had 
been washed.
PA caused a dose- and time-dependent increase in total IPs 
accumulated but to determine whether PA was activating PL C 
and stimulating PtdIns(4,5)P2 hydrolysis the individual IPs
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formed had to be investigated. The changes that were seen in 
the formation of the individual IPs are in general agreement 
with those that are associated with PA-induced changes in 
other cell types. The pattern of accumulation of individual 
IPs in astrocytes is similar to those seen by other workers 
using fibroblasts exposed to PA. Using A431 cells Moolenaar 
et al (1986) found increased InsP^ accumulation after 30 
seconds exposure to PA at 50 y^gml . Murayama and Ui 
(1987a) showed that PA caused the accumulation of InsP^ in 
3T3 cells which preceded that of InsP^ ^ which in turn was 
seen before an increase in InsP^ . The increases that were 
seen in InsP^ and InsP^ may also have been due to the action 
of a calcium-dependent PL C on Ptdlns and PtdIns(4)P 
(Majerus et al 1985). Not all the InsP^ and InsP2 seen 
could have been produced from InsP^ since the amount of 
Ptdlns(4)P and PtdIns(4,5)P2 present in the cell membrane is 
much smaller than Ptdlns. Between 92% and 95% of the 
[^H]inositol radiolabel incorporated into astrocyte cell 
membranes is associated with Ptdlns and the remaining 
[^H]inositol radiolabel is equally distributed in Ptdlns(4)P 
and Ptdlns(4,5)P2 * Calcium mobilisation could thus have 
initiated the hydrolysis of Ptdlns or Ptdlns(4)P by a 
calcium-dependent PL C to liberate InsP^ and InsP2 *
These changes in individual IPs are also in agreement with 
the effect of other calcium mobilising stimuli that activate 
PPI turnover in their target cells. Thrombin activation of 
fibroblasts leads to InsPg and InsP2 formation which 
precedes that of InsP^ (L’Allemain et al 1986) and 
stimulation by PDGF elicits InsP^ and InsP2 formation before
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that of InsPj^  (Berridge et al 1984). Similar patterns of 
accumulation of individual IPs have also been seen in 
astrocytes in response to agonists whose receptors are known 
to be linked to PPI turnover. After short periods of 
exposure, up to 1 minute, increases are seen in InsP^ and 
InsP^ accumulation in response to carbachol and 
noradrenaline but after longer exposure, for example up to 
60 minutes, increases in InsP^ and InsP2 only are seen 
(Pearce et al 1986a). Glutamate and ATP have also been 
shown to bring about early changes in the accumulation of 
InsPg and InsP2 in astrocytes (Pearce et al 1986b; 1989).
The changes seen in the labelling of the inositol
phospholipids of astrocytes in response to PA are also in
agreement with the initial action of PA being that of
promoting the hydrolysis of Ptdlns(4)P by PL G. The effect
of PA on inositol phospholipid metabolism has not be^
investigated in similar studies looking at the effect of PA
on PPI turnover in other cell types, but the action of PA on
astrocytes agrees with that seen in response to agonists
that are known to mobilise calcium in their target cell by
activating PPI breakdown. The action of acetylcholine on
32
iris smooth muscle initially produced a loss of P 
radiolabel from labelled Ptdlns(4,5)P2 (Abdel-Latif 1986) 
and the action of bradykinin on NO 108-15 cells, a
32
neuroblastoma glioma hybrid, also caused a loss of P from 
PtdIns(4,5)P2 (Yano et al 1984). At later time points 
however the stimulation of fibroblasts with PDGF causes a 
loss of [^H]inositol label from Ptdlns and an increase in 
label in PtdIns(4)P and Ptdlns(4,5)P2 (Berridge et al 1984),
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as Ptdlns is used to replenish the PtdIns(4)P and 
Ptdlns(4,5)P^  lipid pools.
PA was shown to have an effect on calcium mobilisation in 
astrocytes as demonstrated by increased efflux of ^^Ca^^ 
from prelabelled astrocytes. This effect of PA on 
astrocytes is in agreement with its action on other cell 
types. PA at similar concentrations to those that were used 
in this study caused a transient increase in [Ca^^]^ in A431 
cells (Moolenaar et al 1986) and osteoblasts (Kawase and 
Suzuki 1988) as well as eliciting Ca^^ efflux from perfused 
rat liver (Altin and Bygrave 1987). Increased efflux
has been reported in glial cells in response to a number of 
agonists whose action involves the promotion of PPI 
turnover. Carbachol, glutamate and noradrenaline elicit 
^^ Ca'^ '’ efflux from 138 MG glioma cells (Lazarewicz and Kan je 
1981) and ATP, carbachol, glutamate and noradrenaline 
promote efflux from cerebral astrocytes ( Pearce and
Murphy 1988; Pearce et al 1986b; 1989).
The omission of calcium reduced the total IPs accumulated in 
response to PA in astrocytes and the inclusion of EGTA 
abolished the response to PA altogether in this study which 
is in contrast to the results obtained using 3T3 cells where 
the omission of calcium from the incubation medium had no 
effect on the action of PA (Murayama and Ui 1987a).
Moolenaar et al (1986) using A431 cells found that the 
addition of EGTA caused only a slight reduction in the 
effect that PA had on increasing [Ca’^'^ ]^  and the action of 
PA on increasing [Ca^ ]^ in osteoblasts was also independent
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of extracellular calcium (Kawase and Suzuki 1988). This 
lack of dependence on extracellular calcium for the action 
of PA has also been demonstrated in human platelet membranes 
where the addition of EGTA had no effect on the stimulatory 
effect of PA on Ptdlns(4,5)P2 hydrolysis by PL C (Jackowski 
and Rock 1989). The action of PA on astrocytes appears to be 
different from that seen in other cell types since it does 
demonstrate a requirement for micromolar concentrations of 
calcium. The actions of carbachol and noradrenaline on 
astrocytes are little changed when calcium is cxnitted from 
"the incubation medium (Pearce et al 1986a), but a reduction 
in response was seen when astrocytes were exposed to 
carbachol, noradrenaline or glutamate in calcium-free 
incubation medium containing EGTA (Pearce et al 1986a; 
1986b). p a ’s calcium dependence seems to be different from 
that of conventional agonists linked to PPI turnover in 
astrocytes. Could these differences be explained by PA 
acting as a calcium ionophore?
From work done with the calcium ionophore A23187 on 
astrocytes ( Pearce et al 1987 ) it does not seem that PA is 
acting like an ionophore in these cells since different 
patterns of accumulation of individual IPs and different 
changes in the labelling of inositol phospholipids are seen. 
A23187 stimulates PPI turnover in astrocytes, but increases 
were seen in InsP2 and InsP^ and unlike PA, no increase in 
InsPg was seen. Changes were also seen in the labelling of 
Ptdlns and PtdIns(4)P in astrocytes in response to A23187, 
but no change was seen in Ptdlns(4,5)P2 labelling whereas 
change was seen in response to PA.
164
A number of mechanisms have however been suggested for the 
way in which PA may be stimulating PL C hydrolysis of 
PtdIns(4,5)P2« PA could be released from the cell to 
interact with specific PA binding sites that are linked to 
PPI turnover (Murayama and Ui 1987a) or PA could cause 
membrane perturbation that would make Ptdlns(4,5)P2 more 
suspectible to PL C attack (Moolenaar et al 1986).
PA had no effect on the total IPs accumulation in 
fibroblasts of meningeal origin under the same conditions 
that promoted PPI turnover in astrocytes. The PPI turnover 
seen in astrocytes in response to PA was therefore not due 
to the presence of contaminating fibroblasts. PA did 
however stimulate PPI breakdown in 3T3 (Murayama and Ui 
1987a) and A431 fibroblasts (Moolenaar et al 1986). Murayama 
and Ui (1987a) demonstrated an effect of PA in 3T3 cells but 
not in platelets. These differences between different cell 
types were explained by Murayama and Ui (1987a) as being due 
to the presence or absence of specific binding sites for PA.
Further evidence for the possible existence of specific 
binding sites for PA comes from studies using other cells 
that show that PA of a particular structural conformation 
appears to be required for this phospholipid to have its 
maximal effect. This requirement for the presence of long 
chain fatty acids in PA is seen in astrocytes both for its 
effect on PPI turnover and on ^^Ca^^ efflux. The effect of 
PA in 3T3 cells (Murayama and Ui 1987a) was also dependent 
on the presence of long chain unsaturated fatty acids. These 
workers observed that PA containing the saturated fatty acid
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lauric acid (C 2^ .Q) was able to antagonise the inhibitory 
action of PA containing the unsaturated fatty acid oleic i 
acid (C^g.^). Similar structural requirements of PA were 
demonstrated by Moolenaar et al (1986). The addition of PA 
from lecithin (the naturally occurring form of PA) to A431 
cells elicited a transient increase in [Ca'^'*']^ but the 
response to PA containing palmitic acid (C^g,Q) was 
variable, and that to PAs containing myristic acid (C^^.g) 
or lauric acid ( 1^ 2 *0  ^ effect. Skaper et al (1989)
found that only PA from lecithin was capable of inhibiting 
the morphological changes associated with increased levels 
of cAMP in astroglial cells, PA containing oleic acid 
(C1 8 .1 )/ stearic acid (C^ q.q), palmitic acid 
myristic acid or lauric acid (C^2:0^ without
effect. Shortening the chain length of the fatty acids in PA 
also reduced the effectiveness of PA in activating the 
hydrolysis of PtdIns(4,5)P2 by PL C in human platelet 
membranes (Jackowski and Rock 1989). The effect of PA on 
inositol phospholipid labelling in astrocytes was also 
dependent on the presence of long chain fatty acids for 
maximal effect.
Further support for the existence of specific PA binding 
sites comes from studies that show that the action of PA in 
a number of different cell systems seems to be specific for 
PA since other phospholipids or free fatty acids cannot 
mimick its effects. PS, PC and arachidonic acid (AA) were 
unable to mimick the effects of PA on 3T3 cells (Murayama 
and Ui 1987a). Ptdlns, PC and the fatty acids AA, C^ g^.^  and 
Cfs Q were unable to increase [Ca ] in A431 cells
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(Moolenaar et al 1986). PE, PC, Ptdlns and PS had no effect 
on the activation of Ptdlns(4,5)P2 hydrolysis by PL C 
(Jackowski and Rock 1989) or the conversion of epithelial- 
like astrocytes to process-bearing cells induced by 
increased cAMP levels (Skaper et al 1989). PC, PE and 
Ptdlns had no effect on [Ca^^]^ in osteoblasts (Kawase and 
Suzuki 1988).
Evidence for the mode of action of PA being that of 
perturbing the membrane structure has come from work showing 
the effectiveness of endogenously-produced PA. The action 
of PL D, which cleaves membrane phospholipids to yield PA, 
has been shown to elevate [Ca ] in A431 cells (Moolenaar 
et al 1986) and to inhibit the changes in astrocyte cell 
morphology (Skaper et al 1989). PA produced within the cell, 
during PPI turnover, could be acting at the membrane to 
amplify the initial signal that activated PPI turnover.
The question remains, however, as to how PA affects PPI 
turnover and DNA synthesis in astrocytes? Is PA released 
from astrocytes to interact with specific cell surface 
receptors or is PA produced at the cell membrane to amplify 
the original signal that stimulated PPI breakdown? The 
following chapter details investigations into how PA might 
be working in astrocytes by studying the production of 
labelled PA in astrocytes and whether or not PA is released. 
The effect that blocking PA production has on PPI turnover 
and calcium mobilisation is also detailed.
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CHAPTER 4 IS PHOSPHATIDIC ACID RELEASED FROM ASTROCYTES 
FOLLOWING PPI TURNOVER?
4.1. INTRODUCTION
PA has been shown to have a growth factor-like action on 
astrocytes (Chapter 2), and to activate PPI turnover and 
mobilise calcium in astrocytes (Chapter 3). The possibility 
that endogenously formed PA may be able to act in a similar 
manner to exogenous PA has led to the proposal that PA may 
J30 involved in a positive feedback loop (Moolenaar et al 
1986 ). PA produced within the cell during PPI turnover 
could by acting on PL C to amplify the initial calcium- 
mobilising stimulus.
The mechanisms which have been proposed for the way in which 
PA could itself be activating the very system that -leads to 
its production can be thought of as falling into two 
categories. T h e  first category involves the direct or 
indirect interaction of PA with PL C and the second group 
are membrane effects which PA may be having that lead to the 
activation of PPI metabolism.
Evidence in support of an interaction between PA and PL C 
has come from work on 3T3 fibroblasts by Murayama and Ui 
(1987). Changes in the fatty acid composition of PA led to 
dramatic differences in the effect of PA in these cells and 
its effect was specific for PA and was not mimicked by other 
phospholipids. These points led these workers to propose 
the existence of specific PA binding sites on the
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extracellular surface of 3T3 cells. Rabbit platelets were 
found to be unresponsive to PA in this same study and this 
was attributed to the lack of such PA receptors on these 
cells. The interaction of PA with membrane-bound receptors 
could be a means by which PA brings about its effect since 
compounds which contain long chain fatty acids are too 
hydrophobic to insert into the membrane (Takai et al 1985). 
Jackowski and Rock (1989) have also suggested a direct 
activation of human platelet membrane PL C by PA.
Murayama and Ui (1987) also demonstrated that platelets 
released PA in response to thrombin, an agonist which is 
known to activate PPI breakdown. This increase in 
radioactivity associated with PA outside the cell led to the 
proposal that PA formed during PPI turnover is released from 
the cell to interact with receptors on the cell surface.
The other way in which PA may be having its effect is by its 
ability to change the cell membrane lipid bilayer structure. 
The lipid configuration (Irvine et al 1984a) and substrate 
presentation (Irvine et al 1985) in the membrane have been 
found to be important factors in controlling the activity of 
rat brain phosphodiesterase on Ptdlns(4,5)P2 * The activity 
of phosphodiesterase has been shown to be dependent on its 
phospholipid environment. Choline-containing phospholipids 
were found to have an inhibitory action on PL C while PA and 
PS were stimulatory (Irvine et al 1979a). Anionic 
phospholipids, such as PA, could effect the physical form of 
Ptdlns(4,5 )P2 making it more susceptible to phospholipase 
attack (Jackowski and Rock 1989). The fatty acid content of
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membranes also has a role to play in controlling PPI 
turnover (Irvine et al 1979b). Membrane perturbation from 
an organised tightly packed bilayer to an undefined 
structure has been reported to increase the hydrolysis of 
bilayer forming phospholipids by phospholipases (Dawson et 
al 1983). Unsaturated long chain fatty acid diacylglycerols 
were found to be more effective than those containing 
saturated short chain fatty acids at increasing 
phospholipase activity (Dawson et al 1984). PA containing 
palmitic stearic acid (C^g.g) fatty acids were
more effective than that containing decanoic acid (C q^ .q ) 
because they had a greater disruptive effect on the packing 
of phospholipids (Dawson et al 1980).
So the main question about how PA may be activating PPI 
turnover is whether it is produced and then released from 
the cell to interact with cell surface receptors or if once 
produced within the cell it has local effects on the cell 
membrane?
PA production during PPI turnover is by the action of the 
enzyme DG kinase on DG (Lapetina and Cuatrecasas 1979). DG 
kinase catalyses the phosphorylation of DG to PA using ATP 
and enables DG to be re-used in the Ptdlns(4,5)P2 cycle (Lin 
et al 1986). It is an efficient mechanism for terminating 
the action of the intracellular second messenger DG and 
controlling the concentration of DG. DG kinase has been 
reported to be present in both the soluble and membrane- 
bound fractions frcan pig brain (Kanoh et al 1989), the 
cytosol from bovine brain as well as in a number of other
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animal tissues (Lin et al 1986). A membrane-bound DG 
kinase has been isolated that specifically phosphorylates DG 
containing arachidonic acid (AA) (MacDonald et al 1988).
In order to assess the contribution of intracellularly 
formed PA in amplifying a calcium-mobilising stimulus a way 
of inhibiting its production is required. De Chaffoy de 
Courcelles et al (1985) found that the compound 6-[2-[4-[(4- 
fluorophenyl) phenylmethylene]-1-piperidinyl]ethyl]-7- 
methyl-5 H-thiazolo-[3,2-a] pyrimidin-5-one (R59 022) 
inhibited the ^^P labelling of PA and increased the levels 
of DG in response to thrombin in platelets and red blood 
cell membranes. R59 022 was found to be a specific 
inhibitor of DG kinase, it had no effect on Ptdlns or 
Ptdlns(4)P kinase. R59 022 was also reported to be a weak 
dopamine adrenergic, and histamine antagonist and
a strong serotonin 5^^ antagonist (de Chaff oy de Courcelles 
1985). R59 022 increased the levels of DG in neutrophils in 
response to agonists which act via PL C (Muid et al 1987).
An increase in DG-stimulated PKC activity was observed when 
R59 022 was added to fMet-Leu-Phe stimulated neutrophils and 
to thrombin-stimulated platelets (Muid et al 1987; Halenda 
and Rehm 1987).
Consequently there are a number of questions to be answered 
about the action of PA on astrocytes. Is PA formation seen 
in astrocytes in response to agonists linked to PPI 
turnover? Is this PA being released from astrocytes to then 
interact with cell surface receptors or is it having its 
effects within the cell at the membrane? Inositol
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phospholipids have been reported to be enriched in 
arachidonic acid (AA) compared to other phospholipids (Holub 
and Kuksis 1978; Dudley and Spector 1986). By labelling
o
astrocyte cultures with [ H]AA the production and release of 
labelled PA from labelled phospholipids in response to 
various agonists could be investigated.
If PA is involved in amplifying the initial calcium- 
mobilising stimulus in astrocytes, blocking its production 
by the presence of the DG kinase inhibitor R59 022 should 
have an effect on PPI turnover and Ca"*"^ mobilisation in 
response to agonists linked to PPI turnover in these cells. 
The effect of R59 022 on carbachol-stimulated PA production 
and IPs formation in astrocytes, and ^^Ca^^ efflux from 
astrocytes was therefore investigated.
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In the remainder of this chapter I shall present evidence to 
show that:
(i) Carbachol, noradrenaline and ATP increased the 
formation of labelled PA at the cell membrane but had no 
effect on the release of PA from astrocytes into the 
extracellular medium.
(ii) R59 022 inhibited astrocyte PA production and Ca 
mobilisation but had no effect on IPs formation.
++
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4.2. METHODS AND MATERIALS
4.2.1. Astrocyte cultures
Astrocyte-enriched cultures were prepared as described in 
Chapter 2, section 2.2.1..
4.2.2. Labelling of astrocyte phospholipids 
4.2.2.1. Incubations
Cells grown for 18-22 div in 6 well plates were labelled in 
GM containing 0.25yuiCiml  ^ [^ H]AA. After rinsing twice with 
PBS, incubations were carried out in fresh PBS for 1 minute 
with the appropriate agonist additions. The incubation 
medium was removed and, after washing twice with PBB, the 
cells were harvested. Lipids were extracted from both the 
incubation medium and the cells using 1ml CHClg:MeOH (1:2 
v/v). 0.3ml CHClg and 0.3ml H^O were added and after
thorough mixing the aqueous and organic phases were 
separated by centrifugation for 10 minutes at 180g at 4 C. 
Aliquots of the lipid and aqueous fractions of the 
incubation medium and the cells were taken for liquid 
scintillation counting.
4.2.2.2. Thin layer chromatography
The phospholipid composition of the lipid fraction of the 
incubation medium and cell samples was determined by thin 
layer chromatography according to the method of Tolbert et
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al (1980). Each sample was dried and spiked with a 
phospholipids standards mixture in CHClg containing lO^g of 
each of the following phospholipids: PA, Ptdlns, PS, PC and 
PE. Separation was performed on 20cm x 20cm silica gel 60F 
TLC plates by a mobile phase containing CHClg:MeOH: 28% 
NH^OHiH^O (65:35:3:2 v/v). After drying at room 
temperature, the plates were exposed to iodine vapour to 
visualise the phospholipids. The following values were 
obtained for the phospholipid standards: PA 0.09; Ptdlns
0.17; PS 0.19; PC 0.29 and PE 0.54. The spots were scraped 
into 0.5ml H^O and 8ml Emulsifier Safe scintillant added. 
The [^H]AA content of the phospholipids was then determined 
by liquid scintillation counting.
4.2.3. DG kinase inhibitor (R59 022) studies
A 50mM stock solution of R59 022 in ethanol was freshly 
prepared. This was diluted with 5mM HCl and then with H^O 
according to the method of de Chaffoy de Courcelles et al 
(1985) to give a final R59 022 concentration of lOyiM in 
each incubation. The cells were well washed to ensure that 
all growth medium was removed so that R59 022 was not 
absorbed by any plasma proteins that may have been present. 
R59 022 or the vehicle alone was added to the appropriate 
incubations. The effect of R59 022 on carbachol-stimulated 
PA production, PPI metabolism and ^^ Ca"'”’ efflux was 
investigated as outlined below.
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4.2.3.1, PA production
PA production in [^H]AA-labelled astrocytes in response to 
carbachol was determined as previously described in section
4.2.2. R59 022 or vehicle was added 5 minutes prior to
carbachol.
4.2.3.2. Phosphoinositide metabolism.
Cells grown for 18-22 div in 6 well plates were labelled for 
24h in GM containing 1yuCiml”l [ ] myo-inositol. The 
labelling medium was removed, the cells rinsed twice with 
PSS and incubated for 45 minutes in inositol-free PSS. The 
cells were again rinsed and pre-incubated for 5 minutes in 
fresh PSS containing R59 022 or vehicle. The appropriate 
carbachol addition was then made and the cells incubated for 
1 minute. The incubation was stopped by removing the 
incubation medium, rinsing twice with PSS and then adding 
1ml MeOH to each well (Pearce et al 1989). The cells from 
all 6 wells from each 6 well plate were combined and 
extracted with 3ml CHClg and 3ml deionised H2O. After 
mixing, the suspensions were centrifuged at 180g for 10 
minutes at 4°C to separate the aqueous and organic phases.
An aliquot of the CHClg layer was removed for liquid 
scintillation counting. An aliquot of the aqueous layer was 
diluted with H2O and the individual IPs were separated by 
anion exchange chromatography as described earlier in 
Chapter 3, section 3.2.2.3.
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4.2.3.3. Measurement of efflux,
^^Ca^^ efflux from pre-labelled astrocytes grown for 18-22 
div in 6 well plates in response to various concentrations 
of carbachol was determined as described in Chapter 3, 
section 3.2.3. R59 022 or vehicle was added at the same
time as the appropriate concentration of carbachol.
4.2.4. Statistical analysis
Statistical analysis was carried out using the Mann-Whitney 
U test. Various degrees of significance are indicated as 
follows: - * p level 0.05, ** 0.025, *** 0.01, **** 0.005.
4.2.5. Materials
The following phospholipid standards: the sodium salt of . 
Ptdlns from bovine brain and PS, PC and PE from bovine brain 
and iodine were obtained from Sigma. NH^ solution was 
obtained from BDH. PA was obtained from Serdary Research 
Labs., Canada. TLC plates were obtained from Merck. R59 022 
was obtained from Janssen Life Science Products, Wantage,
UK. [5,6,8,9,11,12,14,15-^H]arachidonic acid in ethanol 
(210Ci/mmol), myo-[2- H]inositol in water:ethanol 9:1 v/v 
(15Ci/mmol) and "^ c^alcium chloride in 0.15M HCl (15mCi/mg 
calcium) were obtained from Amersham International PLC.
177
4.3. RESULTS
4.3.1. [H]arachidonic acid labelling of astrocyte membrane
lipids.
o
The time course of [ H]AA labelling of astrocyte membrane 
lipids was investigated to determine the optimum labelling 
time for this series of experiments. Astrocyte-enriched 
cultures grown in 6 well plates were exposed to labelled GM 
for 1, 3, 20 or 24 hours. The labelling medium and the 
cells were extracted and the radioactivity present in the 
lipid and aqueous phase at each time point was determined by 
liquid scintillation counting. An increase in the 
incorporation of [^H]AA into cellular lipid was seen from 7% 
of the label applied at Ih to 44% at 24h (Figure 4.1a). A 
small increase was also seen in the radiolabel associated 
with the aqueous fraction of the cells but this only 
accounted for from 0.5% to 1.5% of the label applied over 
the same time period. The [^H]AA content of the labelling 
medium fell from 40% of the radiolabel applied at Ih to 17% 
and 18% at 20h and 24h respectively (Figure 4.1b). An 
increase in the radioactivity associated with the aqueous 
fraction of the labelling medium from 25% to 32% was also 
seen. A labelling time of 24h was chosen for further 
experiments because this gave the largest incorporation of 
[^H]AA into the lipids of these cultures.
[^H]AA is incorporated into a number of different lipid 
classes, for example, mono-, di- and tri-glycerides as well 
as phospholipids. The breakdown of these labelled lipids
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3
Figure 4.1. The time course of [ H]AA labelling of membrane 
lipids of astrocytes.
Astrocyte-enriched cultures were exposed to labelled GM for 
the times indicated. The radioactivity associated with the 
lipid and aqueous phase of the cells (a) and the labelling 
GM (b) was determined. Results are mean dpm +/- SEM (n =
3 wells from a 6 well plate).
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and the incorporation of radiolabel into aqueous products 
can be seen from Fig. 4.1., although the counts involved are 
very small compared to those incorporated into lipids. The 
TLC system employed in this study only determined the 
incorporation of [^H]AA into phospholipids and does not 
visualise incorporation into other lipids or radiolabelled 
aqueous products. This may explain the variation in 
recovery of radiolabel that is seen in this set of 
experiments.
4.3.2. The effect of carbachol, noradrenaline and ATP on PA 
production at the cell membrane of astrocytes.
Cultures were prelabelled with [^H]AA and then exposed to 
carbachol (ImM), noradrenaline ( 1 /AM) or ATP (lOO^M) for 1 
minute to determine whether PA was produced at the cell 
membrane. After incubation the cells were rinsed and then 
extracted. The phospholipid composition of an aliquot of 
the lipid fraction was determined by TLC. A representative 
diagram of the phospholipid separation achieved with this 
TLC system is shown in Figure 4.2. The dpm recovered in the 
PA fraction is expressed as a % of the total dpm recovered 
in the four phospholipid fractions, PA, Ptdlns/PS, PC and 
PE. A one minute incubation with carbachol, noradrenaline 
or ATP caused an increase in radiolabel associated with PA 
compared to control (Figure 4.3). Carbachol elicited a 118% 
of control increase in radiolabel associated with PA, and 
both noradrenaline and ATP caused a 129% of control 
increase.
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Figure 4.2. A representative diagram of the phospholipid 
separation achieved with the TLC system 
employing silica gel 60F TLC plates and mobile 
phase of the following composition: 
CHCl^:MeOH:28% NH^OHzH^O (130:70:6:4 v/v).
Key to samples applied to TLC plate
Sample number Phospholipid Source
1
2
3
4
5
6
7
8 
9
Sample solvent
PA
PA
PA
Ptdlns
PS
PC
PE
Sample solvent
Sigma
Lipid Products
Serdary
Sigma
Sigma
Sigma
Sigma
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Figure 4.3. The effect of agonists that activate PPI
turnover on PA production at the cell membrane 
of astrocytes.
Q
[ H]AA-labelled astrocytes were exposed to the appropriate 
agonist for 1 minute, the cells were then extracted and the 
phospholipid composition analysed by TLC. The PA content is 
expressed as % of control incubations (no agonist addition). 
Results are mean +/- SEM (n = 3 wells from a 6 well plate). 
Total dpm recovered in the four phospholipid fractions for 
control incubations = 68802, 59854, and 62116. The counts 
recovered from the TLC plate in the four phospholipid 
fractions expressed as a % of the total counts applied to 
the plate, the mean recovery, was 27%. dpm associated with 
PA in control incubations = 1117, 1155 and 1204.
Statistical analysis was carried out using the Mann-Whitney 
U test. Various degrees of statistical significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.01 
and **** 0.001. Each condition compared to control 
incubations (no agonist added).
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4.3.3. The effect of carbachol, noradrenaline and ATP on PA 
release from astrocytes.
[^H]AA-labelled cultures were exposed to the agonists for 1 
minute as in the previous experiment. Release of PA into 
the extracellular medium was investigated by combining the 
incubation medium from three samples for extraction. An
aliquot of the lipid fraction was then analysed by TLC. As
;
can be seen from Table 4.1 very low counts were seen in the 
lipid fraction of the incubation medium, and when analysed 
by TLC the amount of radioactivity recovered in the four 
different phospholipid fractions was not appreciably greater 
than background.
No PA release was seen from astrocytes in response to 
agonists that are known to stimulate PPI turnover in these 
cells, even though PA production at the cell membrane was 
seen in response to these agonists under the same 
conditions.
4.3.4. The effect of DG kinase inhibitor, R59 022, on PA
production at the cell membrane of astrocytes.
\
[^H]AA-labelled cultures were exposed to carbachol at 0.1 
and ImM for 1 minute in the absence and presence/of the DG 
kinase inhibitor R59 022. The cells were extracted and an 
aliquot of the lipid fraction analysed by TLC. Carbachol at 
0.1 and ImM caused increases of 30% and 15% respectively in 
the % of the total dpm recovered that was associated with PA 
when compared to control ( Figure 4. 4a and b ). The presence
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Table 4.1. The radioactivity associated with the lipid
fraction extracted from the combined incubation 
medium (IM) samples of agonist-stimulated 
astrocytes.
Sample IM Lipids 
dpm PA
dpm from TLC 
PI/PS PC PE
Control 2268
2268 
2304
Noradrenaline 2628
(1/tM)
Carbachol
(ImM)
ATP
(lOCJlM)
2232
2340
2412
2736
2448
2592
2412
3096
72
74
66
60
63 
62 
66
69 
60 
68
64
70
86
84
64 
58
65 
65 
56 
64
71 
88
72 
63
151
103
101
98
116
106
101
93
101
124
114
100
107
82
90
59 
75
60 
83 
69
69 
72
70 
64
Background samples from top and bottom of plates were 120, 
95, 36 and 35 dpm.
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Figure 4.4. The effect of DG kinase inhibitor, R59 022, on
carbachol-stimulated PA production.
[^H]AA-labelled astrocytes (18-22 div) were exposed to 
carbachol at O.lmM (a) or ImM (b) for 1 minute in the 
absence or presence of 10yUiM R59 022. PA content is 
expressed as % of the appropriate control incubation.
Results are mean +/- SEM (n = 3 wells from a 6 well plate). 
Total dpm recovered in (a) for control-R59 022 incubations = 
114589, 129385 and 103451, and for control+R59 022 
incubations = 126456, 121097 and 124830. The counts 
recovered from the TLC plate in the four phospholipid 
fractions expressed as a % of the total counts applied to 
the plate, the mean recovery, was 42%. dpm associated with 
PA in (a) for control-R59 022 incubations = 1521, 1481 and 
1587 and for control+R59 022 incubations = 1522, 1476 and 
1547. Total dpm recovered in (b) for control-R59 022 
incubations = 63301, 62296 and 89421, and for control+R59 
022 incubations = 76074, 73341 and 77336. Mean recovery was 
20%. dpm associated with PA in (b) for control-R59 022 
incubations = 656, 636 and 822 and for control+R59 022 
incubations = 954, 716 and 815. Statistical analysis was 
carried out using the Mann-Whitney U test. Various degrees 
of statistical significance are indicated as follows:- * p 
level 0.05, ** 0.025, *** 0.01 and **** 0.001. Each 
condition compared to appropriate control incubation (no 
carbachol added).
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of lOyuiM R59 022 inhibited PA formation in response to 
carbachol at 0.1 and ImM.
4.3.5. The effect of DG kinase inhibitor, R59 022, on 
carbachol-induced phosphoinositide metabolism.
[^H]inositol prelabelled astrocytes were exposed to 
carbachol at 0.1 and ImM for 1 minute in the absence or 
presence of 10yiM R59 022. The individual IPs formed in 
response to carbachol were determined. Increases were seen 
in the individual IPs formed in response to carbachol 
whether R59 022 was present or not (Table 4.2).
4.3.6. The effect of DG kinase inhibitor, R59 022, on 
carbachol - induced ^^Ca^^ efflux.
Astrocytes prelabelled with ^^ Ca'^ '*’ were exposed to various
concentrations of carbachol for 1 minute in the absence or
presence of R59 022. Increases in ^Ca efflux from
astrocytes were seen in response to carbachol at 1, 10, 100
and 1000 yitM. The addition of lOywM R59 022 reduced the
45effect that lOOOyOLM carbachol had on Ca++ efflux. The 
efflux in response to 1, 10 and 100/XM carbachol was 
unaffected by the presence of R59 022 (Table 4.3.).
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Table 4.2. The effect of DG kinase inhibitor, R59 022, on
carbachol-stimulated PPI turnover.
[^H]inositol prelabelled astrocytes (18-22 div) were exposed 
to carbachol at 0.1 or ImM for 1 minute in the absence or 
presence of lO/lM R59 022. Results are expressed as % of 
appropriate control incubations and are mean +/- SEM (n = 6 
using a 6 well plate from 2 experiments). Mean normalised 
dpm/IP fraction for carbachol at O.lmM incubations were as 
follows: InsP^ = 5177 dpm, InsP^ = 7101 dpm and InsP^ = 2383 
dpm for control-R59 022 incubations and InsP^ = 4977 dpm, 
InsP^ = 6369 dpm and InsP^ = 2163 dpm for control+R59 022 
incubations. Mean normalised dpm/IP fraction for carbachol 
at ImM incubations were as follows: InsP^ = 4704 dpm, InsP2 
= 5266 dpm and InsP^ = 1147 dpm for control-R59 022 
incubations and InsP^ = 4396 dpm, InsP2 = 4754 dpm and InsP^ 
= 1234 dpm for control+R59 022 incubations. Statistical 
analysis was carried out using the Mann-Whitney U test. 
Various degrees of statistical significance are indicated as 
follows:- * p level 0.05, **0.025, *** 0.01 and **** 0.001. 
Each condition compared to appropriate control incubation 
(no carbachol added).
% control
[Carb] +/- R59 022 InsP^ ^^®^3
O.lmM -R59 022 116+/- 4*** 114+/- 6 123+/-11
+R59 022 118+/- 6**** 125+/- 6*** 133+/-11**
ImM -R59 022 134+/- 8*** 108+/- 9 121+/- 4***
+R59 022 130+/- 5*** 134+/- 7*** 129+/- 5***
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Table 4.3. The effect of DG kinase inhibitor, R59 022, on
carbachol-stimulated ^^Ca^^ efflux.
Astrocytes preloaded with ^Ca were exposed to 1, 10, 100 
or 1000yU-M carbachol for 1 minute in the absence or presence 
of 10 jijM R59 022. The results are expressed as the % of the 
efflux sample prior to carbachol addition (control sample) 
and are mean +/- SEM (n = 6 wells frcan a 6 well plate frcxn 3 
experiments). Mean dpm in carbachol exposure fraction was 
134, 122, 136 and 195 dpm for 1, 10, 100 and lOOCjMM 
carbachol. Mean residual dpm in cells =476 dpm.
Statistical analysis was carried out using the Mann-Whitney 
U test. Various degrees of statistical significance are 
indicated as follows:- * p level 0.05, ** 0.025, *** 0.01 
and **** 0.001. Each +R59 022 incubation compared to 
appropriate -R59 022 incubation.
% control
[Carbachol] - R59 022 + R59 022
yOM
1 144 +/- 9 130 +/- 13
10 163 +/- 13 153 +/- 8
100 181 +/- 16 175 +/- 10
1000 201 +/- 11 165 +/- 9
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4.4. SUMMARY
(i) Carbachol, ATP and noradrenaline caused an increase in 
the formation of labelled PA at the cell membrane of
astrocytes but these agonists did not evoke PA release from 
these cells under the same conditions.
(ii) R59 022 inhibited carbachol-stimulated PA production 
at the astrocyte cell membrane and ^^Ca^^ efflux from 
astrocytes but had no effect on carbachol—induced IPs 
formation.
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4.5. DISCUSSION
PA formation in astrocytes was found in response to 
carbachol, noradrenaline and ATP, (this chapter) agonists 
that are known to be linked to PPI turnover in these cells 
(Pearce et al 1986; Pearce et al 1989). PA formation was 
assumed to be from the breakdown of inositol phospholipids 
to yield DG, which is then phosphorylated by DG kinase to 
give PA (Lapetina and Cuatrecasas 1979; Lapetina 1982). 
Enhanced incorporation of radiolabel into PA and Ptdlns has 
been seen in a number of other tissues which showed agonist- 
stimulated Ptdlns breakdown (Michell 1975; Berridge 1984; 
Fisher and Agranoff 1985; Hokin 1985). It is now known that 
the initial reaction involved in phosphoinositide metablism 
is Ptdlns(4,5)P^  hydrolysis. A decrease in the labelling of 
Ptdlns(4,5)P2 and an increase in that of Ptdlns and PA is 
seen ( Abdel-Latif 1986). PPI turnover has now been 
reported in all tissues in which Ptdlns turnover had 
previously been investigated. PPI turnover has been seen in 
nervous tissue including rat brain and guinea pig 
synaptosomes (Abdel-Latif 1986).
PA formation has been seen in other astroglial cells in 
response to agonists that activate inositol phospholipid 
turnover. Acetylcholine stimulation of [^^C]AA prelabelled 
C62B glioma cells led to an early increase in the amount of 
radiolabel associated with PA (De George et al 1986a), and 
the stimulation of rat astroglia cells by acetylcholine, 
noradrenaline, glutamate or histamine also led to an 
increase in the accumulation of PA (De George et al 1986b).
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Although PA formation was seen in astrocytes in response to 
carbachol, noradrenaline and ATP, no release of PA from 
astrocytes was seen in response to these same agonists under 
the same conditions. PA release from [ H]AA-labelled 
^thrombin-stimulated platelets into the extracellular medium 
was seen by Murayama and Ui (1987a), but in this same study 
no PA release was seen from 3T3 cells. These cell 
differences were used to support the hypothesis of the 
existence of specific PA receptors.
The release of PA from the cell to interact with a specific 
cell surface receptor for PA may however not be ^ necessary 
for PA to have'its effect. PA can be transported across the 
plasma membrane to interact with PL C by a pathway of lipid 
uptake involving lipid dephosphorylation and 
rephosphorylation steps and trsinsbilayer movement. PA has 
been shown to insert into the outer leaflet of the plasma 
membrane of Chinese hcimster fibroblasts (Pagano et al 1981). 
Here it is dephosphorylated to DG, which is rapidly 
translocated to the cytoplasmic face of the plasma membrane 
and then phosphorylated to PA (Pagano and Longmuir 1985).
If PA is not released but can still interact with membrane- 
bound PL C perhaps this is occurring by localised membrane 
perturbation. DG can increase the activity of liver 
phospholipase A^ , intestinal mucosal phospholipase A2 and 
human platelet Ptdlns phosphodiesterase on bilayer-forming 
phospholipids, for example, PC and Ptdlns, by perturbing the 
tightly-packed bilayer structure (Dawson et al 1983). This 
effect of DG depends on the presence of long Chain,
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unsaturated fatty acids for maximum activity (Dawson et al 
1984). DG and molecules of analogous structure, for example 
PA, could have a dramatic effect on cell membrane enzyme 
behaviour. The phospholipid environment of rat brain Ptdlns 
phosphodiesterase has also been shown to be very important.
PC was found to have an inhibitory effect on the hydrolysis 
of Ptdlns whereas PA and PS were stimulatory (Irvine et al 
1979a). These anionic phospholipids can act as activators by 
changing the physical form of the substrate in these assay 
systems and making the substrate more susceptible to enzymic 
attack (Dawson et al 1980). The lipid bilayer configuration 
and the substrate presentation have also been found to be 
important in controlling the activity of the 
phosphodiesterase from rat brain on Ptdlns(4,5)P2 (Irvine et 
al 1984a; 1985). Certain unsaturated fatty acids, for 
example oleic acid (C^S’l have been found to stimulate
PPI turnover in human platelets and human umbilical vein 
endothelial cells (Miles et al 1988; 1989). In contrast, 
the saturated fatty acid stearic acid (C^ q^.q) was found to 
have only a small effect and the trans isomer elaidic acid 
(C18 2 trans) was without effect. Exogenous fatty acids 
readily intercalate into the membrane and produce 
significant changes in the packing of lipid molecules. Cis- 
unsaturated fatty acids are taken up into more fluid 
membrane domains where membrane proteins are located. 
Unsaturated fatty acids may exert their effect by increasing 
membrane fluidity in the region of these membrane proteins. 
Trans-unsaturated or saturated fatty acids have little 
effect on membrane fluidity. The production of PA in the 
astrocyte cell membrane in response to agonists that
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stimulate PPI turnover may provide a local amplification 
system to sustain agonist-induced PPI turnover (Dawson et al 
1980). PA may be acting at the astrocyte cell membrane by 
affecting the membrane fluidity in the region of PL C.
If PA production is involved in the maintenance of agonist- 
induced PPI turnover the inhibition of its production should 
have an effect on inositol phosphate formation and calcium 
mobilisation. The specific DG kinase inhibitor R59 022 
inhibits PA formation in platelets in response to thrombin, 
which activates PPI turnover (De Chaffoy de Courcelles et al 
1985; Nunn and Watson 1987). Inhibition of PA formation in 
astrocytes in response to carbachol was seen in the presence 
of this compound.
Inhibition of PA production reduced the effect of carbachol 
on efflux but had no effect on carbachol-induced
inositol phosphate formation in astrocytes. This is in 
contrast to the results obtained by Nunn and Watson (1987) 
using R59 022 in thrombin-stimulated human platelets. The 
formation of inositol phosphates and the mobilisation of 
calcium was not affected by R59 022 in response to thrombin. 
In this present study and in that carried out by Nunn and 
Watson (1987) a simple anion exchange chromatography method 
was used for the separation of the individual inositol 
phosphates, which does not allow for the identification of 
the individual InsPg isomers, Ins(1,3,4)P^ and Ins(1,4,5)Pg. 
In the presence of the DG kinase inhibitor a reduction in 
the calcium mobilising isomer, Ins(l,4,5)P^, may have 
occurred that was not detectable in this or the previous
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study thus accounting for the effect of R59 022 on 
carbachol-induced calcium mobilisation. The lack of effect 
of R59 022 on thrombin-induced calcium mobilisation may 
reflect differences in the extent that different cell types 
use PA production to amplify agonist-induced PPI turnover.
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CHAPTER 5 GENERAL CONCLUSIONS AND FUTURE DIRECTIONS
The main aim of this thesis was to extend previous findings 
on the mitogenic effect of PA on astrocytes and to determine 
whether PA-stimulated PPI turnover could be responsible for 
this effect.
Chapter 2 showed that primary cultures of neonatal rat
cerebral cortical astrocytes provide a means of
investigating the proliferative action of a number of
mitogens. Astroglial proliferation was seen in response to
3insulin, PDGF and PA as measured by [ H]thymidine 
incorporation into DMA. Further investigations into the 
mitogenic action of PA using a DNA content assay showed that 
its effect was dependent upon a particular structural 
configuration for maximal effect.
In this study investigation of the proliferative response of 
cerebral cortex astrocytes was undertaken. Extensive work 
has not yet been performed on the effect of various growth 
factors, whether their action be linked to protein tyrosine 
kinase activation or increased PPI metabolism, on astrocytes 
from different CNS regions. However, PDGF, a growth factor 
whose action is thought to involve the stimulation of PPI 
turnover (Habenicht et al 1981), has been found to stimulate 
proliferation of rat cerebral astrocytes in this study and 
that of Besnard et al (1987) but to have no effect on 
astrocytes obtained from rat cerebellum (Kniss and Burry 
1988 ). These findings suggest that regional differences may 
exist in the response of astrocytes to growth factors whose
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action involves stimulated PPI turnover. Whether diferences 
are also seen in the response to PA of astrocytes from 
different brain regions could be investigated.
PA-stimulated PPI turnover in astrocytes was determined by 
the accumulation of labelled total inositol phosphates and 
individual inositol phosphates, as well as changes in the 
labelling of inositol phospholipids (Chapter 3). Increased 
efflux from astrocytes, a measure of intracellular 
calcium mobilisation, was also seen in response to PA. As 
was demonstrated for the mitogenic action of PA in Chapter 
2, all these effects were dependent on the presence of PA 
containing long chain fatty acids suggesting a specificity 
for PA of a similar structure to that of the endogenous 
molecule. This stimulation of PPI turnover by PA in 
astrocytes was not due to the presence of fibroblasts in 
these cultures.
Regional differences have been seen in the PPI turnover 
response of cerebral, cerebellar and spinal cord astrocytes 
to a number of neuropeptides (Cholewinski et al 1988). 
Astrocytes from all three regions were found to respond to 
bradykinin, eledoisin and neurokinin^ and cerebral and 
cerebellar astroglial cells responded to oxytocin and 
vasopressin. Only cerebral astrocytes responded to 
adrenocorticotrophic hormone, and neurokininand substance 
P elicited PPI turnover in spinal cord astrocytes only. 
Differences have also been seen in ^-adrenoreceptors, GFAP 
expression, glutamine synthetase activity and glutamate 
uptake in astrocyte cultures from different brain regions
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(Hansson 1988). These properties were also affected by the 
age of the animal at the time of astrocyte culture and the 
age of astrocytes used. Evidence from the study of 
Cholewinski et al (1988) mentioned above showed that 
bradykinin elicited the same PPI turnover response in 
astrocytes from the cerebral cortex, the cerebellum and the 
spinal cord regardless of the age of astrocytes in culture. 
These regional differences in astroglial properties could 
reflect astrocyte specialisations dependent upon varying 
neuronal requirements. Obviously it would be worth 
determining whether PA elicited different PPI turnover 
responses in astrocytes from different CNS regions.
A direct link between PA-stimulated PPI turnover and PA- 
induced cell division in astrocytes has not been established 
in this study but a correlation between PA's mitogenic 
stimulation of astrocytes and PA-induced increased PPI 
hydrolysis in these cells was demonstrated. A causal link 
between PA-stimulated mitogenesis and PPI turnover could be 
established by investigating the effect of activating the 
separate branches of the PPI turnover signal transduction 
pathway. Activation of PKC was found to be involved in the 
mitogenic action of PA on astrocytes since PKC depletion by
prolonged exposure to phorbol ester, a direct activator of
\
PKC (Castagna et al 1982), abolished this effect of PA 
(Chapter 2). Another way of investigating the role of PKC 
activation in PA-induced astroglial proliferation would be 
to use the DG kinase inhibitor, R59 022, to increase the 
levels of DG, the endogenous activator of PKC. In Swiss 3T3 
cells potentiation of PDGF- and bombesin-induced DNA
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synthesis and increased PKC activity has been demonstrated 
in the presence of R59 022 (Morris et al 1988). Further 
evidence for a role for PKC activation in astroglial 
proliferation comes from work by Murphy et al (1987) and 
Bhat (1989) which showed that phorbol ester was mitogenic 
for astrocytes. Short term activation of PKC with phorbol 
ester results in inhibition of agonist-induced PPI turnover 
and calcium mobilisation (Berridge 1987b). Investigation of 
the effect of this negative feedback mechanism on PA-induced 
mitogenesis could provide further evidence of a link between 
stimulated PPI turnover and mitogenesis in response to PA. 
Unfortunately, direct activation of the calcium mobilising 
branch of the PPI breakdown signal transduction pathway by 
employing ionophores has disadvantages in mitogenesis 
experiments. The long incubation times which are used have a 
(detrimental effect on the cells under investigation, for 
example, A23187 has been found to be toxic for astrocytes 
after 48h incubation (Fawthrop and Evans 1987; Murphy et al 
unpubl.).
The direct involvement of PPI hydrolysis in PA-induced 
mitogenesis could also be demonstrated by inhibition of PL 
C, the enzyme responsible for Ptdlns(4,5)P2 hydrolysis. 
Neomycin has been proposed to inhibit PL C (Cockcroft and 
Gomperts 1985) and it has been found to inhibit thrombin- 
induced mitogenesis and Ins(1,4,5) Pg production in 
platelets (Carney et al 1985). The specificity of neomycin 
however remains to be established.
A direct requirement of Ptdlns(4,5)P2 hydrolysis for the
202
action of PDGF and bombesin on NIH 3T3 cells has recently 
been demonstrated by the use of a specific antibody to 
PtdIns(4,5)P2 which inhibited PDGF- and bombesin-induced 
mitogenesis (Matuoka et al 1988). The necessity of 
PtdIns(4,5)P2 breakdown for PA-induced mitogenesis could be 
elucidated using similar antibody studies.
The first evidence for a physical association between a 
component of the PPI breakdown pathway and activated protein 
tyrosine kinases has recently emerged. A Ptdlns kinase that 
phosphorylates the 3' hydroxyl of Ptdlns to yield Ptdlns(3)P 
has been identified (Whitman et al 1988). Novel 3’ 
phosphorylated phosphoinositides may be involved in a 
separate signalling pathway used exclusively by mitogenic 
agents. The action of PA on 3' phosphorylated 
phosphoinositides could also provide evidence of a link 
between PA-induced mitogenesis and PPI turnover.
The possibility that endogenous PA, formed during receptor- 
stimulated PPI breakdown could act in a similar manner to 
exogenously applied PA, to amplify the initial calcium 
mobilising stimulus was investigated in Chapter 4. PA was 
found to be produced at the cell membrane in response to 
agonists known to be linked to PPI turnover in astrocytes, 
but was not released from the cell and therefore must have 
its effect locally at the membrane. The inhibition of PA 
production by the DG kinase inhibitor, R59 022, inhibited 
carbachol-induced intracellular calcium mobilisation but had 
no effect on PPI turnover in response to carbachol.
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A role for PA in amplifying extracellular calcium mobilising 
signals was first suggested by Dawson et al (1980) and 
interest in PA as an intracellular messenger has recently 
been renewed in the light of PA's growth factor-like action 
in a number of fibroblast cell types (Moolenaar et al 1986; 
Siegmann 1987; Yu et al 1988). Preliminary investigations 
into the way in which PA may play a role in a local 
amplification system suggested that PA produced at the cell 
membrane interacted with PL C to sustain receptor-activated 
PPI turnover (Chapter 4) or that it may act by altering the 
membrane in such a way as to make Ptdlns(4,5)P2 more 
suspectible to atack by PL C. Much more information is 
required before a model of how PA actually produces its 
effect at the cell membrane can be postulated.
Further investigations of the basic mechanism of action of 
PA on PPI hydrolysis could involve the determination of 
whether G proteins are involved. G proteins have been found 
to couple surface receptors with PL C in a number of 
different cells (Cockcroft and Gomperts 1985; Gonzales and 
Crews 1985; Hepler and Harden 1986). A G protein has been 
implicated in the coupling of astrocyte muscarinic 
cholinergic receptors in astrocytes to PL C. Using an 
astocyte membrane preparation an enhancement of the PPI 
hydrolysis elicited by a stable analogue of GTP was seen in 
the presence of carbachol (Pearce et al 1988). The 
involvement of a G protein in PA's action on PPI turnover 
could be determined by investigating if GTP was required for 
the stimulation of PPI metabolism by PA in astrocyte 
membrane preparations and whether PA can enhance the PPI
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hydrolysis elicited by stable analogues of GTP or AIF^ , 
which are known to stimulate PL C (Taylor and Merritt 
1986).
Phorbol ester-induced down regulation of astroglial 
muscarinic cholinergic and oC ~^adrenergic receptors linked to 
PPI breakdown has been reported (Pearce et al 1988). Short 
term exposure to phorbol esters inhibits agonist-induced PPI 
turnover. Could PA-induced PPI hydrolysis also be regulated 
in a similar manner?
Evidence for a role for PA in intracellular signalling has 
also come from agonist-induced PC turnover. Signal 
transduction may also occur via PC cycles ( for review see 
Pelech and Vance 1989). PC may be hydrolysed in response to 
a number of stimuli in a number of cell types to yield 
metabolites that had generally been accepted to be products 
of phosphoinositide breakdown. Changes in the levels of PA 
precede those of DG in vasopressin—stimulated rat 
hepatocytes as well as in f-methiony 1-leucyl-phenylalanine- 
stimulated neutrophils (Bocckino et al 1987; Agwu et al 
1989). These workers proposed that PA was not formed by PL 
C action on phosphoinositides but by the action of PL D on 
PC, with the subsequent formation of DG by PA 
phosphohydrolase. Cabot et al (1988) using a rat embryo 
cell line REF52 and vascular smooth muscle cells suggested 
that vasopressin-induced PA formation was due to the action 
of a Ptdlns-specific PL D. A PL D mechanism for the 
production of PA has also been proposed for the action of 
carbachol, histamine and substance P on guinea pig small
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intestine longitudinal smooth muscle and that of A23187 on 
neutrophils, since no correlation was seen between PA 
formation and PPI turnover in either of these studies 
(Mallows and Bolton 1987; Balsinde et al 1988). PC 
hydrolysis has also been attributed to the action of a PC- 
specific PL C in vasopressin-stimulated rat hepatocytes and 
purinergic-stimulated rat liver plasma membranes (Besterman 
et al 1985; Irving and Exton 1987).
q
In Chapter 4 [ H]AA labelling was used as a means of 
determining PA production. Phosphoinositides are 
particularly enriched in AA and so this method enabled PA 
production from predominantly phosphoinositides to be 
studied. In view of the alternative sources of PA outlined 
above other methods for the determination of PA from other 
phospholipids would need to be utilised to study overall PA 
production. Cabot et al (1988) have used the preferential 
[^H]myristic acid labelling of PC to look at PA formation 
from this phospholipid and a sensitive HPLC and fluorimetric 
detection method was used to determine PA levels by Yamada 
et al (1988).
The relative importance of these two pathways for PA 
production, that using PL C and that employing PL D, may be 
dependent on the cell type and agonist under investigation. 
PA may play an important role in the early stages of 
stimulus-response, coupling, for example, PA from PC 
hydrolysis, as well as phosphoinositides, may act on PL C to 
stimulate PPI breakdown. Cell-specific responses to a 
particular agonist may therefore reflect the ability of a
206
particular agonist receptor to interact with a certain 
phospholipase enzyme. The fatty acid and polar headgroup 
composition of the membrane phospholipids in the region of 
the agonist receptor may also influence which particular 
pathway is utilised. The possibility of PA being produced 
from different phospholipid sources also implies that DG of 
differing fatty acid compositions could be produced which 
could activate the different PKC isoezymes that have been 
identified (Nishizuka 1988). The intracellular role of the 
phospholipid PA warrants further investigation in view of 
the emerging complex interactions of agonist-induced 
phospholipid cycles.
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